User Image Cart Icon 0 Search Image

Cd36

  1. CD36 and macrophages in atherosclerosis
  2. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism
  3. CD36: a critical anti-angiogenic receptor
  4. Hepatic fatty acid transporter CD36 is a common target of LXR, PXR, and PPARγ in promoting steatosis
  5. CD36 is a receptor for oxidized low density lipoprotein
  6. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells
  7. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
  8. CD36 is a sensor of diacylglycerides
  9. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36
  10. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic …
  11. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity
  12. Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients
  13. CD36 involvement in orosensory detection of dietary lipids, spontaneous fat preference, and digestive secretions
  14. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species
  15. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer’s disease brains and can mediate production of reactive oxygen species in response to β …
  16. Scavenger receptors class AI/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in …
  17. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism
  18. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice
  19. Expression cloning of SR-BI, a CD36-related class B scavenger receptor.
  20. CD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestine
  21. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation
  22. Malaria susceptibility and CD36 mutation
  23. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36
  24. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation
  25. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL
  26. Identification of CD36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats
  27. … membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36.
  28. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines: evidence implicating the lipid moiety of the lipoprotein as the …
  29. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype
  30. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects.
  31. A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria
  32. CD36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products
  33. Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro.
  34. Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion …
  35. Regulation of fatty acid transport by fatty acid translocase/CD36
  36. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine
  37. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-γ
  38. CD36 mediates the innate host response to β-amyloid
  39. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain
  40. … accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36
  41. CD36: implications in cardiovascular disease
  42. An essential role for a CD36-related receptor in pheromone detection in Drosophila
  43. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal
  44. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis.
  45. CD36 deficiency associated with insulin resistance
  46. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice
  47. Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes
  48. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes
  49. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis.
  50. CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice
  51. A link between diabetes and atherosclerosis: glucose regulates expression of CD36 at the level of translation
  52. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice
  53. Molecular Basis of Sequestration in Severe and Uncomplicated Plasmodium falciparum Malaria: Differential Adhesion of Infected Erythrocytes to CD36 and ICAM-l
  54. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding
  55. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma …
  56. CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood
  57. Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor AI/II
  58. Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family.
  59. CD36 deficiency rescues lipotoxic cardiomyopathy
  60. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling
  61. CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium
  62. A CD36-initiated signaling cascade mediates inflammatory effects of β-amyloid
  63. Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum–parasitized erythrocytes: a role for CD36 in malarial clearance
  64. Oxidized phosphatidylserine–CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells
  65. Role of CD36 in membrane transport of long-chain fatty acids
  66. Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy
  67. Oxidized LDL–induced NF-κB activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient …
  68. The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia
  69. Reversible binding of long-chain fatty acids to purified FAT, the adipose CD36 homolog
  70. Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36
  71. A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes.
  72. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (αvβ3)
  73. Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle
  74. Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting
  75. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells
  76. CD36 is palmitoylated on both N-and C-terminal cytoplasmic tails
  77. Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet.
  78. Increased CD36 protein as a response to defective insulin signaling in macrophages
  79. FAT/CD36-mediated long-chain fatty acid uptake in adipocytes requires plasma membrane rafts
  80. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators
  81. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids
  82. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta
  83. Opposite regulation of CD36 ubiquitination by fatty acids and insulin: effects on fatty acid uptake
  84. Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane
  85. Identification of a Region of PfEMP1 That Mediates Adherence of Plasmodium falciparum Infected Erythrocytes to CD36: Conserved Function With Variant Sequence
  86. Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis
  87. Differential roles of CD36 and αvβ5 integrin in photoreceptor phagocytosis by the retinal pigment epithelium
  88. Association and coexpression of fatty‐acid‐binding protein and glycoprotein CD36 in the bovine mammary gland
  89. A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36
  90. Transforming growth factor-β1 (TGF-β1) and TGF-β2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase …
  91. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes
  92. HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in …
  93. Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification
  94. Drosophila RNAi Screen Reveals CD36 Family Member Required for Mycobacterial Infection
  95. AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36
  96. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein …
  97. Mapping and characterization of the binding site for specific oxidized phospholipids and oxidized low density lipoprotein of scavenger receptor CD36
  98. Platelet CD36 mediates interactions with endothelial cell–derived microparticles and contributes to thrombosis in mice
  99. Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain
  100. CD36 Mediates the Phagocytosis of Plasmodium falciparum–Infected Erythrocytes by Rodent Macrophages
  101. Structural organization of the gene for human CD36 glycoprotein.
  102. Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats
  103. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic …
  104. Caveolin-1 is required for fatty acid translocase (FAT/CD36) localization and function at the plasma membrane of mouse embryonic fibroblasts
  105. … VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von …
  106. Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis
  107. Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration
  108. Molecular basis of human CD36 gene mutations
  109. The gustatory pathway is involved in CD36‐mediated orosensory perception of long‐chain fatty acids in the mouse
  110. Pathophysiology of human genetic CD36 deficiency
  111. A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein
  112. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol
  113. Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets.
  114. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
  115. A role for CD36 in the regulation of dendritic cell function
  116. CD36, serves as a receptor for advanced glycation endproducts (AGE)
  117. New insights into long-chain fatty acid uptake by heart muscle: a crucial role for fatty acid translocase/CD36
  118. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion
  119. Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm
  120. Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling
  121. Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1
  122. Rolling and stationary cytoadhesion of red blood cells parasitized by Plasmodium falciparum: separate roles for ICAM‐1, CD36 and thrombospondin
  123. Expression of the CD36 homolog (FAT) in fibroblast cells: effects on fatty acid transport.
  124. Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations
  125. Role of CD36 in membrane transport and utilization of long-chain fatty acids by different tissues
  126. … of rat alveolar macrophage-derived latent transforming growth factor β-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36
  127. Gut expression and regulation of FAT/CD36: possible role in fatty acid transport in rat enterocytes
  128. CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPARδ/β-mediated adaptation to metabolic stress
  129. Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake
  130. Polysialic acid in human milk: CD36 is a new member of mammalian polysialic acid-containing glycoprotein
  131. CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine
  132. Transgenic rescue of defective CD36 ameliorates insulin resistance in spontaneously hypertensive rats
  133. α-Tocopherol decreases CD36 expression in human monocyte-derived macrophages
  134. Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes
  135. Localization of the lipid receptors CD36 and CLA-1/SR-BI in the human gastrointestinal tract: towards the identification of receptors mediating the intestinal absorption …
  136. … -derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and …
  137. Antiatherogenic effect of Pistacia lentiscus via GSH restoration and downregulation of CD36 mRNA expression
  138. CD36 gene deletion reduces fat preference and intake but not post-oral fat conditioning in mice
  139. Widespread functional specialization of Plasmodium falciparum erythrocyte membrane protein 1 family members to bind CD36 analysed across a parasite genome
  140. CD36 mediates both cellular uptake of very long chain fatty acids and their intestinal absorption in mice
  141. Intercellular adhesion molecule-1 and CD36 synergize to mediate adherence of Plasmodium falciparum-infected erythrocytes to cultured human microvascular …
  142. Interaction of S100A8/S100A9− arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells
  143. A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians
  144. Linoleic acid induces calcium signaling, Src kinase phosphorylation, and neurotransmitter release in mouse CD36-positive gustatory cells
  145. Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia
  146. Antennal SNMPs (sensory neuron membrane proteins) of lepidoptera define a unique family of invertebrate CD36‐like proteins
  147. Troglitazone inhibits atherosclerosis in apolipoprotein E–knockout mice: pleiotropic effects on CD36 expression and HDL
  148. Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: a novel marker of insulin resistance
  149. Light-induced oxidation of photoreceptor outer segment phospholipids generates ligands for CD36-mediated phagocytosis by retinal pigment epithelium: a potential …
  150. Scavenger receptor CD36: its expression, regulation, and role in the pathogenesis of atherosclerosis. Part I
  151. Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling; role of CD14 and CD36
  152. Molecular basis of CD36 deficiency. Evidence that a 478C–> T substitution (proline90–> serine) in CD36 cDNA accounts for CD36 deficiency.
  153. Oxidized LDL increases and Interferon-γ decreases expression of CD36 in human monocyte–derived macrophages
  154. Isoimmunization against CD36 (glycoprotein IV): description of four cases of neonatal isoimmune thrombocytopenia and brief review of the literature
  155. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy?
  156. The SNMP/CD36 gene family in Diptera, Hymenoptera and Coleoptera: Drosophila melanogaster, D. pseudoobscura, Anopheles gambiae, Aedes aegypti …
  157. Snmp-1, a novel membrane protein of olfactory neurons of the silk moth Antheraea polyphemus with homology to the CD36 family of membrane proteins
  158. Fibrillar amyloid protein present in atheroma activates CD36 signal transduction
  159. Fatty Acid Translocase (FAT/CD36) Is Localized on Insulin-Containing Granules in Human Pancreatic β-Cells and Mediates Fatty Acid Effects on Insulin Secretion
  160. Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm
  161. Insulin sensitivity and lipid metabolism in human CD36 deficiency
  162. Role of protein CD36 as a significant risk factor of cardiovascular diseases
  163. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E‐deficient mice from developing atherosclerotic lesions
  164. Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from …
  165. Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin
  166. Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT/CD36)-mediated cellular fatty acid uptake
  167. FoxO1 stimulates fatty acid uptake and oxidation in muscle cells through CD36-dependent and-independent mechanisms
  168. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women
  169. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin-and AICAR-stimulated fatty acid metabolism
  170. Peroxisome proliferator-activated receptor γ-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes …
  171. CD36 expression contributes to age-induced cardiomyopathy in mice
  172. Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL)
  173. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein
  174. Evidence for concerted action of FAT/CD36 and FABPpm to increase fatty acid transport across the plasma membrane
  175. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast
  176. CD36-facilitated fatty acid uptake inhibits leptin production and signaling in adipose tissue
  177. Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study
  178. Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview
  179. Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor.
  180. Regulation of FAT/CD36 gene expression: further evidence in support of a role of the protein in fatty acid binding/transport
  181. CD36 and atherosclerosis
  182. Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester …
  183. Coimmunoprecipitation of FAT/CD36 and CPT I in skeletal muscle increases proportionally with fat oxidation after endurance exercise training
  184. CD36 signals to the actin cytoskeleton and regulates microglial migration via a p130Cas complex
  185. Expression of CD36 in macrophages and atherosclerosis the role of lipid regulation of PPARγ signaling
  186. Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia
  187. Nuclear factor-κB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion
  188. A non-sense mutation in CD36 gene is associated with protection from severe malaria
  189. Isolation and characterization of platelet glycoprotein IV (CD36)
  190. Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36
  191. Macrophage recognition and phagocytosis of apoptotic fibroblasts is critically dependent on fibroblast-derived thrombospondin 1 and CD36
  192. Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability
  193. CD36 deficiency is frequent and can cause platelet immunization in Africans
  194. A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: NAKa platelets lack detectable GPIV (CD36)
  195. Resistin increases lipid accumulation and CD36 expression in human macrophages
  196. CD36 and malaria: friends or foes?
  197. Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated …
  198. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea
  199. Binding of anionic phospholipids to retinal pigment epithelium may be mediated by the scavenger receptor CD36
  200. Nrf2 regulates the alternative first exons of CD36 in macrophages through specific antioxidant response elements
  201. Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor α …
  202. Apoptosis induced by oxidized low density lipoprotein in human monocyte‐derived macrophages involves CD36 and activation of caspase‐3
  203. IL‐13 induces expression of CD36 in human monocytes through PPARγ activation
  204. Minimally oxidized low-density lipoprotein increases expression of scavenger receptor A, CD36, and macrosialin in resident mouse peritoneal macrophages
  205. Uptake of long chain fatty acids is regulated by dynamic interaction of FAT/CD36 with cholesterol/sphingolipid enriched microdomains (lipid rafts)
  206. The CD36, CLA-1 (CD36L1), and LIMPII (CD36L2) gene family: cellular distribution, chromosomal location, and genetic evolution
  207. CD36 deficiency in mice impairs lipoprotein lipase-mediated triglyceride clearance
  208. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes
  209. Lipopolysaccharides from atherosclerosis‐associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2‐induced …
  210. Cellular cholesterol regulates expression of the macrophage type B scavenger receptor, CD36
  211. Phosphatidylserine receptors: role of CD36 in binding of anionic phospholipid vesicles to monocytic cells
  212. Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A
  213. Antagonistic effects of oxidized low density lipoprotein and α-Tocopherol on CD36 scavenger receptor expression in monocytes: involvement of protein kinase b and …
  214. Transcriptional regulation of fatty acid translocase/CD36 expression by CCAAT/enhancer-binding protein α
  215. CD36 associates with CD9 and integrins on human blood platelets
  216. … GST/CD36 Fusion Proteins Define a Thrombospondin Binding Domain: EVIDENCE FOR A SINGLE CALCIUM-DEPENDENT BINDING SITE ON CD36 (∗)
  217. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia
  218. Expression of thrombospondin-1 and its receptor CD36 in human osteoarthritic cartilage
  219. Gene encoding the collagen type I and thrombospondin receptor CD36 is located on chromosome 7q11. 2
  220. Identification of renal CD36 as a determinant of blood pressure and risk for hypertension
  221. CD36-Mediated Nonopsonic Phagocytosis of Erythrocytes Infected with Stage I and IIA Gametocytes of Plasmodium falciparum
  222. CD36 is one of important receptors promoting renal tubular injury by advanced oxidation protein products
  223. CD36 in atherosclerosis: the role of a class B macrophage scavenger receptor
  224. Unsaturated fatty acids and their oxidation products stimulate CD36 gene expression in human macrophages
  225. Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids
  226. Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages
  227. Continued inhibition of atherosclerotic lesion development in long term Western diet fed CD36/apoE mice
  228. CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction.
  229. CD36 is a receptor for oxidized high density lipoprotein: implications for the development of atherosclerosis
  230. Activation of monocytes and platelets by monoclonal antibodies or malaria-infected erythrocytes binding to the CD36 surface receptor in vitro.
  231. … long-chain fatty acid transport in human myocardium: complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 …
  232. Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with Type 2 diabetes mellitus and insulin resistance
  233. The integrins α3β1 and α6β1 physically and functionally associate with CD36 in human melanoma cells: requirement for the extracellular domain of CD36
  234. CD36 may determine our desire for dietary fats
  235. Parasite burden and CD36-mediated sequestration are determinants of acute lung injury in an experimental malaria model
  236. Expression of macrophage (Mφ) scavenger receptor, CD36, in cultured human aortic smooth muscle cells in association with expression of peroxisome proliferator …
  237. The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36
  238. CD36-mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes
  239. Identification of CD36 molecular features required for its in vitro angiostatic activity
  240. CD36 in myocytes channels fatty acids to a lipase-accessible triglyceride pool that is related to cell lipid and insulin responsiveness
  241. Lovastatin reduces expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells
  242. src‐related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells
  243. TGF-β1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages
  244. Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI
  245. Biochemical isolation of a membrane microdomain from resting platelets highly enriched in the plasma membrane glycoprotein CD36
  246. Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction
  247. Vitamin E inhibits CD36 scavenger receptor expression in hypercholesterolemic rabbits
  248. CD36 polymorphism is associated with protection from cerebral malaria
  249. Normal human erythrocytes express CD36, an adhesion molecule of monocytes, platelets, and endothelial cells
  250. Insulin-induced translocation of CD36 to the plasma membrane is reversible and shows similarity to that of GLUT4
  251. Identification of a domain (155–183) on CD36 implicated in the phagocytosis of apoptotic neutrophils
  252. CD36: a multiligand molecule.
  253. Downregulated CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10
  254. Posttransfusion purpura‐like syndrome associated with CD36 (Naka) isoimmunization
  255. Structure‐Function of CD36 and Evidence for its Role in Facilitating Membrane Fatty Acid Transport
  256. Anti‐CD36 antibodies in thrombotic thrombocytopenic purpura
  257. Disruption of CD36 impairs cytokine response to Plasmodium falciparum glycosylphosphatidylinositol and confers susceptibility to severe and fatal malaria in vivo
  258. PPARγ activation induces CD36 expression and stimulates foam cell like changes in rVSMCs
  259. Assignment of disulfide bridges in bovine CD36
  260. Pitavastatin downregulates expression of the macrophage type B scavenger receptor, CD36
  261. … CD36 expression in human monocytes, an effect strengthened when combined with PPAR-γ ligands Putative contribution of Rho GTPases in statin-induced CD36 …
  262. Intestinal lipid absorption is not affected in CD36 deficient mice
  263. CD36 Peptides That Block Cytoadherence Define the CD36 Binding Region for Plasmodium falciparum-Infected Erythrocytes
  264. Sequestrin, a CD36 recognition protein on Plasmodium falciparum malaria-infected erythrocytes identified by anti-idiotype antibodies.
  265. Activation of CD36 inhibits and induces regression of inflammatory corneal neovascularization
  266. CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury
  267. Involvement of phosphatidylserine, αvβ3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages
  268. Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone …
  269. CD36 is differentially expressed on B cell subsets during development and in responses to antigen
  270. Ultrastructural demonstration of CD36 in the alpha-granule membrane of human platelets and megakaryocytes
  271. Analysis of adhesive domains from the A4VAR Plasmodium falciparum erythrocyte membrane protein-1 identifies a CD36 binding domain
  272. Human glomerular mesangial cell phagocytosis of apoptotic neutrophils: mediation by a novel CD36-independent vitronectin receptor/thrombospondin recognition …
  273. Genetics of CD36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension
  274. … , sequencing, and expression of a cDNA encoding rat LIMP II, a novel 74-kDa lysosomal membrane protein related to the surface adhesion protein CD36.
  275. CD36 overexpression in human brain correlates with β-amyloid deposition but not with Alzheimer’s disease
  276. CD36 deficiency leads to choroidal involution via COX2 down-regulation in rodents
  277. Role of scavenger receptors SR-BI and CD36 in selective sterol uptake in the small intestine
  278. Oxidized low-density lipoproteins bind to the scavenger receptor, CD36, of hepatic stellate cells and stimulate extracellular matrix synthesis
  279. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages …
  280. A novel role for CD36 in VLDL-enhanced platelet activation
  281. Identification of molecular defects in a subject with type I CD36 deficiency
  282. Sarcolemmal FAT/CD36 in human skeletal muscle colocalizes with caveolin-3 and is more abundant in type 1 than in type 2 fibers
  283. clag9: A cytoadherence gene in Plasmodium falciparum essential for binding of parasitized erythrocytes to CD36
  284. Peroxisome‐proliferator‐activated‐receptor gamma (PPARγ) independent induction of CD36 in THP‐1 monocytes by retinoic acid
  285. ERK1/2 inhibition prevents contraction‐induced increase in plasma membrane FAT/CD36 content and FA uptake in rodent muscle
  286. CD36 is differentially expressed by CD8+ splenic dendritic cells but is not required for cross-presentation in vivo
  287. Synergically increased expression of CD36, CLA-1 and CD68, but not of SR-A and LOX-1, with the progression to foam cells from macrophages
  288. PAS IV, an integral membrane protein of mammary epithelial cells, is related to platelet and endothelial cell CD36 (GP IV)
  289. … genetic abnormalities in type I CD36 deficiency in Japan: identification and cell biological characterization of two novel mutations that cause CD36 deficiency in man
  290. Estradiol down-regulates CD36 expression in human breast cancer cells
  291. Involvement of CD36 on erythrocytes as a rosetting receptor for Plasmodium falciparum-infected erythrocytes
  292. Phenotype-genotype correlation in CD36 deficiency types I and II
  293. Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha …
  294. Lipoprotein abnormalities in human genetic CD36 deficiency associated with insulin resistance and abnormal fatty acid metabolism
  295. A CD36 nonsense mutation associated with insulin resistance and familial type 2 diabetes
  296. Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein
  297. Thrombospondin-1 induces apoptosis in primary leukemia and cell lines mediated by CD36 and Caspase-3
  298. Plasmodium chabaudi-Infected Erythrocytes Adhere to CD36 and Bind to Microvascular Endothelial Cells in an Organ-Specific Way
  299. Synthesis, Processing, and Intracellular Transport of CD36 during Monocytic Differentiation (∗)
  300. CD36/fatty acid translocase in rats: distribution, isolation from hepatocytes, and comparison with the scavenger receptor SR-B1
  301. Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle
  302. Electrostimulation enhances FAT/CD36-mediated long-chain fatty acid uptake by isolated rat cardiac myocytes
  303. CD36-dependent adhesion and knob expression of the transmission stages of Plasmodium falciparum is stage-specific
  304. Fatty acid oxidation in cardiac and skeletal muscle mitochondria is unaffected by deletion of CD36
  305. Identification of a CD36-related thrombospondin 1–binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1–specific inhibitory factors in human …
  306. Human CD36 deficiency is associated with elevation in low‐density lipoprotein‐cholesterol
  307. Adipocytes recognize and degrade oxidized low density lipoprotein through CD36
  308. Aggregated ursolic acid, a natural triterpenoid, induces IL-1β release from murine peritoneal macrophages: role of CD36
  309. Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages
  310. Vascular biology of CD36: roles of this new adhesion molecule family in different disease states
  311. Female-predominant expression of fatty acid translocase/CD36 in rat and human liver
  312. Fatty acid transport and FAT/CD36 are increased in red but not in white skeletal muscle of ZDF rats
  313. Myocardial CD36 expression and fatty acid accumulation in patients with type I and II CD36 deficiency
  314. Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice
  315. Ectoprotein kinase-mediated phosphorylation of FAT/CD36 regulates palmitate uptake by human platelets
  316. CD36 or αvβ3 and αvβ5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8α+ murine dendritic cells
  317. Changes in FAT/CD36, UCP2, UCP3 and GLUT4 gene expression during lipid infusion in rat skeletal and heart muscle
  318. Genetic study of the CD36 gene in a French diabetic population
  319. CD36 is a novel and potential anti‐fibrogenic target in albumin‐induced renal proximal tubule fibrosis
  320. Impact on fatty acid metabolism and differential localization of FATP1 and FAT/CD36 proteins delivered in cultured human muscle cells
  321. CD36 induction on human monocytes upon adhesion to tumor necrosis factor-activated endothelial cells
  322. A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat
  323. Lysosomal integral membrane protein II binds thrombospondin-1: structure-function homology with the cell adhesion molecule CD36 defines a conserved recognition …
  324. Plasmodium falciparum sequestration: OKM5 antigen (CD36) mediates cytoadherence of parasitized erythrocytes to a myelomonocytic cell line
  325. Hormonal and nutritional regulation of alternative CD36 transcripts in rat liver–a role for growth hormone in alternative exon usage
  326. Ectophosphorylation of CD36 Regulates Cytoadherence of Plasmodium falciparum to Microvascular Endothelium under Flow Conditions
  327. Expression of scavenger receptor CD36 in chronic renal failure patients
  328. CD36 forms covalently associated dimers and multimers in platelets and transfected COS-7 cells
  329. Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients
  330. Expression and localization of thrombospondin-1 and-2 and their cell-surface receptor, CD36, during rat follicular development and formation of the corpus luteum
  331. … LDL Preferentially Binds to CD14high CD16+ Monocytes and Induces Foam Cell Formation Mediated Only in Part by the Class B Scavenger-Receptor CD36
  332. Absence of CD36 mutation in the original spontaneously hypertensive rats with insulin resistance
  333. Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in vitro and during shear stress-induced angiogenesis in vivo
  334. Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line
  335. Oxidised LDL up-regulate CD36 expression by the Nrf2 pathway in 3T3-L1 preadipocytes
  336. Evidence for cAMP-dependent platelet ectoprotein kinase activity that phosphorylates platelet glycoprotein IV (CD36)
  337. Family studies of type II CD36 deficient subjects: linkage of a CD36 allele to a platelet-specific mRNA expression defect (s) causing type II CD36 deficiency
  338. Identification of CD36 as the first gene dependent on the B-cell differentiation factor Oct-2.
  339. Platelets lacking functional CD36 (glycoprotein IV) show reduced adhesion to collagen in flowing whole blood
  340. Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A-and CD36-independent process that involves cellular …
  341. Potential role of a CD36-like class B scavenger receptor in the binding of modified low-density lipoprotein (acLDL) to the tegumental surface of Schistosoma mansoni …
  342. C-terminal fragment of α1-antitrypsin activates human monocytes to a pro-inflammatory state through interactions with the CD36 scavenger receptor and LDL receptor
  343. Alternative promoter usage of the membrane glycoprotein CD36
  344. Macrophage vitronectin receptor, CD36, and thrombospondin cooperate in recognition of neutrophils undergoing programmed cell death
  345. Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency)
  346. Polymorphisms in the CD36 gene modulate the ability of fish oil supplements to lower fasting plasma triacyl glycerol and raise HDL cholesterol concentrations in …
  347. β-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins
  348. Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain
  349. A Drosophila gene encoding an epithelial membrane protein with homology to CD36/LIMP II
  350. Novel 5′ exon of scavenger receptor CD36 is expressed in cultured human vascular smooth muscle cells and atherosclerotic plaques
  351. Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes
  352. Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria
  353. CD36-positive stress reticulocytosis in sicle cell anemia
  354. Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8α+ dendritic cells
  355. RRR-α-tocopherol decreases the expression of the major scavenger receptor, CD36, in human macrophages via inhibition of tyrosine kinase (Tyk2)
  356. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner
  357. Complementary roles for scavenger receptor A and CD36 of human monocyte–derived macrophages in adhesion to surfaces coated with oxidized low-density …
  358. The nonexpression of CD36 on reticulocytes and mature red blood cells does not modify the clinical course of patients with sickle cell anemia
  359. Molecular basis of the CD36 chromosomal deletion underlying SHR defects in insulin action and fatty acid metabolism
  360. Identification of SVTCG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor, CD36
  361. Genomic heterogeneity of type II CD36 deficiency
  362. Translocation of the Csk homologous kinase (Chk/Hyl) controls activity of CD36‐anchored Lyn tyrosine kinase in thrombin‐stimulated platelets
  363. Pathological roles of advanced glycation end product receptors SR‐A and CD36
  364. Pharmacokinetics and metabolism of 123I-BMIPP fatty acid analog in healthy and CD36-deficient subjects
  365. Germ cells and fatty acids induce translocation of CD36 scavenger receptor to the plasma membrane of Sertoli cells
  366. CD36 is a ditopic glycoprotein with the N-terminal domain implicated in intracellular transport
  367. Increased FAT (fatty acid translocase)/CD36-mediated long-chain fatty acid uptake in cardiac myocytes from obese Zucker rats
  368. Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR−/− apoB100/100 mice fed trans-10, cis-12 conjugated linoleic acid1
  369. Stage specific expression of milk fat globule membrane glycoproteins in mouse mammary gland: comparison of MFG-E8, butyrophilin, and CD36 with a major milk …
  370. Importance of the carboxyl terminus of FAT/CD36 for plasma membrane localization and function in long-chain fatty acid uptakes⃞
  371. N‐3 but not N‐6 fatty acids reduce the expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells
  372. CD36 abnormality and impaired myocardial long-chain fatty acid uptake in patients with hypertrophic cardiomyopathy
  373. Different Effect of Statins on Platelet Oxidized-LDLReceptor (CD36 and LOX-1) Expressionin Hypercholesterolemic Subjects
  374. CD36 expression and brain function: does CD36 deficiency impact learning ability?
  375. A Single Nucleotide Insertion in Codon 317 of the CD36 Gene Leads to CD36 Deficiency
  376. Life‐threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti‐CD36 (Naka) isoantibody
  377. Differential Roles of CD36, ICAM-1, and P-selectin in Plasmodium falciparum Cytoadherence In Vivo
  378. Mouse CD36 has opposite effects on LDL and oxidized LDL metabolism in vivo
  379. The influence of diabetes mellitus and insulin resistance on receptor CD36 expression. Part II. The role of receptor CD36 in the pathomechanism of diabetes …
  380. Oxidation as a crucial reaction for cholesterol to induce tissue degeneration: CD36 overexpression in human promonocytic cells treated with a biologically relevant …
  381. Inhibition of platelet adhesion to collagen by monoclonal anti‐CD36 antibodies
  382. Subcellular immunolocalisation of fatty acid translocase (FAT)/CD36 in human type-1 and type-2 skeletal muscle fibres
  383. Thrombospondin induces dimerization of membrane-bound, but not soluble CD36
  384. … in the CD36 binding domain of the Plasmodium falciparum variant antigen are responsible for the inability of chondroitin sulfate A adherent parasites to bind CD36
  385. Molecular basis for the dichotomy in Plasmodium falciparum adhesion to CD36 and chondroitin sulfate A
  386. Structural and Functional Characterization of the Human CD36 Gene Promoter: IDENTIFICATION OF A PROXIMAL PEBP2/CBF SITE (∗)
  387. … for rat fatty acid translocase (CD36) using phage antibodies selected on cell transfectants: abundant presence of fatty acid translocase/CD36 in cardiac and red …
  388. Structural study of the sugar chains of CD36 purified from bovine mammary epithelial cells: Occurrence of novel hybrid-type sugar chains containing the Neu5Ac …
  389. Knob-independent cytoadherence of Plasmodium falciparum to the leukocyte differentiation antigen CD36.
  390. Expression of the thrombospondin 1 receptor CD36 is correlated with decreased stromal vascularisation in colon cancer.
  391. Advanced glycation end products-modified proteins and oxidized LDL mediate down-regulation of leptin in mouse adipocytes via CD36
  392. CD36-TSP-HRGP interactions in the regulation of angiogenesis
  393. Hypercholesterolemia promotes a CD36-dependent and endothelial nitric-oxide synthase-mediated vascular dysfunction
  394. CD36 mRNA EXPRESSION IS INCREASED IN CD14+ MONOCYTES OF PATIENTS WITH CORONARY HEART DISEASE
  395. CD36 overexpression in ritonavir-treated THP-1 cells is reversed by α-tocopherol
  396. Identification of an immunodominant functional domain on human CD36 antigen using human-mouse chimaeric proteins and homologue-replacement mutagenesis
  397. CD36, a class B scavenger receptor, functions as a monomer to bind acetylated and oxidized low‐density lipoproteins
  398. … improved microassay for Plasmodium falciparum cytoadherence using stable transformants of Chinese hamster ovary cells expressing CD36 or intercellular adhesion …
  399. Opposite effects of thrombospondin-1 via CD36 and CD47 on homotypic aggregation of monocytic cells
  400. Takotsubo-shaped cardiomyopathy with type I CD36 deficiency
  401. Carrageenans inhibit the in vitro growth of Plasmodium falciparum and cytoadhesion to CD36
  402. Structural, functional, and antigenic differences between bovine heart endothelial CD36 and human platelet CD36.
  403. The fatty acid translocase (FAT)/CD36 and the glucose transporter GLUT4 are localized in different cellular compartments in rat cardiac muscle
  404. Cholesteryl ester hydroperoxides increase macrophage CD36 gene expression via PPARα
  405. CD36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat.
  406. Thrombospondin-1 inhibits in vitro megakaryocytopoiesis via CD36
  407. Monocyte CD163 and CD36 expression in human whole blood and isolated mononuclear cell samples: influence of different anticoagulants
  408. Fatty acid translocase/CD36 mediates the uptake of palmitate by type II pneumocytes
  409. Insulin acutely upregulates protein expression of the fatty acid transporter CD36 in human skeletal muscle in vivo
  410. Induction of CD36 by all‐trans retinoic acid: retinoic acid receptor signaling in the pathogenesis of atherosclerosis
  411. Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67
  412. Adhesive functions of platelets lacking glycoprotein IV (CD36)
  413. Differential effects of ABT-510 and a CD36-binding peptide derived from the type 1 repeats of thrombospondin-1 on fatty acid uptake, nitric oxide signaling, and …
  414. Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36
  415. Aged garlic extract inhibits homocysteine-induced CD36 expression and foam cell formation in human macrophages
  416. Conformation of an endogenous ligand in a membrane bilayer for the macrophage scavenger receptor CD36
  417. Cytoadherence of Plasmodium falciparum-infected erythrocytes is mediated by a redox-dependent conformational fraction of CD36
  418. … of a human CD36 isoform produced by exon skipping. Conservation of exon organization and pre-mRNA splicing patterns with a CD36 gene family member, CLA-1.
  419. … metabolic abnormalities in CD36-defective SHR: Uncoupling of glucose oxidation from cellular entry accompanied with enhanced protein O-GlcNAcylation in CD36 …
  420. Cytomegalovirus stimulated mRNA accumulation and cell surface expression of the oxidized LDL scavenger receptor, CD36
  421. Receptor CD36 expression on peripheral blood monocytes in women with visceral obesity
  422. A recombinant peptide based on Pf EMP‐1 blocks and reverses adhesion of malaria‐infected red blood cells to CD36 under flow
  423. CD36 genotype and long-chain fatty acid uptake in the heart
  424. Localization of CD36 and scavenger receptor class A in human coronary arteries—a possible difference in the contribution of both receptors to plaque formation
  425. The role of CD36 in peripheral nerve remyelination after crush injury
  426. Acute and chronic regulation of CD36-mediated fatty acid uptake by rat heart and skeletal muscle
  427. Induction of CD36 expression elicited by fish oil PUFA in spontaneously hypertensive rats
  428. Purification of the major substrate for palmitoylation in rat adipocytes: N-terminal homology with CD36 and evidence for cell surface acylation
  429. Structural characterization of bovine CD36 from the milk fat globule membrane
  430. LTA recognition by bovine γδ T cells involves CD36
  431. Matrix-mediated canal formation in primmorphs from the sponge Suberites domuncula involves the expression of a CD36 receptor-ligand system
  432. … , a subset of recently discovered endogenous CD36 ligands, spontaneously generate novel furan-containing phospholipids lacking CD36 binding activity in vivo
  433. CD36 and intercellular adhesion molecule 1 mediate adhesion of developing Plasmodium falciparum gametocytes
  434. Changes in plasma membrane properties and phosphatidylcholine subspecies of insect Sf9 cells due to expression of scavenger receptor class B, type I, and CD36
  435. The role of hyperglycemia in FAT/CD36 expression and function
  436. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination
  437. Human monocytes CD36 and CD16 are signaling molecules. Evidence from studies using antibody-induced chemiluminescence as a tool to probe signal …
  438. Differential regulation of CD36 expression in antigen‐presenting cells: Oct‐2 dependence in B lymphocytes but not dendritic cells or macrophages
  439. A growth hormone-releasing peptide promotes mitochondrial biogenesis and a fat burning-like phenotype through scavenger receptor CD36 in white adipocytes
  440. CD36-dependent fatty acid uptake regulates expression of peroxisome proliferator activated receptors
  441. Recombinant CD36 inhibits oxLDL-induced ICAM-1-dependent monocyte adhesion
  442. Anti-oxLDL IgG blocks oxLDL interaction with CD36, but promotes FcγR, CD32A-dependent inflammatory cell adhesion
  443. Ceramides reduce CD36 cell surface expression and oxidised LDL uptake by monocytes and macrophages
  444. CD36 deficiency induced by antiretroviral therapy
  445. Adhesion of Plasmodium falciparum-infected red blood cells to CD36 under flow is enhanced by the cerebral malaria-protective trait South–East Asian …
  446. A Structural/Functional Domain on Human CD36 Is Involved in the Binding of Anti-Nakα Antibodies
  447. A carboxyl terminal truncation mutant of CD36 is secreted and binds thrombospondin: evidence for a single transmembrane domain
  448. Differential expression of CD14, CD36 and the LDL receptor on human monocyte-derived macrophages: a novel cell culture system to study macrophage …
  449. Anti‐CD36 autoantibodies in thrombotic thrombocytopenic purpura and other thrombotic disorders: identification of an 85 kD form of CD36 as a target antigen
  450. CD36 polymorphism and its relationship with body mass index and coronary artery disease in a Korean population
  451. Anti‐CD36 antibodies in patients with lupus anticoagulant and thrombotic complications
  452. The association between CD36 and Lyn protein tyrosine kinase is mediated by lipid
  453. Pioglitazone promotes peripheral nerve remyelination after crush injury through CD36 upregulation
  454. Decreasing intramuscular phosphagen content simultaneously increases plasma membrane FAT/CD36 and GLUT4 transporter abundance
  455. Two sibling cases of hydrops fetalis due to alloimmune anti-CD36 (Naka) antibody
  456. ApoA-II modulates the association of HDL with class B scavenger receptors SR-BI and CD36
  457. Characterization of CD36/LIMPII Homologues inDictyostelium discoideum
  458. The pivotal role of scavenger receptor CD36 and phagocyte-derived oxidants in oxidized low density lipoprotein-induced adhesion to endothelial cells
  459. CD36, insulin resistance, and coronary heart disease
  460. Endothelin-1 decreases CD36 protein expression in vascular smooth muscle cells
  461. Ionizing radiation induces macrophage foam cell formation and aggregation through JNK-dependent activation of CD36 scavenger receptors
  462. The carboxyl-terminal cytoplasmic domain of CD36 is required for oxidized low-density lipoprotein modulation of NF-kappaB activity by tumor necrosis factor-alpha.
  463. Dipyridamole alters cardiac substrate preference by inducing translocation of FAT/CD36, but not that of GLUT4
  464. Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein
  465. Increased CD36 expression on circulating monocytes during HIV infection
  466. Formation of one or more intrachain disulphide bonds is required for the intracellular processing and transport of CD36
  467. Stable transfection of fatty acid translocase (CD36) in a rat heart muscle cell line (H9c2)
  468. Normal and pathological human testes express hormone-sensitive lipase and the lipid receptors CLA-1/SR-BI and CD36
  469. Neonatal isoimmune thrombocytopenia caused by type I CD36 deficiency having novel splicing isoforms of the CD36 gene
  470. Upregulation of thrombospondin-1 (TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis
  471. Oct-2 regulates CD36 gene expression via a consensus octamer, which excludes the co-activator OBF-1
  472. Absent myocardial iodine-123i-BMIPP uptake and platelet/monocyte CD36 deficiency
  473. A CD36-binding peptide from thrombospondin-1 can stimulate resorption by osteoclasts in vitro
  474. Identification of cryptic splice site, exon skipping, and novel point mutations in type I CD36 deficiency
  475. Identification of a Suppressor of the Dictyostelium Profilin-minus Phenotype as a CD36/LIMP-II Homologue
  476. Normal aggregations of glycoprotein IV (CD36)‐deficient platelets from seven healthy Japanese donors
  477. Plasmodium falciparum-infected erythrocyte receptor (s) for CD36 and thrombospondin are restricted to knobs on the erythrocyte surface.
  478. Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-γ
  479. Increased platelet CD36 constitutes a common marker in myeloproliferative disorders
  480. The role of fatty-acid transport proteins (FAT/CD36, FABPpm, FATP) in lipid metabolism in skeletal muscles
  481. CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: In vitro drug sensitivity and outcome
  482. Collagen induces normal signal transduction in platelets deficient in CD36 (platelet glycoprotein IV)
  483. CD36 is not involved in scavenger receptor–mediated endocytic uptake of glycolaldehyde-and methylglyoxal-modified proteins by liver endothelial cells
  484. FAT/CD36 expression alone is insufficient to enhance cellular uptake of oleate
  485. CD36-mediated signal transduction in human monocytes by anti-CD36 antibodies but not by anti-thrombospondin antibodies recognizing cell membrane-bound …
  486. Ultrastructural localization of CD36 in human hepatic sinusoidal lining cells, hepatocytes, human hepatoma (HepG2-A16) cells, and C32 amelanotic melanoma cells
  487. Hypochlorite-oxidized low-density lipoprotein upregulates CD36 and PPARγ mRNA expression and modulates SR-BI gene expression in murine macrophages
  488. The leukocyte expression of CD36 is low in patients with Alzheimer’s disease and mild cognitive impairment
  489. FIP2 and Rip11 specify Rab11a-mediated cellular distribution of GLUT4 and FAT/CD36 in H9c2-hIR cells
  490. Plasmodium falciparum: pfalhesin and CD36 form an adhesin/receptor pair that is responsible for the pH-dependent portion of cytoadherence/sequestration
  491. PS-liposome and ox-LDL bind to different sites of the immunodominant domain (# 155-183) of CD36: a study with GS95, a new anti-CD36 monoclonal antibody
  492. Increased risk of colorectal cancer due to interactions between meat consumption and the CD36 gene A52C polymorphism among Japanese
  493. RUNX3 negatively regulates CD36 expression in myeloid cell lines
  494. Modulation of CD36 protein expression by AGEs and insulin in aortic VSMCs from diabetic and non-diabetic rats
  495. Fenofibrate enhances CD36 mediated endocytic uptake and degradation of oxidized low density lipoprotein in adipocytes from hypercholesterolemia rabbit
  496. Genetic ablation of CD36 induces age-related corneal neovascularization
  497. Role of PPAR-gamma in the modulation of CD36 and FcgammaRII induced by LDL with low and high degrees of oxidation during the differentiation of the monocytic …
  498. The Plasmodium falciparum–CD36 Interaction Is Modified by a Single Amino Acid Substitution in CD36
  499. Metabolic changes in human CD36 deficiency displayed by glucose loading
  500. Cytoadherence characteristics to endothelial receptors ICAM-1 and CD36 of Plasmodium falciparum populations from severe and uncomplicated malaria cases
  501. Attenuated aerobic exercise capacity in CD36 deficiency
  502. Tamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissues
  503. Bone marrow chimeric mice reveal a dual role for CD36 in Plasmodium berghei ANKA infection
  504. CD36 Expression in Sltered in Retinal Pigment Epithelial Cells of the RCS Rat
  505. The C-Terminal Segment of the Cysteine-Rich Interdomain of Plasmodium falciparum Erythrocyte Membrane Protein 1 Determines CD36 Binding and Elicits …
  506. A promoter polymorphism in CD36 is associated with an atherogenic lipid profile in a French general population
  507. CD36 antisense expression in 3T3-F442A preadipocytes
  508. Chemical modifications of band 3 protein affect the adhesion of Plasmodium falciparum-infected erythrocytes to CD36
  509. Association of the Pro90Ser CD36 mutation with elevated free fatty acid concentrations but not with insulin resistance syndrome in Japanese
  510. Rosiglitazone fails to improve hypertriglyceridemia and glucose tolerance in CD36-deficient BN. SHR4 congenic rat strain
  511. Investigation of the expression and localization of glucose transporter 4 and fatty acid translocase/CD36 in equine skeletal muscle
  512. Sulfated glycoconjugates enhance CD36-dependent adhesion ofPlasmodium falciparum–infected erythrocytes to human microvascular endothelial cells
  513. Platelet activation results in a redistribution of glycoprotein IV (CD36).
  514. Harnessing CD36 to rein in inflammation
  515. Arachidonic acid uptake by human platelets is mediated by CD36
  516. Myristic acid stimulates endothelial nitric-oxide synthase in a CD36-and an AMP kinase-dependent manner
  517. The terminal six amino-acids of the carboxy cytoplasmic tail of CD36 contain a functional domain implicated in the binding and capture of oxidized low-density …
  518. … to resting human dermal microvascular endothelial cells is down‐regulated upon maturation and partially depends on CD11a–CD18, CD11b–CD18 and CD36
  519. CD36 regulates fatty acid composition and sensitivity to insulin in 3T3-L1 adipocytes
  520. Regulation of FAT/CD36 mRNA gene expression by long chain fatty acids in the differentiated 3T3-L1 cells
  521. Degree of oxidation of low density lipoprotein affects expression of CD36 and PPARγ, but not cytokine production, by human monocyte-macrophages
  522. Phagocytosis of cholesteryl ester is amplified in diabetic mouse macrophages and is largely mediated by CD36 and SR-A
  523. Hyperexpression of ICAM‐1 and CD36 in placentas infected with Plasmodium falciparum: a possible role of these molecules in sequestration of infected red blood …
  524. Third promoter and differential regulation of mouse and human fatty acid translocase/CD36 genes
  525. Glycolaldehyde‐Modified Bovine Serum Albumin Downregulates Leptin Expression in Mouse Adipocytes via a CD36‐Mediated Pathway
  526. CD4 T cells from malaria-nonexposed individuals respond to the CD36-binding domain of Plasmodium falciparum erythrocyte membrane protein-1 via an MHC class …
  527. Cloning of the cDNA encoding human platelet CD36: comparison to PCR amplified fragments of monocyte, endothelial and HEL cells
  528. Antibodies to CD36 (GPIV) inhibit platelet adhesion to subendothelial surfaces under flow conditions
  529. CD36 does not play a direct role in HDL or LDL metabolism
  530. Heterogeneity of platelet responsiveness to anti‐CD36 in plasma associated with adverse transfusion reactions
  531. Definition of the minimal domain of CIDR1α of Plasmodium falciparum PfEMP1 for binding CD36.
  532. Phospholipids in oxidized LDL not adducted to apoB are recognized by the CD36 scavenger receptor
  533. Macrophage chemotaxis to apoptotic Burkitt’s lymphoma cells in vitro: role of CD14 and CD36
  534. Analysis of CD36 expression on human monocytic cells and atherosclerotic tissue sections with quantum dots: investigation by flow cytometry and spectral imaging …
  535. Mast cell growth factor modulates CD36 antigen expression on erythroid progenitors from human bone marrow and peripheral blood associated with ongoing …
  536. Dissociation of apoptosis induction and CD36 upregulation by enzymatically modified low-density lipoprotein in monocytic cells
  537. Mechanism linking atherosclerosis and type 2 diabetes: increased expression of scavenger receptor CD36 in monocytes
  538. Hypertrophic cardiomyopathy with type I CD36 deficiency
  539. Effects of aldehydes on CD36 expression
  540. Cholesterol depletion inhibits fatty acid uptake without affecting CD36 or caveolin-1 distribution in adipocytes
  541. Enzymatically modified low-density lipoprotein upregulates CD36 in low-differentiated monocytic cells in a peroxisome proliferator-activated receptor-γ-dependent …
  542. Rosiglitazone but not losartan prevents Nrf-2 dependent CD36 gene expression up-regulation in an in vivo atherosclerosis model
  543. Expression of CD36 (OKM5) antigen on epidermal cells in normal and diseased skin
  544. A detergent-sensitive 113-kDa conformer/complex of CD36 exists on the platelet surface
  545. Regulation of CD36 expression in human melanoma cells
  546. Expression of the myelomonocytic antigens CD36 and L1 by keratinocytes in squamous intraepithelial lesions of the cervix
  547. CD36 is spatially associated with glycoprotein IIb-IIIa (αIIbβ3) on the surface of resting platelets
  548. CD36 deficiency has little influence on the pathophysiology of hypertrophic cardiomyopathy
  549. Localization of thrombospondin, CD36 and CD51 during prenatal development of the human mammary gland
  550. CD36 mediates binding of soluble thrombospondin‐1 but not cell adhesion and haptotaxis on immobilized thrombospondin‐1
  551. Characterization of two alternatively spliced 5′-untranslated exons of the human CD36 gene in different cell types
  552. Haemolytic uraemic syndrome is an immune‐mediated disease: role of anti‐CD36 antibodies
  553. Lack of Myocardial Iodine-123 15-(p-iodiphenyl)-3-R, S-methylpentadecanoic Acid (BMIPP) Uptake and CD36 Abnormality CD36 Deficiency and Hypertrophic …
  554. Fatty acids modulate the effect of darglitazone on macrophage CD36 expression
  555. Platelet activation and inhibition of malarial cytoadherence by the anti-CD36 IgM monoclonal antibody NL07
  556. CD36 signaling inhibits the translation of heat shock protein 70 induced by oxidized low density lipoprotein through activation of peroxisome proliferators-activated …
  557. Novel immunoblotting monoclonal antibodies against human and rat CD36/fat used to identify an isoform of CD36 in rat muscle
  558. Up-regulation of CD36/FAT in preadipocytes in familial combined hyperlipidemia
  559. Inhibitory Activity of Human Lactoferrin and Its Peptide on Chondroitin Sulfate A-, CD36-, and Thrombospondin-Mediated Cytoadherence ofPlasmodium falciparum …
  560. Characterization of Two Vaccinia CD36 Recombinant‐Virus‐Generated Monoclonal Antibodies (10/5, 13/10) Effects on Malarial cytoadherence and Platelet Functions
  561. Polymorphisms of CD36 in Thai malaria patients
  562. Platelet membrane protein CD36.
  563. Adhesion to thrombospondin by human embryonic fibroblasts is mediated by multiple receptors and includes a role for glycoprotein 88 (CD36)
  564. Plasmodium falciparum-infected erythrocytes do not adhere well to C32 melanoma cells or CD36 unless rosettes with uninfected erythrocytes are first disrupted
  565. Analysis of the human CD36 leucocyte differentiation antigen by means of the monoclonal antibody NL07
  566. CD36 and Proteoglycan-Mediated Pathways for (n-3) Fatty Acid–Enriched Triglyceride-Rich Particle Blood Clearance in Mouse Models In Vivo and in …
  567. CD36 deficiency and insulin resistance
  568. CD44, a signal receptor for the inhibition of the cytoadhesion of CD36-binding Plasmodium falciparum-infected erythrocytes by CSA-binding infected …
  569. Reduced adhesion of monocyte-derived macrophages from CD36-deficient patients to type I collagen
  570. CD36 LIMPII analogous-1, a human homolog of the rodent scavenger receptor B1, provides the cholesterol ester for steroidogenesis in adrenocortical cells
  571. PPARgamma agonists can be expected to potentiate the efficacy of metronomic chemotherapy through CD36 up-regulation
  572. Different patterns of 123I-BMIPP myocardial accumulation in patients with type I and II CD36 deficiency
  573. Phenotype, Ultrastructure, and Function of CD1+DR+ Epidermal Cells that Express CD36 (OKM5) in Cutaneous T‐Cell Lymphoma
  574. Scavenger receptor A and CD36 are implicated in mediating platelet activation induced by oxidized low-density lipoproteins
  575. Macrophages, but not Langerhans cell-like cells of dendritic lineage, express the CD36 molecule in normal human dermis: relevance to downregulatory cutaneous …
  576. Genetics of CD36 and the hypertension metabolic syndrome
  577. The supportive effects of erythropoietin and mast cell growth factor on CD34+/CD36-sorted bone marrow cells of myelodysplasia patients
  578. Identification of CD36 as a new surface marker of marginal zone B cells by transcriptomic analysis
  579. CD36: taste the difference?
  580. Keratinocyte and epidermal leukocyte expression of CD36 (OKM5) in benign and malignant skin diseases
  581. CD36 folding revealed by conformational epitope expression is essential for cytoadherence of Plasmodium falciparum‐infected red blood cells
  582. Lack of significant association between rosette formation and parasitized erythrocyte adherence to purified CD36
  583. Antibodies against human cell receptors, CD36, CD41a, and CD62P crossreact with porcine platelets
  584. Erythroid involvement in CD36 deficiency
  585. Glycoxidised LDL isolated from subjects with impaired glucose tolerance increases CD36 and peroxisome proliferator–activator receptor γ gene expression in …
  586. CD36 immunization in a patient undergoing hematopoietic stem cell transplantation
  587. Association of thrombospondin-1 with the actin cytoskeleton of human thrombin-activated platelets through an αIIbβ3-or CD36-independent mechanism
  588. Variability of the CD36 gene in West Africa
  589. Lipoprotein binding preference of CD36 is altered by filipin treatment
  590. Interaction of a monoclonal antibody to glycoprotein IV (CD36) with human platelets and its effect on platelet function
  591. A one-step procedure for purification of bovine mammary epithelial cell CD36
  592. Systemic lupus erythematosus, thrombocytopenia, microangiopathic haemolytic anaemia and anti-CD36 antibodies.
  593. Emerging roles for the CD36 scavenger receptor as a potential therapeutic target for corneal neovascularization
  594. Antigenic and functional differences in adhesion of Plasmodium falciparum-infected erythrocytes to human and bovine CD36
  595. High P-selectin expression and low CD36 occupancy on circulating platelets are strong predictors of restenosis after coronary stenting in patients with coronary artery …
  596. Immunohistochemical study of thrombospondin and its receptors alpha root of beta 3 and CD36 in normal thyroid and in thyroid tumours.
  597. Flow cytometry and spectral imaging multiphoton microscopy analysis of CD36 expression with quantum dots 605 of untreated and 7-ketocholesterol-treated human …
  598. Thrombospondin receptor (CD36) expression of human keratinocytes during wound healing in a SCID mouse/human skin repair model
  599. Plasmodium falciparum gametocyte adhesion to C32 cells via CD36 is inhibited by antibodies to modified band 3
  600. Quantitation of platelet glycoprotein IV (CD36) in healthy subjects and in patients with essential thrombocythemia using an immunocapture assay
  601. Improvement in cardiac function and free fatty acid metabolism in a case of dilated cardiomyopathy with CD36 deficiency
  602. High tissue factor‐expressing human monocytes carry low surface CD36: application to intersubject variability
  603. Coordinately regulated expression of FAT/CD36 and FACS1 in rat skeletal muscle
  604. Expression of thrombospondin-1 (TSP1) and its receptor (CD36) in healthy and diseased human skin.
  605. Successful autologous hematopoietic progenitor cell transplantation in a patient with an isoantibody against CD36 (glycoprotein IV, Naka)
  606. Link between anti-CD36 antibodies and thrombosis in the antiphospholipid syndrome
  607. CD36 (Naka) sensitization with platelet-transfusion refractoriness in a liver transplant recipient
  608. CD36 is significantly correlated with adipophilin in human carotid lesions and inversely correlated with plasma ApoAI
  609. CD36 mRNA and protein expression levels are significantly increased in the heart and testis of apoE deficient mice in comparison to wild type (C57BL/6)
  610. CD34+/CD36− cells from myelodysplasia patients have a limited capacity to proliferate but can differentiate in response to Epo and MGF stimulation
  611. Surface expression of fatty acid translocase (FAT/CD36) on platelets in myeloproliferative disorders and non-insulin dependent diabetes mellitus: effect on arachidonic …
  612. Alternatively spliced mRNA molecules of the thrombospondin receptor (CD36) in human PBMC
  613. CD36 and CD14 immunoreactivity of Reiter cells in inflammatory synovial fluids
  614. Primary ex vivo culture of keratinocytes isolated from hypertrophic scars as a means of biochemical characterization of CD36
  615. Structural and functional analysis of a new upstream promoter of the human FAT/CD36 gene
  616. Keratinocyte expression of CD36 antigen in benign and malignant epidermal cell‐derived tumours
  617. Ritonavir increases CD36, ABCA1 and CYP27 expression in THP-1 macrophages
  618. Detection of GPIV (CD36) mRNA in Naka− platelets
  619. EX VIVO AND IN VITRO IMPAIRMENT OF CD36 EXPRESSION AND TUMOR NECROSIS FACTOR-α PRODUCTION IN HUMAN MONOCYTES IN RESPONSE TO …
  620. CD36 is rapidly and transiently upregulated on phytohemagglutinin (PHA)‐stimulated peripheral blood lymphocytes. Analysis by a new monoclonal antibody (UN7)
  621. Human platelet CD36 (GPIIIb, GPIV) binds to cholesteryl-hemisuccinate and can be purified by a simple two-step method making use of this property
  622. Functional roles of membrane glycoprotein CD36
  623. Complex connection between CD36 and atherosclerosis, lipid metabolism, and insulin resistance syndromes
  624. Plasmodium falciparum: CD36 Dependent Cytoadherence or Rosetting of Infected Erythrocytes is Modulated by Knobs
  625. Influence of CD36 deficiency on heart disease in children
  626. Arsenite modulates cardiac substrate preference by translocation of GLUT4, but not CD36, independent of mitogen-activated protein kinase signaling
  627. CD36 deficiency and absent myocardial iodine-123-(R,S)-15-(p-iodophenyl)-3-methylpentadecanoic acid uptake in a girl with cardiomyopathy
  628. Different expression of CD36 antigen molecule on the surface of megakaryocyte lineage leukemias and megakaryocyte leukemia cell lines MEG-01 and HEL.
  629. CD36 autoantibodies and thrombotic diathesis, thrombocytopenia and repeated early fetal losses
  630. Expression of CD29 on lymphoma cells and/or CD36 on microvascular endothels correlates with high serum LDH level in diffuse large B-cell lymphomas (DLBCLs) …
  631. Effect of cerivastatin on endothelial dysfunction and aortic CD36 expression in diabetic hyperlipidemic rats
  632. Plasmodium yoelii sporozoites infect CD36-deficient mice
  633. Fatty acid composition and CD36 expression in breast adipose tissue of premenopausal and postmenopausal women.
  634. Expression, of the thrombospondin receptor (CD36) on the cell surface in megakaryoblastic and promegakaryocytic leukemias: Increment of the receptor by …
  635. Gene-environment interactions in wet beriberi: effects of thiamine depletion in CD36-defect rats
  636. Increased CD36 expression in vertically human immunodeficiency virus-infected children unrelated to antiretroviral therapy
  637. Effect of bowel resection and high-fat diet on heart CD36/fatty-acid translocase expression in a rat model of short-bowel syndrome
  638. Thrombin-stimulated calcium mobilization is inhibited by thrombospondin via CD36
  639. Identification of a functional site on CD36 involved in the interaction between platelets and collagen
  640. CD36 deficiency and insulin resistance
  641. CD36 expression and its relationship with obesity in blood cells from people with and without Prader–Willi syndrome
  642. Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells
  643. CD36 selection of 3D7 Plasmodium falciparum associated with severe childhood malaria results in reduced VAR4 expression
  644. E-NTPase/E-NTPDase: a potential regulatory role in E-kinase/PKA-mediated CD36 activation
  645. The human anion transport protein, band 3, contains a CD36-like binding domain for Plasmodium falciparum-infected erythrocytes
  646. Plasmodium falcipamm—Infected Erythrocytes and Oxidized Low-Density Lipoprotein Bind to Separate Domains of CD36
  647. Purification, immunochemical quantification and localization in rat heart of putative fatty acid translocase (FAT/CD36)
  648. Platelet-agglutinating protein p37 from a thrombotic thrombocytopenic purpura plasma forms complexes with platelet membrane glycoprotein IV (CD36).
  649. Detection of Naka Antigen and GP lV (CD36) mRNA in Monocytes of Naka-Negative Subiects
  650. Isolation and partial characterization of CD36 from skim milk
  651. The role and regulation of CD36 for fatty acid imaging of the heart: Implications in diabetes mellitus and chronic kidney disease
  652. Deficiency of platelet glass bead adhesion and platelet membrane glycoprotein IV (CD36) in Duchenne muscular dystrophy
  653. Fat preference and acceptance in the CD36 knockout mice.
  654. CD36 (OKM5) antigen expression on human mucosal epithelia is associated with keratinization type
  655. Ribozyme mediated down-regulation of thrombospondin receptor CD36 inhibits the growth of the human osteosarcoma cell line
  656. PART B. THE ROLE OF CD36 AS A THROMBOSPONDIN RECEPTOR
  657. The CD36 protein functions as an immunogenic domain of the RT8 alloantigen
  658. Hypertrophic cardiomyopathy showing no 123I-BMIPP myocardial accumulation with type I CD36 deficiency
  659. Photopheresis up-regulates CD36 on monocytes and reduces CD25+ and CD28+ T cell numbers
  660. CD36 N-terminal cytoplasmic domain is not required for the internalization of oxidized low-density lipoprotein
  661. Immunohistological study on bovine, swine and ovine skeletal muscle fibers for the localization of fatty acid translocase FAT/CD36
  662. Regulation of FAT/CD36 expression in human skeletal muscle
  663. Regulatory role of E‐NTPase/NTPDase in fat/CD36‐mediated fatty acid uptake
  664. Genetic Variation in CD36 and Dietary Fat Intake
  665. CD36-mediated apoptotic cell clearance in SLE
  666. CD36, the macrophage class B scavenger receptor: regulation and role in atherosclerosis
  667. Epitopic Heterogeneity of the CD36 Antigen Expressed by Normal and Neoplastic Endothelial Cells: An Immunohistochemical Study with a Novel Monoclonal …
  668. Reduced secretion of tumor necrosis factor-α and interleukin-1β from monocyte-derived macrophages of CD36-deficient subjects in response to oxidized LDL
  669. Scavenger receptor CD36 has a role in HDL metabolism in mice
  670. Type I CD36 deficiency in hematologic disorder
  671. Identification of defective CD36 as a quantitative trait locus for cardiovascular risk factor clustering in the spontaneously hypertensive rat
  672. Refractory thrombocytopenia due to allo-immune anti-CD36 complicating unrelated donor bone marrow transplant in a CD36-Negative recipient.
  673. A patient with type I CD36 deficiency whose myocardium accumulated123I-BMIPP after 4 years
  674. Effect of a high fat diet on fatty acid translocase (FAT/CD36) expression and fatty acid transport in isolated enterocytes in a rat model of short bowel syndrome
  675. Uptake of fatty acids by parenchymal cells: role of FAT/CD36
  676. Functional significance of fatty acid translocase (FAT/CD36) in rodent cardiac muscle
  677. Immunohistochemical analysis of CD31, CD36, and CD44 antigens in human omentum.
  678. Prothrombotic Platelet Signaling by the Scavenger Receptor, CD36.
  679. ERK1/2 inhibition prevents the contraction-induced increase in muscle FA metabolism and plasma membrane CD36 content, without affecting AMPK activity, in a dose …
  680. Age–dependent Spontaneous Induction of Corneal Neovascularization in CD36 Knock–out Mice
  681. Plat-elet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes~ J~
  682. CD36 is expressed in atherosclerotic lesion and its expression is upregulated by oxidized LDL
  683. CD36 expression in leukemia cells checked with multi-parameter flow cytometry and its significance
  684. Methionine 156 in the immunodominant domain of CD36 contributes to define the epitope recognized by the NL07 MoAb
  685. Gene and protein expression of Srb1 (scavenger receptor class B, type 1) a cell surface HDL receptor of CD36 superfamilly, in the adult rat retina
  686. Effects of experimental spinal cord injury on food intake, body composition and gastrointestinal expression of CD36 mRNA in rats
  687. Effects of probucol on ox-LDL induced apoptosis and CD36, Caveolin-1 expression in THP-1 macrophages
  688. No 123I-BMIPP accumulation in the myocardium and type I CD36 deficiency in a patient with acute subendocardial infarction: a case report
  689. Expression of the myelomonocytic antigens L1 and CD36 in human epidermis
  690. Polymorphisms of scavenger receptor CD36 and its expression of monocyte surface in type 2 diabetic patients
  691. TSP‐1 Binds Thr92 Phosphorylated CD36 in a Calcium Dependent Manner and the Ligands of CD36 Regulate the Phosphorylation of Thr92 in Mouse Macrophages
  692. CD36 Specific Effects of Oxidized Lipids on OS Phagocytosis by the Retinal Pigment Epithelium
  693. The role of CD36 in atherogenesis as a receptor for OxLDL
  694. Spontaneous bacterial keratitis in CD36 knockout mice
  695. CD36 antisense expression in 3T3-F442A preadipocytes is associated with low rates of both fatty acid transport and preadipocyte differentiation
  696. Activation of CD36 Inhibits and Prevents Progression of Corneal Neovascularization
  697. Molecular basis of CD36 deficiency
  698. Expression of CD36 in Cultured Human Aortic Smooth Muscle Cells (HASMCs)
  699. CD36 Prevents Corneal Scarring Following Epithelial Wounds
  700. The effect of caveolin‐1 (CAV‐1) on fatty acid uptake and CD36 localization in vascular smooth muscle (VSM) cells
  701. Decreased expression of CD36 precedes amyloid accumulation in the 3xTgAD mouse model of Alzheimer’s disease
  702. Variability of CD36 Expression on Platelets Is Determined in Part by Genetic Polymorphisms and Can Influence Platelet Function.
  703. Absence of CD36 is Protective at Late Time Points in the apoE Knockout (KO), and Additional Absence of Scavenger Receptor AI/II (SRA) Provides no Added Benefit
  704. CD36 null mice reveal a key role for CD36 in β‐amyloid induced microglial activation
  705. CD36 Interaction Is Modified by a Single− The Plasmodium falciparum
  706. Quantitative Flow Cytometric Assessment of CD36 (Platelet Glycoprotein IV) Expression on Monocytes and Platelets: Assay Development, Role in …
  707. Regulation of Angiogenesis by CD36/TSP‐1 Signaling In Rat Mesentery Provides Evidence for the Functional Significance of a CD36‐Capillary Sprout‐Specific …
  708. CD36 Deficiency Leads to Choroidal Involution via Cox-2 Downregulation In Rpe
  709. CD36-mediated clearance of Plasmodium falciparum-infected erythrocytes by rodent monocytes/macrophages
  710. Ionizing radiation induces macrophage foam cell formation and aggregation through JNK-dependent activation of CD36 scavenger receptors
  711. Analysis of the function and subcellular localization of FAT/CD36 in hepatocytes and transfected cell lines of hepatic and non-hepatic origin.
  712. O-2: The fatty acid transporter CD36 is a major determinant of the insulin sensitizing actions of pioglitazone in the spontaneously hypertensive rat
  713. CD36 deficiency and insulin resistance
  714. 39 EXPRESSION OF THE PATTERNING RECEPTOR CD36 IS CHONDROPROTECTIVE BY DISENGAGING INFLAMMATION FROM DYSREGULATED …
  715. Regulation of CD36 by PPARγ: Pro-or Antiatherogenic?
  716. Emerging roles for the CD36 scavenger receptor in neovascular ocular disease
  717. Short-term overexpression of CD36 in the liver augments hepatic lipid storage and VLDL-triglyceride secretion: Implications for diet-induced obesity and type 2 …
  718. Effects of oral administration of sugar and lipid on expression behavior of multi-functional protein CD36
  719. CD36 deficiency associated with insulin resistance
  720. Expression of Thrombospondin-1 and its receptor CD36 in human articular cartilage
  721. Role of CD36 in Platelet Function
  722. Role of CD36 in Platelet Function
  723. Localizaton of CD36 and scavenger receptor class
  724. Sex-different regulation of fatty acid translocase/CD36 expression in rat liver
  725. Lysosomal integral membrane protein II, a member of the CD36 gene family: Comparative analysis of structure-function relationships
  726. Endothelial Derived Microparticles Bind and Activate Platelets in a CD36 Dependent Manner.
  727. Increased Prevalence of Anti-CD36 and Elevated Endothelial Microparticles in Patients with Recurrent Thrombosis.
  728. CD36 Expression in Human Monocytic Leukemia Cell Lines: THP-1 and THP-1 Subtype, Show Different Expressions of Type I and Type II Scavenger Receptors
  729. CD36-Mediated Nonopsonic Phagocytosis of
  730. Signaling through the scavenger receptor CD36: Identification of CD36-dependent pathways in macrophages activated by modified low density lipoproteins
  731. The effect of interactions among variants of CD36 on hypertensive heart disease phenotypes
  732. The expression of CD36 by Langerhans cells and Langerhans cell-like dendritic cells exhibits phenotypic plasticity. An in situ immunoelectron microscopy study of …
  733. Peroxisome Proliferator-Activated Receptor gamma (PPARγ) Regulates CD36 Gene Expression in Megakaryocytic Cell Lines.
  734. Expression Profiling in the Heart Failure Rat Model SHHF and Analysis of the Molecular Basis and Function for the Candidate Gene CD36
  735. Technical Report: Triple-Colour Staining Flow Cytometry for Co-Distribution of Thrombospondin Receptor (CD36), Ribonucleic Acid (RNA) and Fetal Haemoglobin …
  736. Requirement of FAT/CD36 for acute leptin stimulatory effect on lipid oxidation in skeletal muscle
  737. Role of CD36 in Endothelial Activation by TLR2 Ligands
  738. Effect of bowel resection and high-fat diet on heart CD36/fatty-acid translocase expression in a rat model of short-bowel syndrome
  739. Role of Scavenger Receptor CD36 in Cholesterol Metabolism in Hepatocytes.
  740. ORIGINAL ARTICLE Immunohistological study on bovine, swine and ovine skeletal muscle fibers for the localization of fatty acid translocase FAT/CD36.
  741. The role of CD36 in peripheral nerve remyelination after crush injury
  742. Endocytosis of Oxidized LDL through Scavenger Receptor CD36 Utilizes a Lipid Raft Pathway That Does Not Require Caveolin-1
  743. Transgenic Rescue of Defective CD36 Attenuates Insulin Resistance, Dyslipidemia, and Hypertension in Spontaneously Hypertensive Rats
  744. Molecular mechanisms of the CD36-Plasmodium falciparum interaction in cytoadherence.
  745. The Role of Mitochondrial Thioesterase-I, Uncoupling Protein-3, and CD36 in Cardiac Mitochondria
  746. CD36-dependent Regulation of Muscle FoxO1 and PDK4 in the PPARδ/-mediated Adaptation to Metabolic Stress
  747. Aggregated ursolic acid, a natural triterpenoid, binds to CD36 for inducing interleukin-1β release from murine peritoneal macrophages
  748. THE CLESH DOMAIN OF HISTIDINE-RICH GLYCOPROTEIN IS IMPORTANT FOR MODULATION OF THE TSP-1-CD36 ANTI-ANGIOGENIC PATHWAY
  749. Identification of a Domain (155–183) on CD36 Implicated in the Phagocytosis of Apoptotic Neutrophils
  750. The effects of PPARγ/TGFβ cross-talk on CD36 gene expression in the intestinal epithelium
  751. The role of CD36 in the pathophysiology of malaria: validation of a murine model and design of a clinical study
  752. The functional effects of ceramide on the monocyte CD36 scavenger receptor and NADPH oxidase
  753. In silico prediction of regulatory SNPs in the CD36 gene and evaluation of their effect in a clinical study for coronary artery disease
  754. Effects of high density lipoprotein 2 and 3 on expression of PPAR# gamma# and CD36, and cellular lipid accumulation in THP-1 macrophages
  755. Purification of thrombospondin receptor (CD36) from human platelet membrane
  756. The roles of PPAR [alpha], PPAR [gamma] and PGC-1 [alpha] on the regulation of the fatty acid transport proteins FAT/CD36 and FABPpm and effects on …
  757. Predictive Diagnostic and Prognostic Value of Platelets Microparticles (PMP), but Not of Reticulated Platelets (RP) or CD36 Expression in Essential …
  758. Molecular Basis of CD36 Deficiency
  759. Correlation between local hormones and CD36 transcription level in women with polycystic ovary
  760. RELATIONSHIP BETWEEN THE ABILITY OF ANTI-CD36 ANTIBODIES-CONTAINING SERA TO INDUCE PLATELET ACTIVATION AND ANTIBODY TITER
  761. Decreased expression of scavenger receptor CD36 in peritoneal macrophage of women with endometriosis
  762. Investigations of the physiological role of CD36 in fatty acid uptake and metabolism
  763. Ritonavir incrementa la expresión de CD36 y ABCA1 en macrófagos THP-1
  764. Uptake of fatty acids by parenchymal cells: role of FAT/CD36 b Jan FC Glatz, a,* Joep FF Brinkmann, Arend Bonen
  765. Distribution and function of a CD36 orthologue defined by monoclonal antibody UA009 in the rat
  766. 1P-0257 Binding of thrombospondin 1 to CD36 induces apoptosis of human endothelial cells through activation of p38 mitogen activated protein kinase
  767. Hydroxyurea Therapy Reduces the Gene Expression of Adhesion Molecules VLA-4 and CD36 in Sickle Erythrocytes, with a Concomitant Decrease in Adhesion to …
  768. Purification and characterization of Bovine CD36 from heart microsomes
  769. Characterization of ligands mediating adherence of Plasmodium falciparum-infected erythrocytes to CD36 and ICAM-1
  770. Increased myocardial glucose oxidation in fatty acid translocase (FAT/CD36) deficient mice attenuates age-dependent decreases in cardiac performance
  771. MONOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS ERITHEMATOSUS HAVE NORMAL EXPRESSION OF CD36 AND CD163 SCAVENGER RECEPTOR: 174
  772. Chromosome assignment of CD36 transgenes in two rat SHR lines by FISH and linkage mapping of transgenic insert in the SHR-TG19 line.
  773. Ex Vivo-Generated CD36
  774. Absent Myocardial Iodine-123-BMIPP Uptake and Platelet/Monocyte CD36 Deficiency
  775. Degree of oxidation of low density lipoprotein affects expression of CD36 and PPARg, but not cytokine production, by human monocyte-macrophages
  776. High Glucose Promotes Intracellular Lipid Accumulation by Impairing the Balance between CD36 and ATP-Binding Cassette Transporter G1 in Vascular Smooth …
  777. Knob-independent cytoadherence of Plasmodium falciparum to the leukocyte differentiation antigen CD36
  778. The* C5a chemotactic cofactor function of the vitamin D binding protein is regulated by thrombospondin 1 and CD36
  779. The role of FAT/CD36 in regulating fatty acid oxidation in the heart
  780. Regulation of human monocyte/macrophage CD36 expression
  781. The Leukocyte Expression of CD36 and other Biomarkers: Risk Indicators of Alzheimer’s Disease
  782. Induction of CD36~ o by phorbol 12-myristate 13-acet at e
  783. CLEAVAGE OF THE AMINO-TERMINAL DOMAIN OF CD36 BY HIV-1 PROTEASE
  784. CD36 Mediated Reactive Oxygen Species Formation Contributes to Thrombosis.
  785. Specific Oxidized Phospholipids Modulate Platelet Reactivity In Vivo During Hyperlipidemia Via CD36: A Mechanism Linking Hyperlipidemia, Oxidant Stress And A …
  786. Lipoprotein Abnormalities in Human Genetic CD36
  787. Lipoproteins regulate expression of the class B macrophage scavenger receptor, CD36
  788. Hyperglycemia regulates post-transcriptional expression and phosphopalmnxylation of the oxidized-ldl/thrombospondin receptor, CD36
  789. A novel mis‐sense mutation in the platelet glycoprotein CD36 is associated with protection from malaria
  790. Significance of expression of thrombospondin-1 and receptor-CD36 in hepatocellular carcinoma
  791. The PPAR target gene CD36 is a rate limiting factor for the sensing of gram positive S-aureus in vascular smooth muscle cells but not in macrophages
  792. CD36 is Downregulated by VEGF‐A and the Removal of Wall Shear Stress: Implications for the Regulation of a CD36‐Capillary Sprout Specific Endothelial …
  793. Lack of Association between Pro90Ser CD36 Mutation and Insulin Resistance in Japanese
  794. CD36 Mediates Macrophage Spreading and Migration in response to oxidized LDL.
  795. Vitamin E antagonizes oxLDL‐induced CD36 over‐expression in monocytes
  796. Effect of activated nuclear receptors PPAR?, LXR?, RXR? on ABC1 and CD36 mRNA expression in THP-1 cell
  797. Differential Gene Expression in the CD36 Knockout Mouse RPE
  798. A Central Role for CD36 in Mediating Oxidized LDL and Fatty Acid Induced Insulin Resistance
  799. Synthetic ceramides inhibit CD36 expression in U937 cells through a reduction in cytosolic peroxide
  800. Membrane glycoprotein CD36 deficiency promotes insulin resistance in C57BL/6 mice
  801. Effect of oxidized low density lipoprotein on CD36 expression in macrophage
  802. CD36 and the Molecular Basis of Insulin Resistance in the Stroke-Prone Spontaneously Hypertensive Rat
  803. The role of CD36 and Caveolin‐1 in atherosclerotic lesion formation
  804. Over-expression of FABP (pm) in cultured muscle cells: Does FABP (pm) function to transport fatty acids only in the presence of CD36?
  805. Immunohistochemical analysis of CD31, CD36, and CD44 antigens in human omentum
  806. The role of CD36 and Caveolin‐1 in left ventricular heart function
  807. Mutation in CD36gene protects from malaria
  808. Effects of probucol on ox-LDL induced apoptosis and CD36, Caveolin-1 expression in THP-1 macrophages
  809. CD36 Modulates Macrophage Spreading and Migration in response to oxidized LDL
  810. Effects of monocyte-endothelium interaction on the expression of CD36 in monocytes
  811. CD36–a marker for drug sensitive acute megakaryoblastic leukemia
  812. Cellular cholesterol regulates expression of the macrophage type B scavenger receptor, CD36.
  813. Characterization of ligands mediating adherence of Plasmodium falciparum-infected erythrocytes to CD36 and ICAM-1.
  814. Role of CD36‐HRGP‐TSP‐1 Pathway in Tumor Biology
  815. … ] P [superscript] M in Cultured Muscle Cells: Does FABP [superscript] P [superscript] M Function to Transport Fatty Acids Only in the Presence of CD36?.
  816. CD36 Plays a Role in Murine Thrombosis Induced by Vascular Injury
  817. Change of CD36 expression in minipigs fed high fat/high cholesterol diet
  818. EP80317, a selective ligand of the CD36 scavenger receptor, reduces 111In‐labeled macrophages trafficking to atherosclerotic lesions in apoE‐deficient mice
  819. Cytokine Upregulation of CD36, But Not ICAM-1, Increases Plasmodium Falciparum-Infected Erythrocyte Adherence to Microvascular Endothelial Cells under Shear …
  820. Influences of wild-type p53 gene overexpression on the differentiation, apoptosis and expression of scavenger receptor CD36 in U937 cells
  821. CD36 is a specific platelet receptor for native and modified low-density lipoproteins
  822. CD36 polymorphism and its relationship with body mass index and coronary artery disease in a Korean population.
  823. Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-γ
  824. Effect of activated nuclear receptors PPAR# gamma#, LXR# alpha#, RXR# alpha# on ABC1 and CD36 mRNA expression in THP-1 cells
  825. Hemolytic Uremic Syndrome Is an Immune Mediated Disease: Role of Anti-CD36 Antibodies.
  826. COLLEGEN TYPE 1 RECEPTOR (CD36) TAQMAN
  827. Inflammatory stress induces insulin resistance in CD36 knockout mice
  828. Expression of the OKM5 antigen (CD36) in normal keratinocytes and inflamed mucosa
  829. Effects of adrenaline on TGF-β1, SR-A1 and CD36 expression in THP-1 macrophages.
  830. Degree of modification of low density lipoprotein (LDL) displays different properties in size and eletric charge and induction of CD11B and CD36 in THP-1 cells
  831. Ectophosphorylation of CD36 Regulates
  832. Influences of transforming growth factor-? 1 on scavenger receptor class A and class B (CD36) in THP-1 derived macrophages
  833. Expression of CD36 (GPIIIb) on platelets in MDS.
  834. Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR⁻/⁻ apoB¹⁰⁰/¹⁰⁰ mice fed trans-10, cis-12 conjugated linoleic acid
  835. Plasmodium Falciparum: Cytoadherence occurring in the absence of knobs uses the thrombospondin receptor (CD36)
  836. Epigallocatechin gallate concomitantly increases the low density lipoprotein receptor and the CD36 protein in the liver of hypercholesterolaemic rabbits
  837. CD36—one molecule encodes many functions
  838. Thrombospondin from Activated Platelets Promotes Sickle Erythrocyte Adherence to Human Microvascular Endothelial Cells Via CD36 and Integrin Receptors
  839. … , Lauren A. Tierney, Padma K. Narayanan, and Lester W. Schwartz, the authors of “In vitro expansion of human cord blood CD36 erythroid progenitors: Temporal …
  840. Erratum: A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians (Human Molecular …
  841. Effect of Exogenous Rb Gene on Expression of CD36 Gene in U937 Cells Treated with Oxidized Low Density Lipoprotein
  842. The leukocyte expression of CD36 is reduced in patients with Alzheimer disease and an early phase of dementia
  843. Blood monocytes CD36 expression and carotid plaques
  844. CD36 and melanoma cell metastasis: 204
  845. CD36 as a multiple-ligand signaling receptor in atherothrombosis
  846. Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism
  847. Soluble CD36− a marker of the (pathophysiological) role of CD36 in the metabolic syndrome?
  848. CD36: the common soil for inflammation in obesity and atherosclerosis?
  849. CD36 is important for adipocyte recruitment and affects lipolysis
  850. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior
  851. CD36, a scavenger receptor implicated in atherosclerosis
  852. CD36: promotion from scavenger receptor to mediator of migration?
  853. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation
  854. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
  855. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and …
  856. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima
  857. CD36: linking lipids to the NLRP3 inflammasome, atherogenesis and atherothrombosis
  858. Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36
  859. CD36 as a lipid sensor
  860. Regulation of fatty acid uptake into tissues: lipoprotein lipase-and CD36-mediated pathways
  861. CD36 as a biomarker of atherosclerosis.
  862. Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile
  863. Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36
  864. Sulfo-N-succinimidyl oleate (SSO) inhibits fatty acid uptake and signaling for intracellular calcium via binding CD36 lysine 164: SSO also inhibits oxidized low density …
  865. Regulation of AMPK activation by CD36 links fatty acid uptake to β-oxidation
  866. Mechanisms of cell signaling by the scavenger receptor CD36: implications in atherosclerosis and thrombosis
  867. CD36-and GPR120-mediated Ca2+ signaling in human taste bud cells mediates differential responses to fatty acids and is altered in obese mice
  868. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress
  869. The origin of circulating CD36 in type 2 diabetes
  870. Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma
  871. The lipid-sensor candidates CD36 and GPR120 are differentially regulated by dietary lipids in mouse taste buds: impact on spontaneous fat preference
  872. The fatty acid translocase gene CD36 and lingual lipase influence oral sensitivity to fat in obese subjects
  873. Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression
  874. Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice
  875. CD36-mediated hematoma absorption following intracerebral hemorrhage: negative regulation by TLR4 signaling
  876. Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36
  877. A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling
  878. Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1 and differential effects on fatty acid …
  879. PCSK9 induces CD36 degradation and affects long-chain fatty acid uptake and triglyceride metabolism in adipocytes and in mouse liver
  880. CD36 and TLR interactions in inflammation and phagocytosis: implications for malaria
  881. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36
  882. CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs
  883. CD36 and malaria: friends or foes? A decade of data provides some answers
  884. Luminal lipid regulates CD36 levels and downstream signaling to stimulate chylomicron synthesis
  885. Apical CD36 immunolocalization in human and porcine taste buds from circumvallate and foliate papillae
  886. CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues
  887. Cytoskeletal control of CD36 diffusion promotes its receptor and signaling function
  888. CD36 mediated fatty acid-induced podocyte apoptosis via oxidative stress
  889. PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice
  890. CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD
  891. Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-β
  892. Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia
  893. Common Variants in the CD36 Gene Are Associated With Oral Fat Perception, Fat Preferences, and Obesity in African Americans
  894. CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice [S]
  895. OxLDL-induced IL-1beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation
  896. Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells
  897. In vivo, fatty acid translocase (CD36) critically regulates skeletal muscle fuel selection, exercise performance, and training-induced adaptation of fatty acid oxidation
  898. Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptors
  899. Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms
  900. Soluble CD36 ectodomain binds negatively charged diacylglycerol ligands and acts as a co-receptor for TLR2
  901. … vesicle-associated membrane proteins in insulin-and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes
  902. Chylomicron remnants are increased in the postprandial state in CD36 deficiency
  903. Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice
  904. Insulin and AMPK regulate FA translocase/CD36 plasma membrane recruitment in cardiomyocytes via Rab GAP AS160 and Rab8a Rab GTPase
  905. CD36 enhances fatty acid uptake by increasing the rate of intracellular esterification but not transport across the plasma membrane
  906. Multimolecular signaling complexes enable Syk-mediated signaling of CD36 internalization
  907. Oxidized LDL activates blood platelets through CD36/NOX2–mediated inhibition of the cGMP/protein kinase G signaling cascade
  908. The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion
  909. CD36 promotes adipocyte differentiation and adipogenesis
  910. Scavenger receptor CD36 expression contributes to adipose tissue inflammation and cell death in diet-induced obesity
  911. Exosome poly‐ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro‐atherothombotic cellular functions
  912. Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytes
  913. CD36-dependent 7-ketocholesterol accumulation in macrophages mediates progression of atherosclerosis in response to chronic air pollution exposure
  914. Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells
  915. The role of TLR2, TLR4 and CD36 in macrophage activation and foam cell formation in response to oxLDL in humans
  916. CD36 is involved in lycopene and lutein uptake by adipocytes and adipose tissue cultures
  917. Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36
  918. Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease
  919. CD36-dependent signaling mediates fatty acid-induced gut release of secretin and cholecystokinin
  920. CD36 binds oxidized low density lipoprotein (LDL) in a mechanism dependent upon fatty acid binding
  921. CD36 is involved in astrocyte activation and astroglial scar formation
  922. CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells
  923. The emerging roles of fatty acid translocase/CD36 and the aryl hydrocarbon receptor in fatty liver disease
  924. CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes
  925. FAT/CD36 is located on the outer mitochondrial membrane, upstream of long-chain acyl-CoA synthetase, and regulates palmitate oxidation
  926. FAT/CD36: a major regulator of neuronal fatty acid sensing and energy homeostasis in rats and mice
  927. Downregulation of CD36 results in reduced phagocytic ability of peritoneal macrophages of women with endometriosis
  928. Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes
  929. The human scavenger receptor CD36: glycosylation status and its role in trafficking and function
  930. CD36 is indispensable for thermogenesis under conditions of fasting and cold stress
  931. CD36 and SR-BI are involved in cellular uptake of provitamin A carotenoids by Caco-2 and HEK cells, and some of their genetic variants are associated with …
  932. Innate immunity receptor CD36 promotes cerebral amyloid angiopathy
  933. Endoplasmic reticulum stress promotes macrophage-derived foam cell formation by up-regulating cluster of differentiation 36 (CD36) expression
  934. A high content drug screen identifies ursolic acid as an inhibitor of amyloid β protein interactions with its receptor CD36
  935. CD36 plays an important role in the clearance of oxLDL and associated age-dependent sub-retinal deposits
  936. Contraction-induced skeletal muscle FAT/CD36 trafficking and FA uptake is AMPK independent
  937. CD36 and Na/K-ATPase-α1 form a proinflammatory signaling loop in kidney
  938. Intramyocellular lipid accumulation is associated with permanent relocation ex vivo and in vitro of fatty acid translocase (FAT)/CD36 in obese patients
  939. CD36-deficient mice are resistant to alcohol-and high-carbohydrate-induced hepatic steatosis [S]
  940. Free fatty acid uptake in humans with CD36 deficiency
  941. Inhibition of CD36-dependent phagocytosis by prostaglandin E2 contributes to the development of endometriosis
  942. CD36 protein is involved in store-operated calcium flux, phospholipase A2 activation, and production of prostaglandin E2
  943. The macrophage phagocytic receptor CD36 promotes fibrogenic pathways on removal of apoptotic cells during chronic kidney injury
  944. Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6
  945. Supporting roles of platelet thrombospondin-1 and CD36 in thrombus formation on collagen
  946. Amyloid-β-induced astrocytic phagocytosis is mediated by CD36, CD47 and RAGE
  947. TR4 nuclear receptor functions as a fatty acid sensor to modulate CD36 expression and foam cell formation
  948. Reduced CD36-dependent tissue sequestration of Plasmodium-infected erythrocytes is detrimental to malaria parasite growth in vivo
  949. Interactions between CD36 and global intestinal alkaline phosphatase in mouse small intestine and effects of high-fat diet
  950. CD36 AA genotype is associated with decreased lipid taste perception in young obese, but not lean, children
  951. Hypoxia up-regulates CD36 expression and function via hypoxia-inducible factor-1-and phosphatidylinositol 3-kinase-dependent mechanisms
  952. Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner
  953. CD36 genetics and the metabolic complications of obesity
  954. oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4
  955. CD36 Mediates Endothelial Dysfunction Downstream of Circulating Factors Induced by O3 Exposure
  956. Hyperinsulinemia enhances hepatic expression of the fatty acid transporter CD36 and provokes hepatosteatosis and hepatic insulin resistance
  957. Resistin increases lipid accumulation by affecting class A scavenger receptor, CD36 and ATP-binding cassette transporter-A1 in macrophages
  958. CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in …
  959. Hypoxia enhances lipid uptake in macrophages: role of the scavenger receptors Lox1, SRA, and CD36
  960. Scavenger receptor CD36 mediates uptake of high density lipoproteins in mice and by cultured cells [S]
  961. Nrf2, a PPARγ alternative pathway to promote CD36 expression on inflammatory macrophages: implication for malaria
  962. Endothelial CD36 contributes to postischemic brain injury by promoting neutrophil activation via CSF3
  963. Macrophage ADAM17 deficiency augments CD36-dependent apoptotic cell uptake and the linked anti-inflammatory phenotype
  964. CD36 level and trafficking are determinants of lipolysis in adipocytes
  965. Clearance of apoptotic cells by macrophages induces regulatory phenotype and involves stimulation of CD36 and platelet-activating factor receptor
  966. … fatty acid oxidation, and insulin signal transduction in primary human muscle cells: effects of severe obesity, fatty acid incubation, and fatty acid translocase/CD36 …
  967. Apoptosis is associated with CD36/fatty acid translocase upregulation in non‐alcoholic steatohepatitis
  968. Genetic deletion of CD36 enhances injury after acute neonatal stroke
  969. Associations between orosensory perception of oleic acid, the common single nucleotide polymorphisms (rs1761667 and rs1527483) in the CD36 gene, and 6-n …
  970. The A allele of cluster of differentiation 36 (CD36) SNP 1761667 associates with decreased lipid taste perception in obese Tunisian women
  971. Single‐nucleotide polymorphism of CD36 locus and obesity in European adolescents
  972. A novel lipopeptide from skin commensal activates TLR2/CD36-p38 MAPK signaling to increase antibacterial defense against bacterial infection
  973. Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling
  974. Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade
  975. Crucial role for LKB1 to AMPKα2 axis in the regulation of CD36-mediated long-chain fatty acid uptake into cardiomyocytes
  976. Genetic variants in BCMO1 and CD36 are associated with plasma lutein concentrations and macular pigment optical density in humans
  977. Curcumin inhibits oxLDL-induced CD36 expression and foam cell formation through the inhibition of p38 MAPK phosphorylation
  978. Decreased expression of CD36 in circumvallate taste buds of high-fat diet induced obese rats
  979. Uptake of oxLDL and IL-10 production by macrophages requires PAFR and CD36 recruitment into the same lipid rafts
  980. Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells
  981. FAT/CD36-null mice reveal that mitochondrial FAT/CD36 is required to upregulate mitochondrial fatty acid oxidation in contracting muscle
  982. Oxidized LDL–bound CD36 recruits an Na+/K+-ATPase–Lyn complex in macrophages that promotes atherosclerosis
  983. The thrombospondin-1 receptor CD36 is an important mediator of ovarian angiogenesis and folliculogenesis
  984. CD9 tetraspanin interacts with CD36 on the surface of macrophages: a possible regulatory influence on uptake of oxidized low density lipoprotein
  985. The human CD5L/AIM-CD36 axis: a novel autophagy inducer in macrophages that modulates inflammatory responses
  986. Gene expression of fatty acid‐binding proteins, fatty acid transport proteins (CD36 and FATP) and β‐oxidation‐related genes in Atlantic salmon (Salmo salar L.) fed …
  987. The scavenger receptor CD36 downmodulates the early inflammatory response while enhancing bacterial phagocytosis during pneumococcal pneumonia
  988. Inhibition of glutathione production induces macrophage CD36 expression and enhances cellular-oxidized low density lipoprotein (oxLDL) uptake
  989. Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low‐density lipoprotein
  990. CD36 in the periphery and brain synergizes in stroke injury in hyperlipidemia
  991. Oxidized LDL induces alternative macrophage phenotype through activation of CD36 and PAFR
  992. CD36 inhibitors reduce postprandial hypertriglyceridemia and protect against diabetic dyslipidemia and atherosclerosis
  993. Increased mitochondrial activity in BMP7-treated brown adipocytes, due to increased CPT1-and CD36-mediated fatty acid uptake
  994. Palmitoylation of CD36/FAT regulates the rate of its post-transcriptional processing in the endoplasmic reticulum
  995. Cardiomyocyte-specific ablation of CD36 improves post-ischemic functional recovery
  996. Hematopoietic cell–restricted deletion of CD36 reduces high-fat diet–induced macrophage infiltration and improves insulin signaling in adipose tissue
  997. Genetic variant of BDNF (Val66Met) polymorphism attenuates stroke-induced angiogenic responses by enhancing anti-angiogenic mediator CD36 expression
  998. Oral Fat Sensing and CD36 Gene Polymorphism in Algerian Lean and Obese Teenagers
  999. Vasculostatin Inhibits Intracranial Glioma Growth and Negatively Regulates In vivo Angiogenesis through a CD36-Dependent Mechanism
  1000. Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes
  1001. Molecular and functional characterization of the scavenger receptor CD36 in zebrafish and common carp
  1002. Rosiglitazone-induced CD36 up-regulation resolves inflammation by PPARγ and 5-LO-dependent pathways
  1003. A CD36-related transmembrane protein is coordinated with an intracellular lipid-binding protein in selective carotenoid transport for cocoon coloration
  1004. CD36 deficiency attenuates experimental mycobacterial infection
  1005. The putative diabetic plasma marker, soluble CD36, is non‐cleaved, non‐soluble and entirely associated with microparticles
  1006. Induction of CD36 and thrombospondin-1 in macrophages by hypoxia-inducible factor 1 and its relevance in the inflammatory process
  1007. Obesity alters the gustatory perception of lipids in the mouse: plausible involvement of lingual CD36
  1008. CD36 as a target to prevent cardiac lipotoxicity and insulin resistance
  1009. Studies on CD36 deficiency in South China: two cases demonstrating the clinical impact of anti-CD36 antibodies
  1010. Rapamycin-mediated CD36 translational suppression contributes to alleviation of hepatic steatosis
  1011. Class B scavenger receptor types I and II and CD36 mediate bacterial recognition and proinflammatory signaling induced by Escherichia coli, lipopolysaccharide, and …
  1012. CD36/SR-B2-TLR2 Dependent Pathways Enhance Porphyromonas gingivalis Mediated Atherosclerosis in the Ldlr KO Mouse Model
  1013. Patients with CD36 deficiency are associated with enhanced atherosclerotic cardiovascular diseases
  1014. Selenoprotein K is required for palmitoylation of CD36 in macrophages: implications in foam cell formation and atherogenesis
  1015. CD36-mediated cholesterol efflux is associated with PPARγ activation via a MAPK-dependent COX-2 pathway in macrophages
  1016. CD36 is involved in high glucose-induced epithelial to mesenchymal transition in renal tubular epithelial cells
  1017. Dependence of brown adipose tissue function on CD36-mediated coenzyme Q uptake
  1018. Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice
  1019. Dietary cholesterol plays a role in CD36-mediated atherogenesis in LDLR-knockout mice
  1020. Induction of TGF-β1 synthesis by macrophages in response to apoptotic cells requires activation of the scavenger receptor CD36
  1021. Differential translocation of the fatty acid transporter, FAT/CD36, and the glucose transporter, GLUT4, coordinates changes in cardiac substrate metabolism during …
  1022. The macrophage Ox-LDL receptor, CD36 and its association with type II diabetes mellitus
  1023. Inflammatory stress increases hepatic CD36 translational efficiency via activation of the mTOR signalling pathway
  1024. Oxidized LDL/CD36 interaction induces loss of cell polarity and inhibits macrophage locomotion
  1025. Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients
  1026. Advanced Oxidation Protein Products Activate Intrarenal Renin–Angiotensin System via a CD36-Mediated, Redox-Dependent Pathway
  1027. Molecular basis of antiangiogenic thrombospondin-1 type 1 repeat domain interactions with CD36
  1028. Discovery of antagonists for human scavenger receptor CD36 via an ELISA-like high-throughput screening assay
  1029. High insulin levels are required for FAT/CD36 plasma membrane translocation and enhanced fatty acid uptake in obese Zucker rat hepatocytes
  1030. Uptake of oxidized low density lipoprotein by CD36 occurs by an actin-dependent pathway distinct from macropinocytosis
  1031. Structural Basis for the Recognition of Oxidized Phospholipids in Oxidized Low Density Lipoproteins by Class B Scavenger Receptors CD36 and SR-BI 2
  1032. CD36 mediates proximal tubular binding and uptake of albumin and is upregulated in proteinuric nephropathies
  1033. CD36 as a therapeutic target for endothelial dysfunction in stroke
  1034. Soluble CD36 (sCD36) clusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabetes risk
  1035. Dietary α-tocopherol and atorvastatin reduce high-fat-induced lipid accumulation and down-regulate CD36 protein in the liver of guinea pigs
  1036. Interleukin-18-induced atherosclerosis involves CD36 and NF-κB crosstalk in Apo E−/− mice
  1037. Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunction
  1038. Ca2+ signaling in taste bud cells and spontaneous preference for fat: unresolved roles of CD36 and GPR120
  1039. Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice
  1040. Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase
  1041. CD36 homolog divergence is responsible for the selectivity of carotenoid species migration to the silk gland of the silkworm Bombyx mori [s]
  1042. Role of FAT/CD36 in fatty acid sensing, energy, and glucose homeostasis regulation in DIO and DR rats
  1043. Lipid‐induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL
  1044. Post-translational modifications, a key process in CD36 function: lessons from the spontaneously hypertensive rat heart
  1045. Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1–dependent signaling pathway
  1046. Pathogenic role of scavenger receptor CD36 in the metabolic syndrome and diabetes
  1047. The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation
  1048. CD36 upregulation mediated by intranasal LV-NRF2 treatment mitigates hypoxia-induced progression of Alzheimer’s-like pathogenesis
  1049. CD36 ectodomain phosphorylation blocks thrombospondin-1 binding: structure-function relationships and regulation by protein kinase C
  1050. Structure–activity relationships of GHRP-6 azapeptide ligands of the CD36 scavenger receptor by solid-phase submonomer azapeptide synthesis
  1051. Potential pathological roles for oxidized low-density lipoprotein and scavenger receptors SR-AI, CD36, and LOX-1 in aortic valve stenosis
  1052. CD36, but not G2A, modulates efferocytosis, inflammation, and fibrosis following bleomycin-induced lung injury [S]
  1053. Anthocyanin extracted from Hibiscus attenuate oxidized LDL-mediated foam cell formation involving regulation of CD36 gene
  1054. PKCδ signalling regulates SR-A and CD36 expression and foam cell formation
  1055. CD36-specific antibodies block release of HIV-1 from infected primary macrophages and its transmission to T cells
  1056. EP 80317, a selective CD36 ligand, shows cardioprotective effects against post-ischaemic myocardial damage in mice
  1057. Facilitation of fatty acid uptake by CD36 in insulin-producing cells reduces fatty-acid-induced insulin secretion and glucose regulation of fatty acid oxidation
  1058. Variants of CD36 gene and their association with CD36 protein expression in platelets
  1059. Curcumin enhances non-opsonic phagocytosis of Plasmodium falciparum through up-regulation of CD36 surface expression on monocytes/macrophages
  1060. Increased CD36 expression signals monocyte activation among patients with type 2 diabetes
  1061. Porphyromonas gingivalis lipopolysaccharide increases lipid accumulation by affecting CD36 and ATP-binding cassette transporter A1 in macrophages
  1062. Co-stimulation of PAFR and CD36 is required for oxLDL-induced human macrophages activation
  1063. Amyloid-β inhibits No-cGMP signaling in a CD36-and CD47-dependent manner
  1064. Oleic acid induces smooth muscle foam cell formation and enhances atherosclerotic lesion development via CD36
  1065. Highly upregulated expression of CD36 and MSR1 in circulating monocytes of patients with acute coronary syndromes
  1066. ADAMTS13 binds to CD36: a potential mechanism for platelet and endothelial localization of ADAMTS13
  1067. VPA response in SMA is suppressed by the fatty acid translocase CD36
  1068. Vav protein guanine nucleotide exchange factor regulates CD36 protein-mediated macrophage foam cell formation via calcium and dynamin-dependent processes
  1069. D4F alleviates macrophage-derived foam cell apoptosis by inhibiting CD36 expression and ER stress-CHOP pathway [S]
  1070. Genetic ablation of CD36 does not alter mouse brain polyunsaturated fatty acid concentrations
  1071. Variants in the CD36 Gene Locus Determine Whole‐Body Adiposity, but Have No Independent Effect on Insulin Sensitivity
  1072. Polymorphisms in the CD36/FAT gene are associated with plasma vitamin E concentrations in humans
  1073. The pattern recognition receptor CD36 is a chondrocyte hypertrophy marker associated with suppression of catabolic responses and promotion of repair responses to …
  1074. Human scavenger protein AIM increases foam cell formation and CD36-mediated oxLDL uptake
  1075. CD36 and taste of fat
  1076. Protein mediated fatty acid uptake: synergy between CD36/FAT-facilitated transport and acyl-CoA synthetase-driven metabolism
  1077. Prostaglandin E2 receptor subtype 2 regulation of scavenger receptor CD36 modulates microglial Aβ42 phagocytosis
  1078. Cluster‐determinant 36 (CD36) impacts on vitamin E postprandial response
  1079. CD36: A multi‐modal target for acute stroke therapy
  1080. Atorvastatin downregulates monocyte CD36 expression, nuclear NFκB and TNFα levels in type 2 diabetes
  1081. Low-bone-mass phenotype of deficient mice for the cluster of differentiation 36 (CD36)
  1082. Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles
  1083. CD36 haplotypes are associated with lipid profile in normal-weight subjects
  1084. Association of CD36 gene variants rs1761667 (G> A) and rs1527483 (C> T) with Type 2 diabetes in North Indian population
  1085. Scavenger receptor CD36 mediates inhibition of cholesterol synthesis via activation of the PPARγ/PGC‐1α pathway and Insig1/2 expression in hepatocytes
  1086. Variants of the CD36 gene and metabolic syndrome in Boston Puerto Rican adults
  1087. Visfatin induces cholesterol accumulation in macrophages through up-regulation of scavenger receptor-A and CD36
  1088. Serum soluble CD36, assessed by a novel monoclonal antibody-based sandwich ELISA, predicts cardiovascular mortality in dialysis patients
  1089. Inhibition of fatty acid translocase cluster determinant 36 (CD36), stimulated by hyperglycemia, prevents glucotoxicity in INS-1 cells
  1090. CD36 is involved in oleic acid detection by the murine olfactory system
  1091. Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress
  1092. Fatty acid (FFA) transport in cardiomyocytes revealed by imaging unbound FFA is mediated by an FFA pump modulated by the CD36 protein
  1093. A brief communication: enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and …
  1094. Cardiac triglyceride accumulation following acute lipid excess occurs through activation of a FoxO1–iNOS–CD36 pathway
  1095. Circulating CD36 and oxLDL levels are associated with cardiovascular risk factors in young subjects
  1096. CD36 protein influences myocardial Ca2+ homeostasis and phospholipid metabolism: conduction anomalies in CD36-deficient mice during fasting
  1097. AGE-modified collagens I and III induce keratinocyte terminal differentiation through AGE receptor CD36: epidermal–dermal interaction in acquired perforating …
  1098. Increased FAT/CD36 cycling and lipid accumulation in myotubes derived from obese type 2 diabetic patients
  1099. Neuronal expression of CD36, Cd44, and Cd83 antigen transcripts maps to distinct and specific murine brain circuits
  1100. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA
  1101. SR-BI/CD36 chimeric receptors define extracellular subdomains of SR-BI critical for cholesterol transport
  1102. Involvement of CD36 and intestinal alkaline phosphatases in fatty acid transport in enterocytes, and the response to a high-fat diet
  1103. Impaired Cd14 and CD36 expression, bacterial clearance, and Toll-like receptor 4-Myd88 signaling in caveolin-1-deleted macrophages and mice
  1104. CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice
  1105. Vav family Rho guanine nucleotide exchange factors regulate CD36-mediated macrophage foam cell formation
  1106. Associations between CD36 gene polymorphisms and susceptibility to coronary artery heart disease
  1107. The Toll‐like receptor 2 (TLR2) ligand FSL‐1 is internalized via the clathrin‐dependent endocytic pathway triggered by CD14 and CD36 but not by TLR2
  1108. Silencing CD36 gene expression results in the inhibition of latent-TGF-β1 activation and suppression of silica-induced lung fibrosis in the rat
  1109. CD36 contributes to malaria parasite-induced pro-inflammatory cytokine production and NK and T cell activation by dendritic cells
  1110. … compound quercitrin dampens VEGF induction and PPARγ activation in oxidized LDL-exposed murine macrophages: association with scavenger receptor CD36
  1111. Soluble CD36 in plasma and urine: a plausible prognostic marker for diabetic nephropathy
  1112. Plasmodium falciparum malaria and the immunogenetics of ABO, HLA, and CD36 (platelet glycoprotein IV)
  1113. Fatty acid transporter CD36 mediates hypothalamic effect of fatty acids on food intake in rats
  1114. A dual mechanism of action for skeletal muscle FAT/CD36 during exercise
  1115. Preference for linoleic acid in obesity-prone and obesity-resistant rats is attenuated by the reduction of CD36 on the tongue
  1116. Regulation of MSR-1 and CD36 in macrophages by LOX-1 mediated through PPAR-γ
  1117. Protective or Deleterious Role of Scavenger Receptors SR-A and CD36 on Host Resistance to Staphylococcus aureus Depends on the Site of Infection
  1118. Expression of CD36 by olfactory receptor cells and its abundance on the epithelial surface in mice
  1119. Interaction of thrombospondin1 and CD36 contributes to obesity-associated podocytopathy
  1120. CD36 Participates in PrP106–126-Induced Activation of Microglia
  1121. CD36 deletion improves recovery from spinal cord injury
  1122. … oxygen species (ROS) mediate p300-dependent STAT1 protein interaction with peroxisome proliferator-activated receptor (PPAR)-γ in CD36 protein expression and …
  1123. Preliminary studies on CD36 gene in type 2 diabetic patients from north India
  1124. NLRP3 inflammasome activation: CD36 serves double duty
  1125. High-density lipoprotein increases the uptake of oxidized low density lipoprotein via PPARγ/CD36 pathway in inflammatory adipocytes
  1126. Cardiospecific CD36 suppression by lentivirus-mediated RNA interference prevents cardiac hypertrophy and systolic dysfunction in high-fat-diet induced obese mice
  1127. CD36 deficiency protects against malarial anaemia in children by reducing Plasmodium falciparum‐infected red blood cell adherence to vascular endothelium
  1128. Adipose and muscle tissue profile of CD36 transcripts in obese subjects highlights the role of CD36 in fatty acid homeostasis and insulin resistance
  1129. Permissive action of protein kinase Cz in insulin-induced CD36-and GLUT4 translocation in cardiac myocytes
  1130. Functional consequences of CD36 downregulation by TLR signals
  1131. Plasmodium falciparum-induced CD36 clustering rapidly strengthens cytoadherence via p130CAS-mediated actin cytoskeletal rearrangement
  1132. Ca2+ binding/permeation via calcium channel, CaV1. 1, regulates the intracellular distribution of the fatty acid transport protein, CD36, and fatty acid metabolism
  1133. Specific binding of hypochlorite-oxidized HDL to platelet CD36 triggers proinflammatory and procoagulant effects
  1134. Two cases of platelet transfusion refractoriness associated with anti‐CD36
  1135. CD36 is essential for regulation of the host innate response to staphylococcus aureus α-toxin–mediated dermonecrosis
  1136. Pathways commonly dysregulated in mouse and human obese adipose tissue: FAT/CD36 modulates differentiation and lipogenesis
  1137. Inflammatory cytokine-mediated regulation of thrombospondin-1 and CD36 in conjunctival cells
  1138. Activation of AMPKα2 is not required for mitochondrial FAT/CD36 accumulation during exercise
  1139. Dietary lipids inform the gut and brain about meal arrival via CD36-mediated signal transduction
  1140. Context dependent role of the CD36-thrombospondin-histidine-rich glycoprotein axis in tumor angiogenesis and growth
  1141. Responses of skeletal muscle lipid metabolism in rat gastrocnemius to hypothyroidism and iodothyronine administration: a putative role for FAT/CD36
  1142. Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African Americans
  1143. The excreted polysaccharide of Pleurotus eryngii inhibits the foam-cell formation via down-regulation of CD36
  1144. Circulating soluble CD36 is associated with glucose metabolism and interleukin-6 in glucose-intolerant men
  1145. Pivotal role for platelet-activating factor receptor in CD36 expression and oxLDL uptake by human monocytes/macrophages
  1146. Selective transport of long-chain fatty acids by FAT/CD36 in skeletal muscle of broilers
  1147. Wnt1 positively regulates CD36 expression via TCF4 and PPAR-γ in macrophages
  1148. Impact of circulating monocyte CD36 level on atrial fibrillation and subsequent catheter ablation
  1149. Multiphasic triacylglycerol dynamics in the intact heart during acute in vivo overexpression of CD36
  1150. CD36 mRNA in the gastrointestinal tract is differentially regulated by dietary fat intake in obesity-prone and obesity-resistant rats
  1151. Receptor of advanced glycation end products (RAGE) positively regulates CD36 expression and reactive oxygen species production in human monocytes in diabetes
  1152. Krüppel-like factor 2 promotes liver steatosis through upregulation of CD36
  1153. Aged garlic extract inhibits CD36 expression in human macrophages via modulation of the PPARγ pathway
  1154. Is plasma soluble CD36 associated with cardiovascular risk factors in early onset coronary artery disease patients?
  1155. A novel ELISA for measuring CD36 protein in human adipose tissue
  1156. ROS-dependent Syk and Pyk2-mediated STAT1 activation is required for 15 (S)-hydroxyeicosatetraenoic acid-induced CD36 expression and foam cell formation
  1157. Polymorphism of the CD36 Gene and Cardiovascular Risk Factors in Patients with Coronary Artery Disease Manifested at a Young Age
  1158. Icariin Inhibits Foam Cell Formation by Down‐Regulating the Expression of CD36 and Up‐Regulating the Expression of SR‐BI
  1159. Lack of Association of CD36 SNPs With Early Onset Obesity: A Meta‐Analysis in 9,973 European Subjects
  1160. FAT/CD36 regulates PEPCK expression in adipose tissue
  1161. FAT/CD36 is localized in sarcolemma and in vesicle-like structures in subsarcolemma regions but not in mitochondria
  1162. SR‐BI, CD36, and caveolin‐1 contribute positively to cholesterol efflux in hepatic cells
  1163. Diverse CD36 expression among Japanese population: defective CD36 mutations cause platelet and monocyte CD36 reductions in not only deficient but also normal …
  1164. Single nucleotide polymorphisms in CETP, SLC46A1, SLC19A1, CD36, BCMO1, APOA5, and ABCA1 are significant predictors of plasma HDL in healthy adults
  1165. Aged garlic extract inhibits homocysteine-induced scavenger receptor CD36 expression and oxidized low-density lipoprotein cholesterol uptake in human …
  1166. Metabolic Syndrome Is Linked to Chromosome 7q21 and Associated With Genetic Variants in CD36 and GNAT3 in Mexican Americans
  1167. CD36 Gene Variants and Their Association with Type 2 Diabetes in an Indian Population
  1168. Oxidized high-density lipoprotein impairs the function of human renal proximal tubule epithelial cells through CD36
  1169. Dysregulation of CD36 upon TLR‐2 stimulation in monocytes from patients with atopic dermatitis and the TLR2 R753Q polymorphism
  1170. Hepatic fat accumulation and regulation of FAT/CD36: an effect of hepatic irradiation
  1171. Each of the four intracellular cysteines of CD36 is essential for insulin-or AMP-activated protein kinase-induced CD36 translocation
  1172. Insight into the mechanism of lipids binding and uptake by CD36 receptor
  1173. FAT/CD36 expression is not ablated in spontaneously hypertensive rats
  1174. Molecular hydrogen attenuates fatty acid uptake and lipid accumulation through downregulating CD36 expression in HepG2 cells
  1175. Ethanol extract of propolis protects macrophages from oxidized low density lipoprotein-induced apoptosis by inhibiting CD36 expression and endoplasmic reticulum …
  1176. Contribution of fatty acid transporter (CD36) genetic variant rs1761667 to body mass index, the TAMRISK study
  1177. Oxidant production, oxLDL uptake, and CD36 levels in human monocyte–derived macrophages are downregulated by the macrophage-generated antioxidant 7, 8 …
  1178. Circulating soluble CD36 is a novel marker of liver injury in subjects with altered glucose tolerance
  1179. CD36 Recruits α5β1 Integrin to Promote Cytoadherence of P. falciparum-Infected Erythrocytes
  1180. Parkin reinvents itself to regulate fatty acid metabolism by tagging CD36
  1181. Estradiol enhances effects of fructose rich diet on cardiac fatty acid transporter CD36 and triglycerides accumulation
  1182. Nrf2-driven CD36 and HO-1 gene expression in circulating monocytes correlates with favourable clinical outcome in pregnancy-associated malaria
  1183. Link between intestinal CD36 ligand binding and satiety induced by a high protein diet in mice
  1184. CD36 and Fyn Kinase Mediate Malaria-Induced Lung Endothelial Barrier Dysfunction in Mice Infected with Plasmodium berghei
  1185. Differential effects of chronic, in vivo, PPAR’s stimulation on the myocardial subcellular redistribution of FAT/CD36 and FABPpm
  1186. HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters
  1187. Comparative studies of vertebrate platelet glycoprotein 4 (CD36)
  1188. CD36 overexpression predisposes to arrhythmias but reduces infarct size in spontaneously hypertensive rats: gene expression profile analysis
  1189. Decreased expression of adipose CD36 and FATP1 are associated with increased plasma non-esterified fatty acids during prolonged fasting in northern elephant seal …
  1190. Omega-3 fatty acids attenuate constitutive and insulin-induced CD36 expression through a suppression of PPARα/γ activity in microvascular endothelial cells
  1191. HIV-1 Nef impairs key functional activities in human macrophages through CD36 downregulation
  1192. Hypochlorite-oxidized LDL induces intraplatelet ROS formation and surface exposure of CD40L—A prominent role of CD36
  1193. Positive association of common variants in CD36 with neovascular age-related macular degeneration
  1194. Calcium signaling recruits substrate transporters GLUT4 and CD36 to the sarcolemma without increasing cardiac substrate uptake
  1195. Enhanced hepatic apoA-I secretion and peripheral efflux of cholesterol and phospholipid in CD36 null mice
  1196. Oxidized high-density lipoprotein impairs endothelial progenitor cells’ function by activation of CD36-MAPK-TSP-1 pathways
  1197. 4-Hydroxynonenal enhances CD36 expression on murine macrophages via p38 MAPK-mediated activation of 5-lipoxygenase
  1198. Molecular signaling operated by a diet‐compatible mixture of oxysterols in up‐regulating CD36 receptor in CD68 positive cells
  1199. Omental adipose tissue overexpression of fatty acid transporter CD36 and decreased expression of hormone-sensitive lipase in insulin-resistant women with …
  1200. Effect of radiation on hepatic fat metabolism in rat and mouse: A role of radiation-induced TNF-α in the regulation of FAT/CD36
  1201. oxHDL decreases the expression of CD36 on human macrophages through PPARγ and p38 MAP kinase dependent mechanisms
  1202. CD36 modulates proinflammatory cytokine responses to Plasmodium falciparum glycosylphosphatidylinositols and merozoites by dendritic cells
  1203. Phytosterol-enriched yogurt increases LDL affinity and reduces CD36 expression in polygenic hypercholesterolemia
  1204. CD36 initiated signaling mediates ceramide-induced TXNIP expression in pancreatic beta-cells
  1205. Molecular cloning, characterization, and expression analysis of fatty acid translocase (FAT/CD36) in the pigeon (Columba livia domestica)
  1206. Role of CD36 in early NAFLD development varies with type of mice used as experimental control groups
  1207. Commentary on Myers et al.: growing role of the innate immunity receptor CD36 in central nervous system diseases
  1208. Trauma-hemorrhagic shock induces a CD36-dependent RBC endothelial-adhesive phenotype
  1209. Pleiotropic effect of pyridoxamine on diabetic complications via CD36 expression in KK-Ay/Ta mice
  1210. Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver disease
  1211. The expression of CD36 in vessels with blood–brain barrier impairment in a stroke‐prone hypertensive model
  1212. FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma
  1213. Thrombospondin-1/CD36 pathway contributes to bone marrow-derived angiogenic cell dysfunction in type 1 diabetes via Sonic hedgehog pathway suppression
  1214. CD36 Gene Variants in Early Prediction of Type 2 Diabetes Mellitus
  1215. Metabolic profiling of hearts exposed to sevoflurane and propofol reveals distinct regulation of fatty acid and glucose oxidation: CD36 and pyruvate dehydrogenase as …
  1216. CD36 genotype associated with ischemic stroke in Chinese Han
  1217. Myocardial energy provision is preserved by increased utilization of glucose and ketone bodies in CD36 knockout mice
  1218. Low levels of CD36 in peripheral blood monocytes in subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study in a Mexican population
  1219. Enhanced CD36 expression changes the role of Nrf2 activation from anti-atherogenic to pro-atherogenic in apoE-deficient mice
  1220. Three dimensional structure prediction of fatty acid binding site on human transmembrane receptor CD36
  1221. Quantitation of CD36 (platelet glycoprotein IV) expression on platelets and monocytes by flow cytometry: Application to the study of Plasmodium falciparum malaria
  1222. Inflammatory stress exacerbates lipid-mediated renal injury in ApoE/CD36/SRA triple knockout mice
  1223. Identification and characterization of class B scavenger receptor CD36 from the hard tick, Haemaphysalis longicornis
  1224. OxLDL or TLR2-induced cytokine response is enhanced by oxLDL-independent novel domain on mouse CD36
  1225. An imbalance between CD36 and ABCA1 protein expression favors lipid accumulation in stroke-prone ulcerated carotid plaques
  1226. Adipokines enhance oleic acid-induced proliferation of vascular smooth muscle cells by inducing CD36 expression
  1227. CD36 gene is associated with thickness of atheromatous plaque and ankle− brachial index in patients with early coronary artery disease
  1228. Impact of different low‐dose ritonavir regimens on lipids, CD36, and Adipophilin expression
  1229. Unsaturated long-chain fatty acids inhibit the binding of oxidized low-density lipoproteins to a model CD36
  1230. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice
  1231. CD36 T188G gene polymorphism and severe falciparum malaria in India
  1232. Fever induction by systemic stimulation with macrophage-activating lipopeptide-2 depends upon TLR2 but not CD36
  1233. Pattern recognition scavenger receptors, SR-A and CD36, have an additive role in the development of colitis in mice
  1234. Common variation in the CD36 (fatty acid translocase) gene is associated with left-ventricular mass
  1235. CD36 and macrophage scavenger receptor a modulate foam cell formation via inhibition of lipid-laden platelet phagocytosis
  1236. The class A scavenger receptor SR-A/CD204 and the class B scavenger receptor CD36 regulate immune functions of macrophages differently
  1237. Refractory platelet transfusion in a patient with CD36 deficiency due to pseudothrombocytopenia
  1238. CD36 single nucleotide polymorphism is associated with variation in low-density lipoprotein-cholesterol in young Japanese men
  1239. Succinimidyl oleate, established inhibitor of CD36/FAT translocase inhibits complex III of mitochondrial respiratory chain
  1240. Imbalanced response of ATP-binding cassette transporter A1 and CD36 expression to increased oxidized low-density lipoprotein loading contributes to the …
  1241. A CD36 synthetic peptide inhibits silica-induced lung fibrosis in the mice
  1242. CD36 is required for myoblast fusion during myogenic differentiation
  1243. CD36, but not GPR120, is required for efficient fatty acid utilization during endurance exercise
  1244. Fenofibrate reduces postprandial hypertriglyceridemia in CD36 knockout mice
  1245. Conjugated linoleic acids regulate triacylglycerol and cholesterol concentrations in macrophages/foam cells by the modulation of CD36 expression
  1246. A role of CD36 in the perception of an oxidised phospholipid species in mice
  1247. Modulation of human monocyte CD36 by type 2 diabetes mellitus and other atherosclerotic risk factors
  1248. The anti-TNF-α antibody infliximab inhibits the expression of fat-transporter-protein FAT/CD36 in a selective hepatic-radiation mouse model
  1249. Both CD62 and CD162 antibodies prevent formation of CD36‐dependent platelets, rosettes, and artefactual pseudoexpression of platelet markers on white blood cells …
  1250. Identification of two antagonists of the scavenger receptor CD36 using a high-throughput screening model
  1251. Lack of consistency between two commercial ELISAs and against an in-house ELISA for the detection of CD36 in human plasma
  1252. … of cellular proteins induced by hyaluronic acid-modified surfaces utilizing a mass spectrometry-based profiling system: over-expression of CD36, CD44, CDK9, and …
  1253. Sterol regulatory element-binding proteins, liver X receptor, ABCA1 transporter, CD36, scavenger receptors A1 and B1 in nephrotic kidney
  1254. Dyslipidemia in human kidney transplant recipients receiving cyclosporine and tacrolimus is associated with different expression of CD36 on peripheral blood …
  1255. Suppression of FAT/CD36 mRNA by human growth hormone in pancreatic β-cells
  1256. COX-2 inhibition and inhibition of cytosolic phospholipase A2 increase CD36 expression and foam cell formation in THP-1 cells
  1257. Peroxisome Proliferator-Activator Receptor: A Link between Macrophage CD36 and Inflammation in Malaria Infection
  1258. Intercellular adhesion molecule-4 and CD36 are implicated in the abnormal adhesiveness of sickle cell SAD mouse erythrocytes to endothelium
  1259. Kimchi methanol extract and the kimchi active compound, 3′-(4′-hydroxyl-3′, 5′-dimethoxyphenyl) propionic acid, downregulate CD36 in THP-1 macrophages …
  1260. Compare the effect of eicosapentaenoic acid and oxidized low-density lipoprotein on the expression of CD36 and peroxisome proliferator-activated receptor …
  1261. … induce translocation of CD36 to the plasma membrane through different signaling pathways in 3T3-L1 adipocytes, and with a differential functionality of the CD36
  1262. Association study of CD36 single nucleotide polymorphisms with essential hypertension in the Northeastern Han Chinese
  1263. Fatty acid ethanolamides modulate CD36-mRNA through dietary fatty acid manipulation in Syrian Golden hamsters
  1264. Transgenic rescue of defective CD36 enhances myocardial adenylyl cyclase signaling in spontaneously hypertensive rats
  1265. Identification, evolution and expression of a CD36 homolog in the basal chordate amphioxus Branchiostoma japonicum
  1266. 7-Ketocholesteryl-9-carboxynonanoate enhances the expression of ATP-binding cassette transporter A1 via CD36
  1267. Intestinal lipid absorption, GLP-2, and CD36: still more mysteries to moving fat
  1268. CD36 c.1264 T>G Null Mutation Impairs Acquisition of IgG Antibodies to Plasmodium falciparum MSP1‐19 Antigen and is Associated with Higher Malaria Incidences …
  1269. Effects of AMPK activators on the sub-cellular distribution of fatty acid transporters CD36 and FABPpm
  1270. The involvement of CD36 in monocyte activation by antiphospholipid antibodies
  1271. The CD36 dynamic change after radiation therapy in lung cancer patients and its correlation with symptomatic radiation pneumonitis
  1272. Association of the CD36 gene with impaired glucose tolerance, impaired fasting glucose, type-2 diabetes, and lipid metabolism in essential hypertensive …
  1273. Clonal variants of Plasmodium falciparum exhibit a narrow range of rolling velocities to host receptor CD36 under dynamic flow conditions
  1274. The effect of caveolin-1 (Cav-1) on fatty acid uptake and CD36 localization and lipotoxicity in vascular smooth muscle (VSM) cells
  1275. CD36 and intestinal fatty acid absorption
  1276. CD36 binds oxldl in a mechanism dependent upon fatty acid binding
  1277. Flow cytometry-evaluated platelet CD36 expression, reticulated platelets and platelet microparticles in essential thrombocythaemia and secondary thrombocytosis
  1278. CD36 deficiency predisposing young children to fasting hypoglycemia
  1279. Common sequence variants in CD36 gene and the levels of triglyceride and high-density lipoprotein cholesterol among ethnic Chinese in Taiwan
  1280. Endomorphin-1 prevents lipid accumulation via CD36 down-regulation and modulates cytokines release from human lipid-laden macrophages
  1281. The effect of albumin on podocytes: the role of the fatty acid moiety and the potential role of CD36 scavenger receptor
  1282. Assessment of key amino-acid residues of CD36 in specific binding interaction with an oxidized low-density lipoprotein
  1283. A Method for Positive and Negative Selection of Plasmodium falciparum Platelet-Mediated Clumping Parasites and Investigation of the Role of CD36
  1284. High-density lipoprotein inhibits the uptake of modified low-density lipoprotein and the expression of CD36 and FcγRI
  1285. Liver-artery interactions via the plasminogen-CD36 axis in macrophage foam cell formation: new evidence for the role of remote organ crosstalk in atherosclerosis
  1286. Cleavage and reduced CD36 ectodomain density on heart and spleen macrophages in the spontaneously hypertensive rat
  1287. CD36 deficiency blunts effects of diet on regulatory T cells in murine gonadal adipose tissue and mesenteric lymph nodes
  1288. Lowbush blueberries inhibit scavenger receptors CD36 and SR-A expression and attenuate foam cell formation in ApoE-deficient mice
  1289. The associations between polymorphisms in the CD36 gene, fat oxidation and cardiovascular disease risk factors in a young adult Australian population: a pilot study
  1290. Synthesis and structure–activity relationship of N-(2-arylethyl) isoquinoline derivatives as human scavenger receptor CD36 antagonists
  1291. Association between rs1049673 polymorphism in CD36 and premature coronary heart disease
  1292. Novel factors and mechanisms in control of CD36-mediated cardiac fatty acid transport
  1293. A synthetic peptide-based assay system for detecting binding between CD36 and an oxidized low-density lipoprotein
  1294. The scavenger receptor CD36 contributes to the neurotoxicity of bone marrow-derived monocytes through peroxynitrite production
  1295. Spontaneous bacterial keratitis in CD36 knockout mice
  1296. Association of CD36 gene polymorphisms with echo- and electrocardiographic parameters in patients with early onset coronary artery disease
  1297. PDC expressing CD36, CD61 and IL-10 may contribute to propagation of immune tolerance: Brief Definite Report
  1298. Elevated platelet expression of CD36 may contribute to increased risk of thrombo-embolism in active inflammatory bowel disease
  1299. Cilostazol attenuates 4-hydroxynonenal-enhanced CD36 expression on murine macrophages via inhibition of NADPH oxidase-derived reactive oxygen …
  1300. Circulating CD36 is reduced in HNF1A-MODY carriers
  1301. CD36‐related protein in Schistosoma japonicum: candidate mediator of selective cholesteryl ester uptake from high‐density lipoprotein for egg maturation
  1302. Signal-enhanced electrochemical immunosensor for CD36 based on cascade catalysis of a GOx labeled Prussian blue functionalized Ceria nanohybrid
  1303. PP2 and piceatannol inhibit PrP106–126-induced iNOS activation mediated by CD36 in BV2 microglia
  1304. … validation of unsaturated long-chain fatty acids as inhibitors for oxidized low-density lipoprotein binding to CD36 via assays with synthetic CD36 peptide-cross-linked …
  1305. The association of CD36 variants with polypoidal choroidal vasculopathy compared to typical neovascular age-related macular degeneration
  1306. Oxidized low density lipoprotein induces macrophage endoplasmic reticulum stress via CD36.
  1307. Platelet CD36 Links Not Only α-Granule–Derived Proteins to Thrombus Stability But Also Metabolic and Oxidant Stress to a Prothrombotic Phenotype
  1308. CD36 expression in the brains of SAMP8
  1309. The macrophage pattern recognition scavenger receptors SR-A and CD36 protect against microbial induced pregnancy loss
  1310. Rapid alternative absorption of dietary long-chain fatty acids with upregulation of intestinal glycosylated CD36 in liver cirrhosis
  1311. In vivo Extravasated Human Monocytes have an Altered Expression of CD16, HLA‐DR, CD86, CD36 and CX3CR1
  1312. The whole genome expression analysis using two microarray technologies to identify gene networks that mediate the myocardial phenotype of CD36 …
  1313. Polymorphism of CD36 gene, carbohydrate metabolism and plasma CD36 concentration in obese children. A preliminary study
  1314. Role of CD36 in oral and postoral sensing of lipids
  1315. Role of FAT/CD36 in novel PKC isoform activation in heart of spontaneously hypertensive rats
  1316. Pharmacogenetic interaction between dexamethasone and CD36-deficient segment of spontaneously hypertensive rat chromosome 4 affects triacylglycerol and …
  1317. Acrolein-induced oxidative stress in NAD (P) H oxidase subunit gp91phox knock-out mice and its modulation of NFκB and CD36
  1318. When monocytes and platelets compete: The effect of platelet count on the flow cytometric measurement of monocyte CD36
  1319. Is CD36 gene polymorphism in region encoding lipid-binding domain associated with early onset CAD?
  1320. Diabetes insipidus contributes to traumatic brain injury pathology via CD36 neuroinflammation
  1321. Differential effects of strength training and testosterone treatment on soluble CD36 in aging men: possible relation to changes in body composition
  1322. Mipu1 inhibits lipid accumulation through down-regulation of CD36 in RAW264. 7 cells
  1323. Analysis of Human CD36 Gene Sequence Alterations in the Oxidized Low-Density Lipoprotein-Binding Region Using Denaturing High-Performance Liquid …
  1324. CD36-deficient congenic strains show improved glucose tolerance and distinct shifts in metabolic and transcriptomic profiles
  1325. Positive association of CD36 gene variants with the visual outcome of photodynamic therapy in polypoidal choroidal vasculopathy
  1326. Association of CD36 Gene Variants and Metabolic Syndrome in Iranians
  1327. Elevated uptake of free fatty acids via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma
  1328. Characterization & evolutionary analysis of human CD36 gene
  1329. The role of CD36 receptor in the phagocytosis of oxidized lipids and AMD
  1330. CD36 gene polymorphism and susceptibility to nephropathies
  1331. Abstract LB-338: A novel LPA-PKD1-FoxO1 pathway in endothelial cells provides an angiogenic switch via down-regulation of CD36 transcription and induction of …
  1332. Development of an in vitro system for screening the ligands of a membrane glycoprotein CD36
  1333. Study of CI962235 (Ins1361A), rs3212018 (16 bp del) and rs1049673 (G>C) CD36 gene polymorphisms in T2DM patients of North India.
  1334. The role of CD36 in the effect of arginine in atherosclerotic rats
  1335. Inhibition of latent transforming growth factor-β1 activation by lentivirus-mediated short hairpin RNA targeting the CD36 gene in NR8383 cells
  1336. The effects and underlying mechanism of CD36 in high glucose-induced rat glomerular mesangial cells apoptosis
  1337. Comment on “Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice”
  1338. Proprotein convertase subtilisin/kexin type 9 (PCSK9) targets the CD36 receptor for degradation
  1339. CD36 modulation in the subintimal trapping and LDL-mediated migration of macrophages
  1340. Synthesis and structure-activity relationship of 13-hexylberberine analogues as CD36 antagonists
  1341. CD36 expression and lipid metabolism following an oral glucose challenge in South Asians
  1342. Inflammatory stress promotes lipid accumulation in the aorta and liver of SR-A/CD36 double knock-out mice
  1343. Indoxyl sulfate stimulates oxidized LDL uptake through up-regulation of CD36 expression in THP-1 macrophages
  1344. Prokaryotic expression of FAT/CD36 fusion protein and the specific effects on the deposition of visceral fat in cockerel chicks.
  1345. Intermedin inhibits uptake of oxidized LDL via CD36 pathway in RAW264. 7 cells
  1346. Tetramethylpyrazine (TMP) switches energy signalling from the PKCζ-GLUT4-glucose pathway back to the SIRT1-CD36-fatty acid pathway similar to …
  1347. Oxidized LDL Signaling “Primes” GPVI-Mediated Platelet Activation in a CD36-Dependent Manner
  1348. Identification of two paralogous caprine CD36 genes that display highly divergent mRNA expression profiles
  1349. Differential translocation of fat/CD36 and glut4 coordinates changes in cardiac substrate metabolism during ischemia and reperfusion
  1350. Growth hormone-releasing peptides, CD36, and stimulation of cholesterol efflux: cyclooxygenase-2 is the link
  1351. Engulfment of spermatozoa by cumulus cells and the role of CD36
  1352. CD36 Mediates a Pro‐inflammatory Signaling Loop in Fat and Contributes to Insulin Resistance
  1353. The inhibitory effect of latent transforming growth factor β1 activation and silicosis by CD36 targeted RNA interference in silicosis model of rat
  1354. Pressure overload induces hypertrophy and impaired cardiac function in long-chain fatty acid transporter CD36 knockout mice
  1355. Scavenger Receptor CD36 Mediates Inhibition of Cholesterol Synthesis via Activation of the LKB1-AMPK Pathway and Insig1/Insig2 Expression in Hepatocytes
  1356. … W P253: Repeated Remote Ischemic Conditioning (RIC) after Intracerebral Hemorrhage Regulates Macrophage Polarization and CD36 Expression to Promote …
  1357. HDAC 7 Couples LPA Signaling to Endothelial Cell CD36 Gene Regulation to Switch off TSP-1 Mediated Antiangiogenic Responses
  1358. Intimate relation between genic expression of scavenger receptor CD36 and transcription factor SREBP2
  1359. Clinical relevance of thrombospondin receptor (CD36) expression in Egyptian de novo adult acute myeloid leukemia
  1360. CD36 regulates the malaria-induced pro-inflammatory cytokine responses and activation of NK and T cell by dendritic cells (P3298)
  1361. Adhesion analysis of different PfEMP1 variants to CD36, ICAM-1 and primary endothelial cells
  1362. cDNA cloning and sequence analysis of Apo A1, CD36 and DGAT2 genes from goose.
  1363. An association analysis between the variability of the caprine CD36 and CD36-like genes and dairy traits
  1364. CD36 polymorphisms are associated with fat discrimination, reported fat ingestive behaviors, and obesity in African‐Americans
  1365. Activation of Vascular Cells by Microparticles and Other Danger Signals Via the CD36 Scavenger Receptor
  1366. Endothelial cell specific CD36 deletion reduces uptake of fatty acids by the heart
  1367. Quantitative analysis of proteins facilitating fatty acid uptake: CD36, Caveolin-1, FATP4 and ACSL1
  1368. Genetic Variation at ICAM-1 and CD36: A Study of Malaria Resistance Candidate Loci in Diverse Global Human Populations
  1369. Thrombospondin 1/CD36 signaling promotes vascular smooth muscle cell proliferation and contributes to neointimal hyperplasia
  1370. A CD36 polymorphism associated with eight-times increased susceptibility to cerebral malaria in Central Sudan
  1371. Oxidised LDL activates platelet NADPH oxidase through CD36 to promote thrombosis
  1372. Plasma scavenger receptor BI and CD36 expression change and susceptibility of atherosclerosis in patients post liver transplantation
  1373. Modulation of TLR2-mediated inflammation by azapeptides as selective ligands of CD36 in atherosclerosis
  1374. Expression of CD36 gene and its association with serum biochemical level in duck.
  1375. Hormonal regulation of the class B scavenger receptors CD36 and SR-BI, in the rat liver.
  1376. Poly Herbal Formulation Prevents Foam Cell Formation Possibly Through Attenuation of CD36 Scavenger Receptor Signalling Cascade
  1377. Interaction Between CD36 and Oxidized LDL Induces Loss of Cell Polarity and Inhibits Macrophage Migration: A Mechanism of Macrophage Trapping
  1378. CD36: an inflammatory mediator in acute brain injury
  1379. EGFP-EGF1 protein-conjugated PEG-PLA nanoparticles for tissue targeted drug delivery of CD36-siRNA for atherosclerosis inhibition
  1380. Mediterranean diet modulates the effect of rs1761667 in the CD36 gene on FFA concentration and BMI in a high cardiovascular risk population
  1381. Regulation of anti-angiogenic pedf through a tsp-1-CD36 pathway in prostate cancer
  1382. Association of rs10499859 A> G and rs13246513 C> T variants of CD36 gene and metabolic syndrome: TLGS
  1383. ICAM-4 and CD36 are implicated in the abnormal adhesiveness to endothelium of sickle cell SAD mouse erythrocytes
  1384. … Factors of Elevated Tricuspid Regurgitant Jet Velocity in Children with Sickle Cell Disease: Association with Age, Hemolysis, Oxygen Saturation and CD36 …
  1385. Polymorphism of CD36 gene and its association with serum biochemical parameters and meat quality in ducks.
  1386. The effect of low volume high intensity interval training on sarcolemmal content of fatty acid transport proteins (FAT/CD36 and FABPpm) in young men
  1387. The Functional Role of CD36 Involved in Fatty Acid Transduction
  1388. Association between the single nucleotide polymorphisms of human CD36 gene and acute coronary syndrome
  1389. Antioxidant and Atherogenic Foam cell Prevention Ability of Methanol and Aqueous Extract of Emblica Officinalis Fruits and Its Effect on CD36 and ABCA1 Gene …
  1390. Transcription factor activator protein-2beta accelerates lipid accumulation in macrophages via enhancing the transcription of CD36.
  1391. Fatty acid binding to CD36 affects oxLDL uptake
  1392. The Expressions of CD36, Inflammatory Markers and Biomarkers of Endothelial Function in Patients with Primary Hypertension
  1393. CD36 Controls VEGF in Choroidal Neovascularization
  1394. Lung Endothelial Barrier Dysfunction In Murine Malaria: Role Of CD36 And Soluble Guanylyl Cyclase (sGC)
  1395. Identification of a caprine locus paralogous to the CD36 gene with a complementary transcriptional expression profile.
  1396. CD36 Sensing of Metabolic Danger Signals is a Common Mechanism of Nlrp3 Inflammasome Activation
  1397. B31 PNEUMONIA, ACUTE RESPIRATORY INFECTION: The Scavenger Receptor CD36 Enhances The Early Inflammatory Response To Intrapulmonary Infection With …
  1398. CD36 regulates hepatic lipid metabolism and the development hepatic steatosis in mice: 1146
  1399. Restoring CD36 trafficking: novel roads for treating diabetic cardiomyopathy
  1400. Inhibition of fatty acid translocase cluster determinant 36 (FAT/CD36) prevents glucotoxicity in INS-1 cells
  1401. Fatty Acid Preference is Differentially Mediated by Nutritional Status and Lingual CD36 in Obesity‐Prone and Resistant Rats
  1402. Frequency of CD36 Deficiency on Platelets and Monocytes in Koreans
  1403. Modulation of CD36 scavenger receptor expression by curcumin and vitamin E affects cellular uptake of lipids and bacteria (639.1)
  1404. CD36 expression in monocytes and ankylosing spondylitis
  1405. GW24-e0756 Nicotine exacerbates atherosclerosis by upregulation and activation of CD36 in macrophage
  1406. The fatty acid translocase CD36 could be burden at life’s winter
  1407. Mechanisms of Anti-Angiogenic Signaling by CD36
  1408. Discovery of novel CD36 receptor modulators as potential drug candidates for choroidal neovascularization.
  1409. Reduced Secretion of Tumor Necrosis Factor-a. and Interleukin-l~ from Monocyte-Derived Macrophages of CD36-Deficient Subjects in Response to Oxidized LDL
  1410. CD36 is one of important receptors promoting renal tubular injury by advanced oxidation protein products.
  1411. LPA/PKD-1-HDAC7-FoxO1 signaling-mediated endothelial CD36 transcriptional repression and proarteriogenic reprogramming
  1412. CD36 Is a Critical Component of the Corneal Epithelial Barrier to Infection
  1413. Expression and distribution of the scavenger receptor CD36 suggests important roles in the pathophysiology of spinal cord injury (729.3)
  1414. The role of CD36 in thrombospondin-1 mediated antiangiogenesis: A study of regulation of CD36 ectophosphorylation and mechanisms of VEGFinhibition
  1415. Oxidized low-density lipoprotein induces autophagy in macrophages via CD36-mediated oxidative stress
  1416. Enhanced Systemic Atherosclerosis in CD36 Deficient Patients With Acute Coronary Syndrome-Impact of CD36 Deficiency on Fat Intake
  1417. CD36 Deficiency Reduces Obesity-associated Inflammation And Oxidative Stress In Heart
  1418. Three-Dimensional Protein Structure Prediction for CD36
  1419. Intestinal CD36. A lipid-sensor involved in the processing of chylomicrons in rodents
  1420. Increased circulating soluble CD36 is associated with advanced steatosis in patients with nonalcoholic fatty liver disease: 561
  1421. STATS PLAYS A CRUCIAL ROLE IN HEPATIC LIPID METABOLISM THROUGH REGULATION OF CD36 EXPRESSION: 1663
  1422. CD36 Impacts Stroke Injury In Hyperlipidemia Through MCP-1/CCR2 Axis.
  1423. Conduction abnormalities in metabolically stressed CD36 deficient mouse
  1424. THE EFFECTS OF A PROMOTER POLYMORPHISM IN THE CD36 GENE ON FUEL UTILISATION AND AEROBIC EXERCISE CAPACITY
  1425. Plasma Membrane Organization Promotes CD36 Signal Transduction in Endothelial Cells
  1426. CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocyte cultures
  1427. Vertebrate Scavenger Thrombospondin Receptor (CD36): Comparative Studies of a Major Cell 7 Surface Glycoprotein 8
  1428. Influence of CD36 gene suppression induced by RNA interference on L-TGF-1 activation derived from macrophages in rats after bleomycin treatment
  1429. BMPR2 mutation in cardiomyocytes impairs insulin‐dependent trafficking of CD36
  1430. Expression and Analysis of Microtus fortis against Schistosoma japonicum CD36 Gene
  1431. CD36 displays features of a lipid-sensor involved in chylomicron processing in the rodent small intestine
  1432. Effect of ciglitazone on THP-1 macrophage CD36 expression and cholesterol influx
  1433. Roles Of The Membrane Protein CD36 In Fatty Acid Transport And Metabolism
  1434. 117: The expression of CD36 in preterm and term pregnancies
  1435. The Implications of CD36 Alteration on Rodent Skeletal Muscle Lipid Metabolism
  1436. CD36 Expression in Human Monocytic Leukemia Cell Lines: THP-l and THP-l Subtype, Show Different Expressions of Type I and Type n Scavenger Receptors
  1437. Platelet CD36 Induces ERK5 Activation through a Redox-Regulated Signaling Pathway to Promote a Prothrombotic Phenotype
  1438. Compare the effect of eicosapentaenoic acid and Ooxidized Low-density lipoprotein on the expression of CD36 and peroxisome proliferator-activated receptor gamma
  1439. Expression of CD36 and LDL-r ex vivo is not influenced by HAART: PIs exert toxic effects in vitro on monocytes but it is reversed by albumin
  1440. Subtle roles of platelet CD36 and thrombospondin-1 in murine thrombus formation on collagen
  1441. Regulation of lipid metabolism in adipocytes and hepatocytes by hexarelin through scavenger receptor CD36
  1442. Purification and Characterisation of the Ectodomain of the Scavenger Receptor CD36.
  1443. The Hypolipidemic Effect of Curcumin Involves Up‐regulation of CD36 Expression in Response to Higher Tissue Levels of cAMP
  1444. Myocardial cell signaling in spontaneously hypertensive rats with transgenic and congenic expression of CD36
  1445. Analysis and identification of a novel CD36 allele, 1142 T> G
  1446. Control of CD36 phosphorylation by global intestinal alkaline phosphatase mediates intestinal adaptation to high-fat diet
  1447. Low RIP140 expression rescues basal FA uptake via differential expression of FATP1 and CD36 in skeletal muscle cells exposed to high palmitate
  1448. Involvement of zinc in fatty acid transport function of CD36: A novel link to type 2 diabetes
  1449. SAT0135 Low Levels of CD36 in Peripheral Blood Monocytes in Subclinical Atherosclerosis in Rheumatoid Arthritis: A Cross-Sectional Study of A Mexican Population
  1450. Detection of Atherosclerotic Lesions and Intimal Macrophages Using CD36-Targeted Liposomes
  1451. LPA-PKD-1-HDAC7/NCoR1-FoxO1 signaling axis regulates endothelial cell CD36 transcription and stimulates arteriogenic responses
  1452. Microparticles Induce Antiangiogenic Signaling in Microvascular Endothelial Cells by Activating a CD36-Dependent Signaling Pathway Involving Src Kinases and …
  1453. Research Article Clearance of Apoptotic Cells by Macrophages Induces Regulatory Phenotype and Involves Stimulation of CD36 and Platelet-Activating Factor …
  1454. Microparticles Inhibit Angiogenic Activities of Microvascular Endothelial Cells via a CD36 Dependent Signaling Pathway Involving Reactive Oxygen Species
  1455. CD36, but not G2A, Modulates Efferocytosis, Inflammation and Fibrosis Following Bleomycin-induced Lung Injury
  1456. Serum Concentrations of Linoleic Acids and Their Derivatives by Lipid Peroxidation Are Increased in Patients With CD36 Deficiency
  1457. Effects of Ginkgo Biloba Extract on Cellular Cholesterol Content and CD36 Expression of Macrophages from Diabetic Rats
  1458. Effect of CD36 deficiency on carbohydrate and lipid metabolism is contextually determined by genomic background and reflected in transcriptomic profile
  1459. The Scavenger Receptor CD36
  1460. Exercise Attenuates Heart failure in Cardiac Lipoprotein Lipase/CD36 Double Knockout Mice
  1461. Activation of Intracellular Protein Kinase C (PKC) Alpha by Phorbol 12-Myristate 13-Acetate (PMA) Induces CD36 Ectodomain Phosphorylation
  1462. INVESTIGATION OF T1264G POLYMORPHISM OF CD36 GENE IN ETHNIC KYRGYZ MALES WITH DYSLIPIDEMIA
  1463. CD36 overexpression predisposes to arrhythmias but reduces infarct size in spontaneously hypertensive rats: gene expression profile analysis 2
  1464. Malaria in the lung: The role of the scavenger receptor CD36 in malaria-induced acute lung injury
  1465. CD36 Genetic Variant Impacts Nitric Oxide Regulation of Endothelial Function: Response to Chronic Treatment with Phosphodiesterase 5 Inhibition
  1466. Thrombospondin‐2 may exert its effects on fetoplacental development in the BPH/5 mouse model of preeclampsia (PE) through CD36 and CD47 receptors
  1467. Expression Of CD36 and The Presence Of Cytoplasmic Granules In Blasts Predicts Poor Prognosis In Children With B-Lymphoblastic Leukemia
  1468. The CD36 mediated uptake of fatty acids in hepatocytes is coupled to membrane bound PLA2: the novel synthetic bile acid-phosholipid conjugate (UDCA-LPE) as …
  1469. 239: CD14 and CD36 Restrain Inducible T reg Generation and Prevent Costimulatory Blockade Extension of Allograft Survival
  1470. Oxidised low-density lipoproteins induce platelet adhesion, activation and spreading through novel CD36-tyrosine kinase/Rho kinase dependent signalling pathways
  1471. Proatherogenic and Proinflammatory Effects of Angiotensin II are Mediated by Activation of HIF-CD36 Pathway in Macrophages
  1472. Cytoskeletal Control of Receptor Diffusion in Membrane Promotes CD36 Function and Signaling
  1473. THE ROLE OF THE LFA-FAMILY OF ADHESION MOLECULES, CD36 (0KM5) AND MEMBRANE BOUND IL-1 (miL-1) IN THE AUTOLOGOUS MECLR IN …
  1474. CD36 expression in chondrocytes is involve in the clearance of apoptotic cells (P3096)
  1475. Prothrombotic Platelet Signaling By the Scavenger Receptor CD36
  1476. Interaction between CD36 and Oxidized LDL Modulates Macrophage Cytoskeletal Functions: A Mechanism of Macrophage Trapping
  1477. Abstract P162: Nicotine via CD36, Cox2 and Oxidative Stress Promotes Podocyte Injury: Link Between E-cigarettes and Renal Disease Progression?
  1478. Sequence variation in the CD36 gene and its relationship with plasma HDL cholesterol levels
  1479. GW24-e0355 Clinical Research on Association of CD36 Single Nucleotide Polymorphisms with Essential Hypertension
  1480. Calcium signaling recruits substrate transporters GLUT4 and CD36 to the sarcolemma without increasing substrate uptake
  1481. The effects of a polymorphism in the CD36 gene on metabolic response to a short-term endurance training program: A pilot study
  1482. CD36 Inhibitors Reduce Postprandial Hypertriglyceridemia and Protect against Diabetic
  1483. … The spontaneously hypertensive rat heart displays a reduced capacity to use long chain fatty acids for energy production prior to hypertrophy: role of CD36
  1484. IS INTRON 3 POLYMORPHISM OF CD36 GENE ASSOCIATED WITH HYPERCHOLESTEROLEMIA RISK IN OVERWEIGHT CHILDREN? A PRELIMINARY …
  1485. High fat diet induces renal injury in mice with CD36/SR-A/ApoE KO knockout and its mechanism.
  1486. Context Dependent Role of the CD36-Thrombospondin-Histidine-Rich
  1487. Thrombospondin-1/CD36 Pathway Contributes to Bone Marrow-Derived Angiogenic Cell
  1488. A Case of Dilated Cardiomyopathy Associated with CD36 Deficiency
  1489. Research Article Oxidized LDL Induces Alternative Macrophage Phenotype through Activation of CD36 and PAFR
  1490. Viral infection of macrophages reduces CD36 expression: Implications for phagocytosis of non-typeable haemophilus influenzae
  1491. Short paper Pharmacogenetic interaction between dexamethasone and CD36-deficient segment of spontaneously hypertensive rat chromosome 4 affects …
  1492. Effect of simvastatin on cholesterol efflux and expression of ABCA1 and CD36 in THP-1 macrophages
  1493. Molecular Imaging and prevention of Atherosclerosis using CD36-targeted nanoparticles and Epigallocatechin gallate
  1494. PS3-18. CD36 contributes to hepatic lipid accumulation and inflammation in aged mice fed a high-fat diet
  1495. Effects of Chlamydia pneumoniae on expression of SR-A1 and CD36 in THP-1-derived macrophages and the associated signal transduction pathway.
  1496. Fatty Acid Transporter CD36 Mediates Hypothalamic Effect of Fatty Acids on Food Intake
  1497. PS9-12. Involvement of zinc in the fatty acid transport function of CD36: a novel link to type 2 diabetes
  1498. Visualization and Quantification of FDG Uptake in Myocardium of CD36-Knockout Mice in vivo Using a Novel High Spatial Resolution Semiconductor PET
  1499. PS9-41. Translocation of substrate transporters glut4 and CD36 to the sarcolemma and subsequent activation to increase substrate uptake are separate events
  1500. INVESTIGATION OF CD36 SCAVENGER TYPE B RECEPTOR EXPRESSING MACROPHAGES IN INTESTINAL INFLAMMATION
  1501. Role of the Thrombospondin-CD36-Histidine Rich Glycoprotein pathway in tumor growth and angiogenesis
  1502. Effects of combined supplementation of vitamins C and E on the oxidative modification of low-density lipoprotein, soluble form of CD36, soluble vascular cell …
  1503. Inflammation enhances the accumulation of lipid in ApoE/SRA/CD36 KO mice liver
  1504. CD36 and Fyn Kinase Mediate Malaria-Induced Lung Endothelial Barrier
  1505. Plasma Levels Of Soluble CD36 In Type 2 Diabetes – A Link Between Platelet Activation, Inflammation And Oxidative Stress
  1506. Handunnetti, SM et al. Involvement of CD36 on erythrocytes as a rosetting receptor for Plasmodium falciparum-infected erythrocytes. Blood 80, 2097-2104
  1507. ROCK2 mediates the uptake of fatty acids through the transcriptional regulation of CD36
  1508. Cortical Cytoskeletal Structures Constrain CD36 Receptor Motion at the Cell Surface to Enhance Aggregation and Signaling
  1509. Abstract P265: Adenosine 2A Receptor Activation Regulates Expression of Scavenger Receptors CD36 and LOX-1 in Human Macrophages and Aortic Endothelial …
  1510. Structural basis for the recognition of oxidized phospholipids in oxidized low density lipoproteins by class B scavenger receptors CD36 and SR-BI
  1511. The TLR2 ligand FSL-1 is internalized via clathrin-dependent endocytic pathway triggered by CD14 and CD36 but not by TLR2
  1512. Response to Comment on “Class B Scavenger Receptor Types I and II and CD36 Targeting Improves Sepsis Survival and Acute Outcomes in Mice”
  1513. Activation of Integrin αMβ2 on Human Monocytes Regulates Alternative Activation of Macrophages: Inhibition of 15-lipoxygenase and Scavenger Receptor CD36
  1514. p53 Promotes Cardiac Dysfunction in Diabetes Mellitus by Excessive Mitochondrial Respiration and Fat/CD36 Upregulation
  1515. HUMAN SOLUBLE CD36
  1516. Research Article Low Levels of CD36 in Peripheral Blood Monocytes in Subclinical Atherosclerosis in Rheumatoid Arthritis: A Cross-Sectional Study in a …
  1517. Docosahexaenoic Acid and Eicosapentaenoic Acid Modulate Calcium Signaling in Murine CD36-Positive Taste Buds Cells, via Phospholipase Pathways
  1518. Decreased expression of adipose fatty acid transporters CD36 and FATP1 contributes to increased plasma free fatty acids during prolonged fasting in northern …
  1519. Ethanol extract of propolis protects macrophages from oxidized low density lipoprotein-induced apoptosis by inhibiting CD36 expression and endoplasmic reticulum …
  1520. Increased Atherosclerosis Associated with Periodontal Disease Is Mediated by CD36
  1521. Patent application title: CD36 MODULATION AND USES THEREOF Inventors: Huy Ong (Ville Mont-Royal, CA) Sylvie Marleau (Rosemere, CA) André …
  1522. CD36 and Atherosclerosis
  1523. Soluble CD36 Cluster with Markers of Insulin Resistance, and High sCD36 Is Associated with Increased Type 2 Diabetes Risk
  1524. Protein Kinase D-1 Regulates CD36 Transcription and Arteriogenic Differentiation of Endothelial Cells
  1525. Effect Of CD36 Expression On H2O2-Induced Barrier Dysfunction In Mouse Lung Microvascular Endothelial Cells
  1526. 28: Frequency of CD36 and CD109 deficiency on platelets: single institute study in Korea
  1527. The Role of Spleen Tyrosine Kinase, Syk, in CD36-Toll Like Receptor Cooperative Signaling in Atherosclerosis
  1528. Platelets in atherothrombosis: roles of CD36 and P2Y12 receptors
  1529. Effect of rosiglitazone on expression of CD36 in peripheral monocytes in patients with type 2 diabetes
  1530. CD36 AA genotype is associated with decreased lipid taste perception in young obese, but not lean, children
  1531. CD36, a scavenger receptor implicated in atherosclerosis
  1532. CD36 promotes adipocyte differentiation and adipogenesis
  1533. The Involvement of CD36 in Antiangiogenic Effects of Lymphocyte-Derived Microparticles on Choroidal Neovscularization
  1534. Establishment of method detecting CD36 expression on human platelet and its application
  1535. ALTERATIONS OF MACROPHAGE GSH/GSSG STATUS REGULATE CD36 EXPRESSION AND FOAM CELL FORMATION: IMPLICATION OF GSH-ANTIOXIDANT …
  1536. Searching the extracellular domain of CD36 for fatty acid binding by Surface Plasmon Resonance
  1537. OP7-4: Chitosan protects against high fat diet-induced atherosclerosis in rats through reduction of CD36 expression and intimal thickening
  1538. Interruption of Protein-Protein Interaction of CD36 With Other Proteins Alters CD36 Biological Functions
  1539. CD36 Is Involved In Sub-retinal Deposits In Age-related Retinal Degeneration
  1540. Role of FAT/CD36 in high-fat diet-induced adipose tissue inflammation
  1541. Probing Mechanism for the Enhancement of Uptake of Fatty Acid into Cells by the Membrane Protein CD36
  1542. Effect of CD36 on cardiac ischemic tolerance and adrenergic signaling in spontaneously hypertensive rats
  1543. Metformin prevent glucotoxicity alleviating oxidative and ER stress induced CD36 in pancreatic β-cells
  1544. Curcumin inhibits oxLDL-induced CD36 expression and foam cell formation through the inhibition of p38 MAPK phosphorylation.
  1545. 807: CD36 expression in trophoblasts: implications for preeclampsia
  1546. Spontane bakterielle Keratitis in CD36-/-Knockout-Mäusen
  1547. Upregulated Expression of FAT/CD36 in Skeletal Muscle Induced by Endurance Training and Its Correlation with Insulin Sensitivity Index in Rats
  1548. CD36 Deficiency Reduces Obesity‐Associated Inflammation and Oxidative Stress in Heart
  1549. CD36 Recruits Na/K-ATPase/Lyn Complex to Mediate Proatherogenic Phenotypes in Macrophages
  1550. Inhibition of Glutathione Production by L‐Buthionine‐(S, R)‐Sulfoximine Induces Macrophage CD36 Expression
  1551. Omental adipocytes promote overexpression of CD36 in ovarian cancer cells and enhance tumorigenicity.
  1552. Pro-resolving effects of 15-deoxy-α12,14-prostaglandin J2 through activation of Nrf2-mediated CD36 expression in murine macrophages
  1553. CD36 Participates in a Signaling Pathway That Regulates Reactive Oxygen Species Formation
  1554. CD36 AA single nucleotide polymorphism (SNP) is associated with decreased lipid taste perception in Tunisian obese women: association with pro-inflammatory TNF …
  1555. CD36 Signaling Regulates Autophagy to Limit Macrophage Cholesterol Accumulation
  1556. Effect of atorvastatin on uptake of ox-LDL and expression of CD36 antigen during the transformation from U937cell into foam cell
  1557. Intravascular ultrasound features of intermediate coronary arterial lesions and the relationship of fractalkine, CD36 and LP-PLA2 with coronary artery stenosis
  1558. CD36 and interacting stresses in cardiomyopathy
  1559. CD36 is Essential to Increased Atherosclerosis Mediated by Oral Infection With Porphromonas gingivalis
  1560. The roles of CD36 in host defense and homeostasis (P3052)
  1561. Expression difference of factors CD36, NR4A1 and HES1 which were before and after the ethanol sclerotherapy for ovarian endometrial cyst detected by gene chips
  1562. GW26-e0255 Targeted down-regulation of cardiac CD36 by lentivirus-mediated RNA interference prevents cardiac hypertrophy and systolic dysfunction in high-fat …
  1563. Expression of CD36 gene and its association with serum biochemical level in duck.
  1564. Purified Mouse Anti-Mouse CD36
  1565. Oral fat sensing and CD36 Gene polymorphism in Algerian lean and obese teenagers
  1566. Selenoprotein K is required for palmitoylation of CD36 in macrophages: implications in foam cell formation and atherogenesis (P1102)
  1567. OP3-2: Metformin protects INS-1 cells from glucotoxicity via suppression of fatty acid translocase/cluster determinant 36 (CD36)
  1568. PE-54: The glucotoxicity protecting effect of ezetimibe in pancreatic beta cells via inhibition of fatty acid translocase/cluster determinant 36 (FAT/CD36)
  1569. CD36 and GPR120 differently mediate Ca2+ signaling in human taste bud cells
  1570. Expression and significance of CD36 on acute radiation-induced lung injury
  1571. Effects of inflammation on FAT/CD36 expressions in HepG2 cells loaded with fatty acids.
  1572. … induce translocation of CD36 to the plasma membrane through different signaling pathways in 3T3-L1 adipocytes, and with a differential functionality of the CD36.
  1573. (13) Genetic variant of CD36 gene is not associated with Cardiovascular risk factors in South Asians
  1574. CD36: a target to restore cardiac function in type 2 diabetes
  1575. CD36, fibroblasts and intestinal inflammation
  1576. Omental adipose tissue overexpression of fatty acid transporter CD36 and decreased expression of hormone-sensitive lipase in insulin-resistant women with …
  1577. Atherosclerosis: Role of the scavenger receptor CD36
  1578. Nicotine Promotes Foam Cell Formation and Atherosclerosis by Receptor-mediated Activation of CD36
  1579. Impact of anti-OX-LDL antibodies on CD36 mRNA expression in monocytes
  1580. … compound quercitrin dampens VEGF induction and PPARγ activation in oxidized LDL-exposed murine macrophages: association with scavenger receptor CD36.
  1581. Effects of noradrenalin on ABCA1, SR-A I and CD36 expression in THP-1 macrophages.
  1582. 15 (S)-Hydroxyeicosatetraenoic Acid Induces Foam Cell Formation by Enhancing CD36 Expression via Activation of ROS-Syk-Pyk2-STAT1 Signaling
  1583. The frequency of gene mutation related to CD36 deficiency in donors in Guangzhou.
  1584. Vav proteins are mechanistically involved in CD36‐dependent atherogenic processes
  1585. PP2 and piceatannol inhibit PrP106-126-induced iNOS activation mediated by CD36 in BV2 microglia.
  1586. CD36 Goes Line Dancing
  1587. Increased myocardial FDG uptake in CD36-deficient mice detected by means of high resolution semiconductor PET
  1588. Association of rs10499859 A> G and rs13246513 C> T variants of CD36 gene and metabolic syndrome: TLGS.
  1589. Effect of direct single-dose irradiation on fat metabolism in rat liver: FAT/CD36 as the main responsible protein?
  1590. Prokaryotic expression of FAT/CD36 fusion protein and the specific effects on the deposition of visceral fat in cockerel chicks.
  1591. Effect of liver X receptors agonists T0901317 on expression of FAT/CD36 gene mRNA in adult human skeletal muscle cell
  1592. Cardiac Surgery for a Patient with CD36 deficiency and Aortic Valve Regurgitation
  1593. Mechanism of intestinal absorption of long chain fatty acid: emerging role of CD36.
  1594. Correction: CD36/SR-B2-TLR2 Dependent Pathways Enhance Porphyromonas gingivalis Mediated Atherosclerosis in the Ldlr KO Mouse Model
  1595. Fat taste bud receptor CD36 identified in humans: Obesity explanation or excuse?
  1596. The excreted polysaccharide of Pleurotus eryngii inhibits the foam-cell formation via down-regulation of CD36.
  1597. Identification and characterization of class B scavenger receptor CD36 from the hard tick, Haemaphysalis longicornis.
  1598. GENETIC POLYMORPHISM OF CD36, FAT TASTE RECEPTOR, IS ASSOCIATED WITH DECREASED PREFERENCE OF DIETARY LIPIDS IN YOUNG OBESE …
  1599. Effects of Nuciferine on CD36 and PPARγ Expressions of THP-1 Derived Macrophage
  1600. The link between systemic and local inflammatory response to colorectal cancer; the role of CD36
  1601. … LIPOPROTEIN (HDL) CAN INFLUENCE THE FORMATION OF FOAM CELLS BY A RAPID REGULATION OF RECEPTORS (FCΓRI AND CD36) INVOLVED IN THE …
  1602. Retraction notice to ”Transcription factor activator protein-2b accelerates lipid accumulation in macrophages via enhancing the transcription of CD36”[FEBS Lett. 584 …
  1603. Patients with CD36 Deficiency Are Associated with Enhanced Atherosclerotic Cardiovascular Diseases
  1604. Provitamin A carotenoid uptake, but not retinol uptake, involves the Scavenger Receptors SR-BI and CD36
  1605. 2009 Russell Ross Memorial Lectureship in Vascular Biology—Macrophage CD36 Signaling Regulates Proatherogenic Responses to Oxidized LDL
  1606. Hypercholesterolemia promotes a CD36-dependent and endothelial nitric-oxide synthase-mediated vascular dysfunction.
  1607. Targeting CD36 as biomarker for metastasis prognostic: how far from translation into clinical practice?
  1608. CD36 gene variants and their clinical relevance: a narrative review
  1609. Dietary fatty acids and CD36-mediated cholesterol homeostasis: potential mechanisms
  1610. The multifunctionality of CD36 in diabetes mellitus and its complications—update in pathogenesis, treatment and monitoring
  1611. Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
  1612. CD36 and lipid metabolism in the evolution of atherosclerosis
  1613. CD36 in atherosclerosis: pathophysiological mechanisms and therapeutic implications
  1614. CD36 in Alzheimer’s disease: an overview of molecular mechanisms and therapeutic targeting
  1615. CD36 tango in cancer: signaling pathways and functions
  1616. CD36 in chronic kidney disease: novel insights and therapeutic opportunities
  1617. Thematic Review Series: Lipid Transfer Proteins: Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization
  1618. Endothelial cell CD36 reduces atherosclerosis and controls systemic metabolism
  1619. The role of CD36 receptor in the pathogenesis of atherosclerosis.
  1620. The role of CD36 in the regulation of myocardial lipid metabolism
  1621. CD36 differently regulates macrophage responses to smooth and rough lipopolysaccharide
  1622. Associations of plasma CD36 and body fat distribution
  1623. Now in 3D! Novel insights into CD36 structure and function
  1624. The CD36-PPARγ pathway in metabolic disorders
  1625. CD36 as a target for metabolic modulation therapy in cardiac disease
  1626. CD36–A novel molecular target in the neurovascular unit
  1627. The role of CD36 in endothelial albumin transcytosis
  1628. CD36 signaling in vascular redox stress
  1629. From fat to FAT (CD36/SR-B2): Understanding the regulation of cellular fatty acid uptake
  1630. CD36 signal transduction in metabolic diseases: novel insights and therapeutic targeting
  1631. Lymphocytes upregulate CD36 in adipose tissue and liver
  1632. CD36 actions in the heart: lipids, calcium, inflammation, repair and more?
  1633. Prognostic and immunological role of CD36: A pan-cancer analysis
  1634. Targeting metastasis-initiating cells through the fatty acid receptor CD36
  1635. CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability
  1636. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis
  1637. Intestinal CD36 and other key proteins of lipid utilization: role in absorption and gut homeostasis
  1638. CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis
  1639. CD36 (SR-B2) as a target to treat lipid overload-induced cardiac dysfunction
  1640. Circulating exosomes deliver free fatty acids from the bloodstream to cardiac cells: Possible role of CD36
  1641. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis
  1642. CD36 is a marker of human adipocyte progenitors with pronounced adipogenic and triglyceride accumulation potential
  1643. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors
  1644. Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice
  1645. The effect of homocysteine on the expression of CD36, PPARγ, and C/EBPα in adipose tissue of normal and obese mice
  1646. Frequency of CD36 deficiency in Thais analyzed by quantification of CD36 on cell surfaces and in plasma
  1647. Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization
  1648. Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer
  1649. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors
  1650. A narrative review on progress and development of anti-CD36 antibody detection
  1651. The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis
  1652. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway
  1653. White adipose tissue surface expression of LDLR and CD36 is associated with risk factors for type 2 diabetes in adults with obesity
  1654. Bariatric surgery reduces CD36-bearing microvesicles of endothelial and monocyte origin
  1655. Regulation of the subcellular trafficking of CD36, a major determinant of cardiac fatty acid utilization
  1656. The structural basis for CD36 binding by the malaria parasite
  1657. CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis
  1658. Endothelial cell CD36 optimizes tissue fatty acid uptake
  1659. CD36 plays a negative role in the regulation of lipophagy in hepatocytes through an AMPK-dependent pathway [S]
  1660. CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys
  1661. CD36-mediated uptake of myelin debris by macrophages and microglia reduces neuroinflammation
  1662. Visceral obesity and insulin resistance associate with CD36 deletion in lymphatic endothelial cells
  1663. CD36 immunization causing platelet transfusion refractoriness: narrative review
  1664. CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway
  1665. CD36 plays a critical role in proliferation, migration and tamoxifen-inhibited growth of ER-positive breast cancer cells
  1666. PCSK9 (proprotein convertase subtilisin/kexin 9) enhances platelet activation, thrombosis, and myocardial infarct expansion by binding to platelet CD36
  1667. Cell surface CD36 protein in monocyte/macrophage contributes to phagocytosis during the resolution phase of ischemic stroke in mice
  1668. A subset of Kupffer cells regulates metabolism through the expression of CD36
  1669. CD36 signaling in diabetic cardiomyopathy
  1670. Fatty acid-induced CD36 expression via O-GlcNAcylation drives gastric cancer metastasis
  1671. CD36-mediated metabolic rewiring of breast cancer cells promotes resistance to HER2-targeted therapies
  1672. CD36 promotes the epithelial–mesenchymal transition and metastasis in cervical cancer by interacting with TGF-β
  1673. Dietary oleic acid-induced CD36 promotes cervical cancer cell growth and metastasis via up-regulation Src/ERK pathway
  1674. Free fatty-acid transport via CD36 drives β-oxidation-mediated hematopoietic stem cell response to infection
  1675. Exogenous lipids promote the growth of breast cancer cells via CD36
  1676. Elevated CD36 expression correlates with increased visceral adipose tissue and predicts poor prognosis in ccRCC patients
  1677. BLTR1 and CD36 expressing microvesicles in atherosclerotic patients and healthy individuals
  1678. Nobiletin inhibits CD36-dependent tumor angiogenesis, migration, invasion, and sphere formation through the CD36/Stat3/Nf-Κb signaling axis
  1679. Mitochondrial metabolic reprogramming by CD36 signaling drives macrophage inflammatory responses
  1680. Fatty acid mobilization from adipose tissue is mediated by CD36 posttranslational modifications and intracellular trafficking
  1681. WISP1 alleviates lipid deposition in macrophages via the PPARγ/CD36 pathway in the plaque formation of atherosclerosis
  1682. Inhibition of fatty acid synthase upregulates expression of CD36 to sustain proliferation of colorectal cancer cells
  1683. CD36 overexpression: A possible etiopathogenic mechanism of atherosclerosis in patients with prediabetes and diabetes
  1684. Post-translational modifications of CD36 (SR-B2): Implications for regulation of myocellular fatty acid uptake
  1685. TREM2 promotes Aβ phagocytosis by upregulating C/EBPα-dependent CD36 expression in microglia
  1686. Quercetin protects against atherosclerosis by regulating the expression of PCSK9, CD36, PPARγ, LXRα and ABCA1
  1687. Hepatic CD36 downregulation parallels steatosis improvement in morbidly obese undergoing bariatric surgery
  1688. LncRNA TINCR/microRNA-107/CD36 regulates cell proliferation and apoptosis in colorectal cancer via PPAR signaling pathway based on bioinformatics analysis
  1689. CD36 is a matrix metalloproteinase-9 substrate that stimulates neutrophil apoptosis and removal during cardiac remodeling
  1690. The enigmatic membrane fatty acid transporter CD36: New insights into fatty acid binding and their effects on uptake of oxidized LDL
  1691. Hyperhomocysteinemia activates the aryl hydrocarbon receptor/CD36 pathway to promote hepatic steatosis in mice
  1692. A CD36 ectodomain mediates insect pheromone detection via a putative tunnelling mechanism
  1693. Metformin prevents glucotoxicity by alleviating oxidative and ER stress–induced CD36 expression in pancreatic beta cells
  1694. Apigenin inhibits STAT3/CD36 signaling axis and reduces visceral obesity
  1695. STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells
  1696. Cinnamaldehyde and allopurinol reduce fructose-induced cardiac inflammation and fibrosis by attenuating CD36-mediated TLR4/6-IRAK4/1 signaling to suppress …
  1697. Circulating CD36 is increased in hyperlipidemic mice: cellular sources and triggers of release
  1698. JUN promotes hypertrophic skin scarring via CD36 in preclinical in vitro and in vivo models
  1699. DHHC4 and DHHC5 facilitate fatty acid uptake by palmitoylating and targeting CD36 to the plasma membrane
  1700. Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice
  1701. Role of the scavenger receptor CD36 in accelerated diabetic atherosclerosis
  1702. Prolactin improves hepatic steatosis via CD36 pathway
  1703. CD36 senses dietary lipids and regulates lipids homeostasis in the intestine
  1704. Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats
  1705. Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype
  1706. PPARγ-induced upregulation of CD36 enhances hematoma resolution and attenuates long-term neurological deficits after germinal matrix hemorrhage in neonatal …
  1707. Regulation of insulin receptor pathway and glucose metabolism by CD36 signaling
  1708. LncRNA MALAT1 regulates oxLDL-induced CD36 expression via activating β-catenin
  1709. Osteoprotegerin promotes liver steatosis by targeting the ERK–PPAR-γ–CD36 pathway
  1710. Air pollution is associated with the development of atherosclerosis via the cooperation of CD36 and NLRP3 inflammasome in ApoE-/-mice
  1711. Autophagy protein ATG5 regulates CD36 expression and anti-tumor MHC class II antigen presentation in dendritic cells
  1712. Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice
  1713. CD36 regulates lipopolysaccharide-induced signaling pathways and mediates the internalization of Escherichia coli in cooperation with TLR4 in goat …
  1714. CD36 shunts eicosanoid metabolism to repress CD14 licensed interleukin-1β release and inflammation
  1715. … plasma PCSK9 in normocholesterolemic subjects is associated with upregulated adipose tissue surface‐expression of LDLR and CD36 and NLRP3 inflammasome
  1716. Empagliflozin ameliorates free fatty acid induced-lipotoxicity in renal proximal tubular cells via the PPARγ/CD36 pathway in obese mice
  1717. Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: APEROXISOME PROLIFERATOR …
  1718. CD36 deficiency affects depressive-like behaviors possibly by modifying gut microbiota and the inflammasome pathway in mice
  1719. Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions
  1720. Myeloid receptor CD36 is required for early phagocytosis of myocardial infarcts and induction of Nr4a1-dependent mechanisms of cardiac repair
  1721. ROS via BTK-p300-STAT1-PPARγ signaling activation mediates cholesterol crystals-induced CD36 expression and foam cell formation
  1722. Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation
  1723. CD36 enhances vascular smooth muscle cell proliferation and development of neointimal hyperplasia
  1724. Scavenger receptor CD36 directs nonclassical monocyte patrolling along the endothelium during early atherogenesis
  1725. Hepatic overexpression of CD36 improves glycogen homeostasis and attenuates high-fat diet-induced hepatic steatosis and insulin resistance
  1726. CD36 is a co-receptor for hepatitis C virus E1 protein attachment
  1727. CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3β/β-catenin-mediated epithelial-to-mesenchymal transition in gastric …
  1728. MicroRNA-29a suppresses CD36 to ameliorate high fat diet-induced steatohepatitis and liver fibrosis in mice
  1729. Extracellular vesicles activate a CD36-dependent signaling pathway to inhibit microvascular endothelial cell migration and tube formation
  1730. CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting
  1731. CD36-mediated uptake of surfactant lipids by human macrophages promotes intracellular growth of Mycobacterium tuberculosis
  1732. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress
  1733. Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy
  1734. Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo
  1735. Tenofovir–disoproxil–fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection
  1736. CD36‐triggered cell invasion and persistent tissue colonization by tumor microvesicles during metastasis
  1737. Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure
  1738. Impact of CD36 on chemoresistance in pancreatic ductal adenocarcinoma
  1739. Transfer of cell-surface antigens by scavenger receptor CD36 promotes thymic regulatory T cell receptor repertoire development and allo-tolerance
  1740. Nitro-oleic acid, a ligand of CD36, reduces cholesterol accumulation by modulating oxidized-LDL uptake and cholesterol efflux in RAW264. 7 macrophages
  1741. Targeting the fatty acid transport protein CD36, a class B scavenger receptor, in the treatment of renal disease
  1742. Dietary sucrose regulates the expression of the CD36 gene in hepatic tissue of rats with obesity and Non Alcoholic Fatty Liver Disease (NAFLD)
  1743. Podocyte-derived microparticles promote proximal tubule fibrotic signaling via p38 MAPK and CD36
  1744. The cell surface marker CD36 selectively identifies matured, mitochondria-rich hPSC-cardiomyocytes
  1745. CD36-mediated lipid accumulation and activation of NLRP3 inflammasome lead to podocyte injury in obesity-related glomerulopathy
  1746. Microglia-derived interleukin-10 accelerates post-intracerebral hemorrhage hematoma clearance by regulating CD36
  1747. Fatty-acid receptor CD36 functions as a hydrogen sulfide-targeted receptor with its Cys333-Cys272 disulfide bond serving as a specific molecular switch to accelerate …
  1748. CD36 and LC3B initiated autophagy in B cells regulates the humoral immune response
  1749. Understanding the distinct subcellular trafficking of CD36 and GLUT4 during the development of myocardial insulin resistance
  1750. CD36 Deficiency Impairs the Small Intestinal Barrier and InducesáSubclinical Inflammation in Mice
  1751. Potential protection against type 2 diabetes in obesity through lower CD36 expression and improved exocytosis in β-cells
  1752. Obesity induces preadipocyte CD36 expression promoting inflammation via the disruption of lysosomal calcium homeostasis and lysosome function
  1753. CTRP13 inhibits atherosclerosis via autophagy‐lysosome‐dependent degradation of CD36
  1754. CD36 expression is associated with cancer aggressiveness and energy source in esophageal squamous cell carcinoma
  1755. The antioxidant peptide SS31 prevents oxidative stress, downregulates CD36 and improves renal function in diabetic nephropathy
  1756. MicroRNA-20a-5p ameliorates non-alcoholic fatty liver disease via inhibiting the expression of CD36
  1757. Breast-associated adipocytes secretome induce fatty acid uptake and invasiveness in breast cancer cells via CD36 independently of body mass index, menopausal …
  1758. LPA/PKD-1-FoxO1 signaling axis mediates endothelial cell CD36 transcriptional repression and proangiogenic and proarteriogenic reprogramming
  1759. Hypoxia‐inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36
  1760. Orosensory detection of bitter in fat-taster healthy and obese participants: Genetic polymorphism of CD36 and TAS2R38
  1761. CD36 deficiency attenuates immune‐mediated hepatitis in mice by modulating the proapoptotic effects of CXC chemokine ligand 10
  1762. High Glucose Promotes CD36 Expression by Upregulating Peroxisome Proliferator-Activated Receptor γ Levels to Exacerbate Lipid Deposition in Renal …
  1763. Protein Kinase Cθ Via Activating Transcription Factor 2-Mediated CD36 Expression and Foam Cell Formation of Ly6Chi Cells Contributes to Atherosclerosis
  1764. Diversity‐Oriented Synthesis of Cyclic Azapeptides by A3‐Macrocyclization Provides High‐Affinity CD36‐Modulating Peptidomimetics
  1765. Lipid oversupply induces CD36 sarcolemmal translocation via dual modulation of PKCζ and TBC1D1: an early event prior to insulin resistance
  1766. Inhibition of sarcolemmal FAT/CD36 by sulfo-N-succinimidyl oleate rapidly corrects metabolism and restores function in the diabetic heart following hypoxia …
  1767. Contribution of rs3211938 polymorphism at CD36 to glucose levels, oxidized low-density lipoproteins, insulin resistance, and body mass index in Mexican …
  1768. Role of microglial and endothelial CD36 in post-ischemic inflammasome activation and interleukin-1β-induced endothelial activation
  1769. PCSK9 regulates Nox2-mediated platelet activation via CD36 receptor in patients with atrial fibrillation
  1770. SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells
  1771. Oxidized lipoprotein uptake through the CD36 receptor activates the NLRP3 inflammasome in human retinal pigment epithelial cells
  1772. Early development of definitive erythroblasts from human pluripotent stem cells defined by expression of glycophorin A/CD235a, CD34, and CD36
  1773. Carbon monoxide controls microglial erythrophagocytosis by regulating CD36 surface expression to reduce the severity of hemorrhagic injury
  1774. Aorta macrophage inflammatory and epigenetic changes in a murine model of obstructive sleep apnea: potential role of CD36
  1775. AMPK facilitates intestinal long‐chain fatty acid uptake by manipulating CD36 expression and translocation
  1776. Inhibition of the CD36 receptor reduces visceral fat accumulation and improves insulin resistance in obese mice carrying the BDNF-Val66Met variant
  1777. The nuclear orphan receptor NR2F6 promotes hepatic steatosis through upregulation of fatty acid transporter CD36
  1778. … silica nanoparticles accelerated atherosclerotic lesion progression in ApoE−/− mice through endoplasmic reticulum stress-mediated CD36 up-regulation in …
  1779. MicroRNA-26a-CD36 signaling pathway: Pivotal role in lipid accumulation in hepatocytes induced by PM2. 5 liposoluble extracts
  1780. Myocardial fatty acid uptake through CD36 is indispensable for sufficient bioenergetic metabolism to prevent progression of pressure overload-induced heart failure
  1781. Synthetic amphipathic helical peptides targeting CD36 attenuate lipopolysaccharide-induced inflammation and acute lung injury
  1782. Oxidized LDL activated eosinophil polarize macrophage phenotype from M2 to M1 through activation of CD36 scavenger receptor
  1783. Blood exosomes regulate the tissue distribution of grapefruit-derived nanovector via CD36 and IGFR1 pathways
  1784. CD36 gene polymorphism is associated with Alzheimer’s disease
  1785. Amentoflavone prevents ox-LDL-induced lipid accumulation by suppressing the PPARγ/CD36 signal pathway
  1786. Oxidized LDL phagocytosis during foam cell formation in atherosclerotic plaques relies on a PLD2–CD36 functional interdependence
  1787. Palmitate aggravates proteinuria-induced cell death and inflammation via CD36-inflammasome axis in the proximal tubular cells of obese mice
  1788. Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles
  1789. The Drosophila CD36 Homologue croquemort Is Required to Maintain Immune and Gut Homeostasis during Development and Aging
  1790. Identification of CD36 as a new interaction partner of membrane NEU1: potential implication in the pro-atherogenic effects of the elastin receptor complex
  1791. The contribution of cross-talk between the cell-surface proteins CD36 and CD47–TSP-1 in osteoclast formation and function
  1792. Polymorphism rs1761667 in the CD36 gene is associated to changes in fatty acid metabolism and circulating endocannabinoid levels distinctively in normal …
  1793. CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix
  1794. Identification of inhibitors of CD36-amyloid beta binding as potential agents for Alzheimer’s disease
  1795. Leishmania amazonensis Engages CD36 to Drive Parasitophorous Vacuole Maturation
  1796. Cysteine sulfenylation by CD36 signaling promotes arterial thrombosis in dyslipidemia
  1797. Inhibition of USP14 suppresses the formation of foam cell by promoting CD36 degradation
  1798. Proatherogenic flow increases endothelial stiffness via enhanced CD36-mediated uptake of oxidized low-density lipoproteins
  1799. Recruited monocytes modulate malaria-induced lung injury through CD36-mediated clearance of sequestered infected erythrocytes
  1800. Exogenous CXCL4 infusion inhibits macrophage phagocytosis by limiting CD36 signalling to enhance post-myocardial infarction cardiac dilation and mortality
  1801. miR-758-5p regulates cholesterol uptake via targeting the CD36 3′ UTR
  1802. Fatty acid-like Pt (IV) prodrugs overcome cisplatin resistance in ovarian cancer by harnessing CD36
  1803. Signal transducer and activator of transcription 5 plays a crucial role in hepatic lipid metabolism through regulation of CD36 expression
  1804. THBS1 regulates trophoblast fusion through a CD36-dependent inhibition of cAMP, and its upregulation participates in preeclampsia
  1805. CD36 deficiency reduces chronic BBB dysfunction and scar formation and improves activity, hedonic and memory deficits in ischemic stroke
  1806. Quercetin suppresses cell survival and invasion in oral squamous cell carcinoma via the miR-1254/CD36 cascade in vitro
  1807. Deregulated lipid sensing by intestinal CD36 in diet-induced hyperinsulinemic obese mouse model
  1808. CD36 gene expression in adipose and hepatic tissue mediates the lipids accumulation in liver of obese rats with sucrose-induced hepatic steatosis
  1809. CD36 and CD97 in pancreatic cancer versus other malignancies
  1810. Advanced oxidation protein products contribute to chronic kidney disease‐induced muscle atrophy by inducing oxidative stress via CD36/NADPH oxidase pathway
  1811. Loss of CD36 protects against diet‐induced obesity but results in impaired muscle stem cell function, delayed muscle regeneration and hepatic steatosis
  1812. Intrahepatic expression of fatty acid translocase CD36 is increased in obstructive sleep apnea
  1813. Oleate protects macrophages from palmitate-induced apoptosis through the downregulation of CD36 expression
  1814. CD36 expression on oral squamous cell carcinoma cells correlates with enhanced proliferation and migratory activity
  1815. PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway
  1816. Involvement of caveolin-1 and CD36 in native LDL endocytosis by endothelial cells
  1817. CD36 maintains the gastric mucosa and associates with gastric disease
  1818. Modulation of cAMP levels by high‐fat diet and curcumin and regulatory effects on CD36/FAT scavenger receptor/fatty acids transporter gene expression
  1819. Higher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36 [S]
  1820. GPR40 deficiency is associated with hepatic FAT/CD36 upregulation, steatosis, inflammation, and cell injury in C57BL/6 mice
  1821. Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathway
  1822. Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor
  1823. Loss of CD36 impairs hepatic insulin signaling by enhancing the interaction of PTP1B with IR
  1824. Eutopic endometrium from patients with endometriosis modulates the expression of CD36 and SIRP‐α in peritoneal macrophages
  1825. Atherogenic lipid stress induces platelet hyperactivity through CD36-mediated hyposensitivity to prostacyclin: the role of phosphodiesterase 3A
  1826. Monocyte CD36 expression associates with atherosclerotic burden in diabetes mellitus
  1827. Deubiquitination of CD36 by UCHL1 promotes foam cell formation
  1828. Fatty acid receptor CD36 functions as a surrogate parameter for lymph node metastasis in oral squamous cell carcinoma
  1829. Absence of CD36 alters systemic vitamin A homeostasis
  1830. The role of CD36 in type 2 diabetes mellitus: β-cell dysfunction and beyond
  1831. Blocking Wnt5a signaling decreases CD36 expression and foam cell formation in atherosclerosis
  1832. Cutting edge: CD36 mediates phagocyte tropism and avirulence of Toxoplasma gondii
  1833. Deciphering the elevated lipid via CD36 in mantle cell lymphoma with bortezomib resistance using synchrotron-based Fourier transform infrared spectroscopy of …
  1834. Simvastatin promotes hematoma absorption and reduces hydrocephalus following intraventricular hemorrhage in part by upregulating CD36
  1835. Hypermethylated CD36 gene affected the progression of lung cancer
  1836. Anti-atherogenic effects of CD36-targeted epigallocatechin gallate-loaded nanoparticles
  1837. Rac1-NADPH oxidase signaling promotes CD36 activation under glucotoxic conditions in pancreatic beta cells
  1838. Exogenous H2S induces Hrd1 S-sulfhydration and prevents CD36 translocation via VAMP3 ubiquitylation in diabetic hearts
  1839. Activation of peroxisome proliferator-activated receptor γ (PPARγ) and CD36 protein expression: the dual pathophysiological roles of progesterone
  1840. CD36 mediates lipid accumulation in pancreatic beta cells under the duress of glucolipotoxic conditions: Novel roles of lysine deacetylases
  1841. Role of CD36 in palmitic acid lipotoxicity in neuro-2a neuroblastoma cells
  1842. CD36 Provides Host Protection Against Klebsiella pneumoniae Intrapulmonary Infection by Enhancing Lipopolysaccharide Responsiveness and Macrophage …
  1843. Dietary α-linolenic acid supplementation alters skeletal muscle plasma membrane lipid composition, sarcolemmal FAT/CD36 abundance, and palmitate transport …
  1844. Alpha-1 antitrypsin inhibits ATP-mediated release of interleukin-1β via CD36 and nicotinic acetylcholine receptors
  1845. S100A12-CD36 axis: A novel player in the pathogenesis of atherosclerosis?
  1846. Platelet CD36 deficiency is present in 2.6% of Arabian individuals and can cause NAIT and platelet refractoriness
  1847. MiR-1254 functions as a tumor suppressor in oral squamous cell carcinoma by targeting CD36
  1848. Astragaloside IV inhibits palmitate-mediated oxidative stress and fibrosis in human glomerular mesangial cells via downregulation of CD36 expression
  1849. Dynamic chirality in the mechanism of action of allosteric CD36 modulators of macrophage-driven inflammation
  1850. A new leptin-mediated mechanism for stimulating fatty acid oxidation: a pivotal role for sarcolemmal FAT/CD36
  1851. CD36 is expressed in a defined subpopulation of neurons in the olfactory epithelium
  1852. A dipeptidyl peptidase-4 inhibitor inhibits foam cell formation of macrophages in type 1 diabetes via suppression of CD36 and ACAT-1 expression
  1853. Involvement of CYP2E1-ROS-CD36/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro
  1854. Plasma soluble CD36 of breast cancer based on pathological and clinical characteristics
  1855. Apolipoprotein C2-CD36 promotes leukemia growth and presents a targetable axis in acute myeloid leukemia
  1856. Ligand-induced growth and compaction of CD36 nanoclusters enriched in Fyn induces Fyn signaling
  1857. Successful prenatal therapy for anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model
  1858. Atypical antipsychotic drugs deregulate the cholesterol metabolism of macrophage-foam cells by activating NOX-ROS-PPARγ-CD36 signaling pathway
  1859. The rs1527483, but not rs3212018, CD36 polymorphism associates with linoleic acid detection and obesity in Czech young adults
  1860. SSO and other putative inhibitors of FA transport across membranes by CD36 disrupt intracellular metabolism, but do not affect FA translocation
  1861. Viral inhibition of bacterial phagocytosis by human macrophages: redundant role of CD36
  1862. SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2
  1863. CD36 as a molecular target of functional DNA aptamer NAFLD01 selected against NAFLD cells
  1864. Protocatechuic acid-ameliorated endothelial oxidative stress through regulating acetylation level via CD36/AMPK pathway
  1865. Tanshinone IIA prevents platelet activation and down-regulates CD36 and MKK4/JNK2 signaling pathway
  1866. Secretory Galectin-3 promotes hepatic steatosis via regulation of the PPARγ/CD36 signaling pathway
  1867. Ochratoxin A induces steatosis via PPARγ-CD36 axis
  1868. Cytotoxic necrotizing factor 1 downregulates CD36 transcription in macrophages to induce inflammation during acute urinary tract infections
  1869. Diversity-Oriented A3-Macrocyclization for Studying Influences of Ring-Size and Shape of Cyclic Peptides: CD36 Receptor Modulators
  1870. CD36 and DGAT2 facilitate the lipid-lowering effect of chitooligosaccharides via fatty acid intake and triglyceride synthesis signaling
  1871. CD36 mediates albumin transcytosis by dermal but not lung microvascular endothelial cells: role in fatty acid delivery
  1872. MMP-9-dependent serum-borne bioactivity caused by multiwalled carbon nanotube exposure induces vascular dysfunction via the CD36 scavenger receptor
  1873. Oxidized LDL upregulates macrophage DPP4 expression via TLR4/TRIF/CD36 pathways
  1874. Polyphyllin I inhibits Propionibacterium acnes-induced IL-8 secretion in HaCaT cells by downregulating the CD36/NOX1/ROS/NLRP3/IL-1β pathway
  1875. Histone methyltransferases G9a mediated lipid-induced M1 macrophage polarization through negatively regulating CD36
  1876. Carnosine stimulates macrophage-mediated clearance of senescent skin cells through activation of the AKT2 signaling pathway by CD36 and RAGE
  1877. Diet-induced obesity links to ER positive breast cancer progression via LPA/PKD-1-CD36 signaling-mediated microvascular remodeling
  1878. Distribution of CD36 deficiency in different Chinese ethnic groups
  1879. Taste changes in patients with inflammatory bowel disease: associations with PROP phenotypes and polymorphisms in the salivary protein, gustin and CD36 receptor …
  1880. Lingual CD36 and nutritional status differentially regulate fat preference in obesity-prone and obesity-resistant rats
  1881. Single nucleotide polymorphism in CD36: Correlation to peptide YY levels in obese and non-obese adults
  1882. IL-34 promotes foam cell formation by enhancing CD36 expression through p38 MAPK pathway
  1883. miRNA-133a attenuates lipid accumulation via TR4-CD36 pathway in macrophages
  1884. Downregulations of CD36 and Calpain-1, inflammation, and atherosclerosis by simvastatin in apolipoprotein E knockout mice
  1885. CD36‐fibrin interaction propagates FXI‐dependent thrombin generation of human platelets
  1886. CD36 expression in peripheral blood mononuclear cells reflects the onset of atherosclerosis
  1887. Exosomes released by imatinib‑resistant K562 cells contain specific membrane markers, IFITM3, CD146 and CD36 and increase the survival of imatinib‑sensitive …
  1888. Successful management of a hydropic fetus with severe anemia and thrombocytopenia caused by anti-CD36 antibody
  1889. Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation
  1890. Cell-surface phenotyping identifies CD36 and CD97 as novel markers of fibroblast quiescence in lung fibrosis
  1891. Ubiquitinated CD36 sustains insulin-stimulated Akt activation by stabilizing insulin receptor substrate 1 in myotubes
  1892. 15-Deoxy-Δ12,14-Prostaglandin J2 Exerts Proresolving Effects Through Nuclear Factor E2-Related Factor 2-Induced Expression of CD36 and Heme Oxygenase-1
  1893. Microarray profiling analysis identifies the mechanism of miR‐200b‐3p/mRNA‐CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor …
  1894. Obesity-driven prepartal hepatic lipid accumulation in dairy cows is associated with increased CD36 and SREBP-1 expression
  1895. Hypothalamic fatty acids and ketone bodies sensing and role of FAT/CD36 in the regulation of food intake
  1896. CD36 promotes podocyte apoptosis by activating the pyrin domain-containing-3 (NLRP3) inflammasome in primary nephrotic syndrome
  1897. Polybrominated diphenyl ether quinone exposure induces atherosclerosis progression via CD36-mediated lipid accumulation, NLRP3 inflammasome activation, and …
  1898. Investigating the association of CD36 gene polymorphisms (rs1761667 and rs1527483) with T2DM and dyslipidemia: Statistical analysis, machine learning based …
  1899. CD36 dependent redoxosomes promotes ceramide-mediated pancreatic β-cell failure via p66Shc activation
  1900. Palmitic acid interferes with energy metabolism balance by adversely switching the SIRT1-CD36-fatty acid pathway to the PKC zeta-GLUT4-glucose pathway in …
  1901. AGE-RAGE axis stimulates oxidized LDL uptake into macrophages through cyclin-dependent kinase 5-CD36 pathway via oxidative stress generation
  1902. … eating behavior in patients undergoing bariatric surgery: associations with PROP phenotypes and polymorphisms in the odorant-binding protein OBPIIa and CD36 …
  1903. CD36 mediates H2O2-induced calcium influx in lung microvascular endothelial cells
  1904. … prevents the development of high fat diet-induced non-alcoholic fatty liver disease (NAFLD) in mice via the inhibition of cluster of differentiation 36 (CD36)
  1905. Cardiotonic steroids stimulate macrophage inflammatory responses through a pathway involving CD36, TLR4, and Na/K-ATPase
  1906. Evaluation of the expression of red blood cell CD36, interleukin-6 and interleukin-8 in sickle cell anemia pediatric patients
  1907. Down-expression of CD36 in pancreatic adenocarcinoma and its correlation with clinicopathological features and prognosis
  1908. Potential effect of maternal dietary sucrose or fructose syrup on CD36, leptin, and ghrelin-mediated fetal programming of obesity
  1909. Hyperoxidized albumin modulates platelets and promotes inflammation through CD36 receptor in severe alcoholic hepatitis
  1910. CD36 receptor regulates malaria-induced immune responses primarily at early blood stage infection contributing to parasitemia control and resistance to mortality
  1911. Impact of a CD36 inhibitor on Porphyromonas gingivalis mediated atherosclerosis
  1912. Chemokine signaling enhances CD36 responsiveness toward oxidized low-density lipoproteins and accelerates foam cell formation
  1913. The influence of subclinical hypothyroidism on serum lipid profile, PCSK9 levels and CD36 expression on monocytes
  1914. Fetal/neonatal alloimmune thrombocytopenia due to anti‐CD36 antibodies: antibody evaluations by CD36‐transfected cell lines
  1915. Replication of a gene-diet interaction at CD36, NOS3 and PPARG in response to omega-3 fatty acid supplements on blood lipids: a double-blind randomized …
  1916. Synthesis and biomedical potential of azapeptide modulators of the cluster of differentiation 36 receptor (CD36)
  1917. Palmitate induces human glomerular mesangial cells fibrosis through CD36-mediated transient receptor potential canonical channel 6/nuclear factor of activated T cell …
  1918. Mitigation of insulin resistance by mangiferin in a rat model of fructose-induced metabolic syndrome is associated with modulation of CD36 redistribution in the …
  1919. Hepatic cholesterol synthesis and lipoprotein levels impaired by dietary fructose and saturated fatty acids in mice: Insight on PCSK9 and CD36
  1920. USP10 deletion inhibits macrophage-derived foam cell formation and cellular-oxidized low density lipoprotein uptake by promoting the degradation of CD36
  1921. Cluster differentiating 36 (CD36) deficiency attenuates obesity-associated oxidative stress in the heart
  1922. Genetic Variation in CD36 Is Associated with Decreased Fat and Sugar Intake in Obese Children and Adolescents
  1923. Common variants in the CD36 gene are associated with dietary fat intake, high-fat food consumption and serum triglycerides in a cohort of Quebec adults
  1924. CD36 mediates cell-surface antigens to promote thymic development of the regulatory T cell receptor repertoire and allo-tolerance
  1925. High-density lipoprotein from subjects with coronary artery disease promotes macrophage foam cell formation: role of scavenger receptor CD36 and ERK/MAPK …
  1926. CD36 family members are TCR-independent ligands for CD1 antigen–presenting molecules
  1927. Insights into binding of S100 proteins to scavenger receptors: class B scavenger receptor CD36 binds S100A12 with high affinity
  1928. … stimulates HC11 mammary epithelial cells proliferation and mammary gland development in peripubertal mice through activation of CD36-Ca2+ and PI3K/Akt …
  1929. Ganoderic acid A inhibits ox-LDL-induced THP-1-derived macrophage inflammation and lipid deposition via Notch1/PPARγ/CD36 signaling
  1930. CD36 genetic variation, fat intake and liver fibrosis in chronic hepatitis C virus infection
  1931. Circulating soluble CD36 is similar in type 1 and type 2 diabetes mellitus versus non-diabetic subjects
  1932. Fatty acid translocase (FAT/CD36) in large yellow croaker (Larimichthys crocea): Molecular cloning, characterization and the response to dietary fatty acids
  1933. Polychlorinated biphenyl quinone promotes atherosclerosis through lipid accumulation and endoplasmic reticulum stress via CD36
  1934. Simvastatin inhibited oxLDL-induced proatherogenic effects through calpain-1–PPARγ–CD36 pathway
  1935. Binding of Plasmodium falciparum to CD36 can be shielded by the glycocalyx
  1936. Liraglutide protects high-glucose-stimulated fibroblasts by activating the CD36-JNK-AP1 pathway to downregulate P4HA1
  1937. Endothelial cell CD36 deficiency prevents normal angiogenesis and vascular repair
  1938. Advanced oxidation protein products induce G1 phase arrest in intestinal epithelial cells via a RAGE/CD36-JNK-p27kip1 mediated pathway
  1939. Preventative, but not post-stroke, inhibition of CD36 attenuates brain swelling in hyperlipidemic stroke
  1940. CD36 gene polymorphism rs1761667 (G> A) is associated with hypertension and coronary artery disease in an Iranian population
  1941. Polymorphism of CD36 determines fat discrimination but not intake of high-fat food in 20-to 40-year-old adults
  1942. Suppression of CD36 attenuates adipogenesis with a reduction of P2X7 expression in 3T3-L1 cells
  1943. Pediococcus acidilactici LAB4 and Lactobacillus plantarum LAB12 assimilate cholesterol and modulate ABCA1, CD36, NPC1L1 and SCARB1 in vitro
  1944. Gene expression patterns and functional characterization of CD36 in normal hematopoietic cells
  1945. Therapeutic potentials of scavenger receptor CD36 mediated innate immune responses against infectious and non-infectious diseases
  1946. The Activation of Phosphatidylserine/CD36/TGF-β1 Pathway prior to Surgical Brain Injury Attenuates Neuroinflammation in Rats
  1947. Human Tongue Electrophysiological Response to Oleic Acid and Its Associations with PROP Taster Status and the CD36 Polymorphism (rs1761667)
  1948. CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma
  1949. Treatment of peroxidase derived from foxtail millet bran attenuates atherosclerosis by inhibition of CD36 and STAT3 in vitro and in vivo
  1950. ISO-alpha-acids improve the hematoma resolution and prevent peri-hematoma inflammations by transforming microglia via PPARgamma-CD36 axis in ICH rats
  1951. CD36 pumps fat to defang killer T cells in tumors
  1952. Hydrops fetalis associated with anti‐CD36 antibodies in fetal and neonatal alloimmune thrombocytopenia: Possible underlying mechanism
  1953. Molecular cloning and gene/protein expression of FAT/CD36 from grass carp (Ctenopharyngodon idella) and the regulation of its expression by dietary energy
  1954. The ω-carboxyl group of 7-ketocholesteryl-9-carboxynonanoate mediates the binding of oxLDL to CD36 receptor and enhances caveolin-1 expression in …
  1955. Overexpression of CD36 in mammary fibroblasts suppresses colony growth in breast cancer cell lines
  1956. Porphyromonas gingivalis infected macrophages upregulate CD36 expression via ERK/NF-κB pathway
  1957. Greater reductions in fat preferences in CALHM1 than CD36 knockout mice
  1958. CML/CD36 accelerates atherosclerotic progression via inhibiting foam cell migration
  1959. Functions of the Dictyostelium LIMP-2 and CD36 homologues in bacteria uptake, phagolysosome biogenesis and host cell defence
  1960. CD36 identified by weighted gene co-expression network analysis as a hub candidate gene in lupus nephritis
  1961. ASK1 mediates apoptosis and autophagy during oxLDL-CD36 signaling in senescent endothelial cells
  1962. Effects of CD36 genotype on oral perception of oleic acid supplemented safflower oil emulsions in two ethnic groups: a preliminary study
  1963. Polymorphisms of peroxisome proliferator-activated receptor γ (PPARγ) and cluster of differentiation 36 (CD36) associated with valproate-induced obesity in epileptic …
  1964. Evaluation of the relationship between MARCO and CD36 single-nucleotide polymorphisms and susceptibility to pulmonary tuberculosis in a Chinese Han population
  1965. Effect of 7, 8-dihydroneopterin mediated CD36 down regulation and oxidant scavenging on oxidised low-density lipoprotein induced cell death in human …
  1966. Association between rs1761667 polymorphism of CD36 gene and risk of coronary atherosclerosis in Egyptian population
  1967. … and vitamin e antagonized the Aβ 25–35-mediated neuron oxidative damage through activation of Nrf2 signaling pathways and regulation of CD36, SRB1 and FABP5 …
  1968. ALDH2 deficiency inhibits Ox-LDL induced foam cell formation via suppressing CD36 expression
  1969. miR-155–5p predictive role to decelerate foam cell atherosclerosis through CD36, VAV3, and SOCS1 pathway
  1970. Tet38 efflux pump affects Staphylococcus aureus internalization by epithelial cells through interaction with CD36 and contributes to bacterial escape from acidic and …
  1971. Developmental expression and immune role of the class B scavenger receptor CD36 in zebrafish
  1972. Immunometabolic modulation of retinal inflammation by CD36 ligand
  1973. Metabolic modulation by medium-chain triglycerides reduces oxidative stress and ameliorates CD36-mediated cardiac remodeling in spontaneously hypertensive rat …
  1974. CD36/sirtuin 1 axis impairment contributes to hepatic steatosis in ACE2-deficient mice
  1975. Feedback regulation of coronary artery disease susceptibility gene ADTRP and LDL receptors LDLR/CD36/LOX-1 in endothelia cell functions involved in …
  1976. Increased hepatic FAT/CD36, PTP1B and decreased HNF4A expression contributes to dyslipidemia associated with ethanol–induced liver dysfunction …
  1977. Fatty acid transport receptor soluble CD36 and dietary fatty acid pattern in type 2 diabetic patients: a comparative study
  1978. Black mulberry ethanol extract attenuates atherosclerosis-related inflammatory factors and downregulates PPARγ and CD36 genes in experimental atherosclerotic …
  1979. Gamma-Linolenic Acid Suppresses NF-κΒ Signaling via CD36 in the Lipopolysaccharide-Induced Inflammatory Response in Primary Goat Mammary Gland Epithelial …
  1980. CD36 gene polymorphism and plasma sCD36 as the risk factor in higher cholesterolemia
  1981. Dexamethasone programs lower fatty acid absorption and reduced PPAR-γ and fat/CD36 expression in the jejunum of the adult rat offspring
  1982. Glucose-dependent insulinotropic polypeptide suppresses foam cell formation of macrophages through inhibition of the cyclin-dependent kinase 5-CD36 pathway
  1983. CD36 is a candidate lipid sensor involved in the sensory detection of fatty acid in zebrafish
  1984. Fatty acid translocase gene CD36 rs1527483 variant influences oral fat perception in Malaysian subjects
  1985. Influence of periodontitis and scaling and root planing on insulin resistance and hepatic CD36 in obese rats
  1986. Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patients
  1987. Adiponectin has a pivotal role in the cardioprotective effect of CP‐3 (iv), a selective CD36 azapeptide ligand, after transient coronary artery occlusion in mice
  1988. A novel index using soluble CD36 is associated with the prevalence of type 2 diabetes mellitus: comparison study with triglyceride-glucose index
  1989. α‐Tocopheryl Phosphate Induces VEGF Expression via CD36/PI3Kγ in THP‐1 Monocytes
  1990. Expression profiling and functional characterization of CD36 in turbot (Scophthalmus maximus L.)
  1991. Exercise training suppresses scavenger receptor CD36 expression in kupffer cells of nonalcoholic steatohepatitis model mice
  1992. Relationship between FAT/CD36 protein in skeletal muscle and whole-body fat oxidation in endurance-trained mice
  1993. Behavioral characterization of CD36 knockout mice with SHIRPA primary screen
  1994. Comparative analysis of endothelial cell and sub-endothelial cell elastic moduli in young and aged mice: Role of CD36
  1995. Identification of mRNAs related to endometrium function regulated by lncRNA CD36–005 in rat endometrial stromal cells
  1996. Plasmodium falciparum-CD36 Structure-Function Relationships Defined by Ortholog Scanning Mutagenesis
  1997. Special series on thrombocytopenia due to immunization against CD36
  1998. Combination inhibition of triple-negative breast cancer cell growth with CD36 siRNA-loaded DNA nanoprism and genistein
  1999. Appetite control by the tongue-gut axis and evaluation of the role of CD36/SR-B2
  2000. The effect of type 2 diabetes on CD36 expression and the uptake of oxLDL: diabetes affects CD36 and oxLDL uptake
  2001. A common CD36 variant influences endothelial function and response to treatment with phosphodiesterase 5 inhibition
  2002. Age, sex, and regional differences in scavenger receptor CD36 in the mouse brain: Potential relevance to cerebral amyloid angiopathy and Alzheimer’s disease
  2003. High glucose‑induced upregulation of CD36 promotes inflammation stress via NF‑κB in H9c2 cells
  2004. CD36 gene variants is associated with type 2 diabetes mellitus through the interaction of obesity in rural Chinese adults
  2005. Oxidatively modified LDL suppresses lymphangiogenesis via CD36 signaling
  2006. Scavenger Receptor Class B, Type I, a CD36 Related Protein in Macrobrachium nipponense: Characterization, RNA Interference, and Expression Analysis …
  2007. CD36 gene polymorphisms are associated with intracerebral hemorrhage susceptibility in a Han Chinese population
  2008. Mass spectrum analysis of membrane proteins reveals that CASK, CD36 and EPB42 are differentially expressed in pancreatic adenocarcinoma
  2009. Effect of chemical interaction between oleic acid and L-Arginine on oral perception, as a function of polymorphisms of CD36 and OBPIIa and genetic ability to taste 6-n …
  2010. An evolutionary transcriptomics approach links CD36 to membrane remodeling in replicative senescence
  2011. Metabolomic insights of macrophage responses to graphene nanoplatelets: Role of scavenger receptor CD36
  2012. Sickle-trait hemoglobin reduces adhesion to both CD36 and EPCR by Plasmodium falciparum-infected erythrocytes
  2013. CD36 knockout mice are protected against lithogenic diet-induced gallstones
  2014. Isoflavone supplementation in postmenopausal women does not affect leukocyte LDL receptor and scavenger receptor CD36 expression: A double‐blind, randomized …
  2015. In vitro inhibition and reversal of Plasmodium falciparum cytoadherence to endothelium by monoclonal antibodies to ICAM-1 and CD36
  2016. CD36 deficiency inhibits retinal inflammation and retinal degeneration in Cx3cr1 knockout mice
  2017. CD36 and GPR120 Methylation Associates with Orosensory Detection Thresholds for Fat and Bitter in Algerian Young Obese Children
  2018. CD36 gene polymorphism-31118 G> A (rs1761667) is associated with overweight and obesity but not with fat preferences in Mexican children
  2019. Varenicline enhances oxidized LDL uptake by increasing expression of LOX-1 and CD36 scavenger receptors through α7 nAChR in macrophages
  2020. Single nucleotide polymorphisms in CD36 are associated with macular pigment among children
  2021. Internalization of tissue factor‐rich microvesicles by platelets occurs independently of GPIIb‐IIIa, and involves CD36 receptor, serotonin transporter and cytoskeletal …
  2022. … preserves heart function under pressure overload in mice and diminishes fatty acid uptake as well as ROS production by direct suppression of Nox4 and CD36
  2023. A scavenger receptor B (CD36)-like protein is a potential mediator of intestinal heme absorption in the hematophagous ectoparasite Lepeophtheirus salmonis
  2024. … preconditioning prevents palmitic acid‐induced cardiomyocyte apoptosis via switching metabolic GLUT4‐glucose pathway back to CD36‐fatty acid dependent
  2025. Puerarin Suppresses Na+-K+-ATPase–Mediated Systemic Inflammation and CD36 Expression, and Alleviates Cardiac Lipotoxicity In Vitro and In Vivo
  2026. CD36 and platelet-activating factor receptor promote house dust mite allergy development
  2027. … root extract ameliorates insulin resistance in fructose-fed rats by modulating sarcolemmal and intracellular fatty acid translocase/CD36 redistribution in skeletal …
  2028. Foam cell formation but not oxLDL cytotoxicity is inhibited by CD36 down regulation by the macrophage antioxidant 7, 8-dihydroneopterin
  2029. Luminescence-Resonance-Energy-Transfer-Based Luminescence Nanoprobe for In Situ Imaging of CD36 Activation and CD36–oxLDL Binding in Atherogenesis
  2030. CD36 and ERK5 link dyslipidemia to apoptotic-like platelet procoagulant function
  2031. Characterization of human dermal sheath cells reveals CD36-expressing perivascular cells associated with capillary blood vessel formation in hair follicles
  2032. Human CD36 overexpression in renal tubules accelerates the progression of renal diseases in a mouse model of folic acid-induced acute kidney injury
  2033. The natural compound dansameum reduces foam cell formation by downregulating CD36 and peroxisome proliferator-activated receptor-gamma; expression
  2034. 4, 4′-Diaponeurosporene-producing Bacillus subtilis increased mouse resistance against Salmonella typhimurium infection in a CD36-dependent manner
  2035. Thromboelastography characterized CD36 null subjects as slow clot formation and indicative of hypocoagulability
  2036. CD36-and obesity-associated granulosa cells dysfunction
  2037. Evaluation of the relationship between CD36 and MARCO single-nucleotide polymorphisms and susceptibility to carotid atherosclerosis in a Chinese Han population
  2038. Rosiglitazone pretreatment influences thrombin-induced phagocytosis by rat microglia via activating PPARγ and CD36
  2039. Visfatin promotes foam cell formation by dysregulating CD36, SRA, ABCA1, and ABCG1 expression in RAW264. 7 macrophages
  2040. High Expression of CD36 in Peripheral Blood Mononuclear Cells from Patients with Crytococcal Meningitis and Its Clinical Significance
  2041. Mapping of phosphatidylserine recognition region on CD36 ectodomain
  2042. CX3CR1 deficiency aggravates brain white matter injury and affects expression of the CD36/15LO/NR4A1 signal
  2043. Functionalization of CD36 cardiovascular disease and expression associated variants by interdisciplinary high throughput analysis
  2044. Minocycline decreases CD36 and increases CD44 in LPS-induced microglia
  2045. oxLDL inhibits differentiation of mesenchymal stem cells into osteoblasts via the CD36 mediated suppression of Wnt signaling pathway
  2046. Agaricus bisporus-derived β-glucan enter macrophages and adipocytes by CD36 receptor
  2047. Adverse maternal environment and postweaning western diet alter hepatic CD36 expression and methylation concurrently with nonalcoholic fatty liver …
  2048. CD36: a key mediator of resistance to HER2 inhibitors in breast cancer
  2049. CD36 deficiency suppresses epileptic seizures
  2050. CD5L‑induced activation of autophagy is associated with hepatoprotection in ischemic reperfusion injury via the CD36/ATG7 axis
  2051. Nifedipine exacerbates lipogenesis in the kidney via KIM-1, CD36, and SREBP upregulation: implications from an animal model for human study
  2052. Severe platelet transfusion refractoriness in association with antibodies against CD36
  2053. Leukotriene D4 upregulates oxidized low-density lipoprotein receptor 1 and CD36 to enhance oxidized LDL uptake and phagocytosis in macrophages …
  2054. Transcription factor SOX2 contributes to nonalcoholic fatty liver disease development by regulating the expression of the fatty acid transporter CD36
  2055. The CD36 Ligand-Promoted Autophagy Protects Retinal Pigment Epithelial Cells from Oxidative Stress
  2056. Correlation of gene polymorphisms of CD36 and ApoE with susceptibility of Alzheimer disease: A case–control study
  2057. High density lipoprotein (HDL) reverses palmitic acid induced energy metabolism imbalance by switching CD36 and GLUT4 signaling pathways in cardiomyocyte
  2058. CD36 gene is associated with intraocular pressure elevation after intravitreal application of anti-VEGF agents in patients with age-related macular degeneration …
  2059. 4, 4′-Diaponeurosporene, a C30 carotenoid, effectively activates dendritic cells via CD36 and NF-κB signaling in a ROS independent manner
  2060. The secretion of total and acyl ghrelin from the mouse gastric mucosa: role of nutrients and the lipid chemosensors FFAR4 and CD36
  2061. CD36 involvement in the olfactory perception of oleic aldehyde, an odour-active volatile compound, in mice
  2062. CD36 modulates fasting and preabsorptive hormone and bile acid levels
  2063. Receptor CD36 links a risk-associated allele to obesity and metabolic disorders
  2064. CD36-positive B-lymphoblasts predict poor outcome in children with B-lymphoblastic leukemia
  2065. The glucotoxicity protecting effect of ezetimibe in pancreatic beta cells via inhibition of CD36
  2066. Tet38 of Staphylococcus aureus binds to host cell receptor complex CD36–Toll-like receptor 2 and protects from teichoic acid synthesis inhibitors tunicamycin and …
  2067. Sulfated cholecystokinin-8 promotes CD36—Mediated fatty acid uptake into primary mouse duodenal enterocytes
  2068. Pressure overload impairs cardiac function in long-chain fatty acid transporter CD36-knockout mice
  2069. Bad cholesterol uptake by CD36 in T-cells cripples anti-tumor immune response
  2070. Decreased PEDF expression promotes adipogenic differentiation through the up-regulation of CD36
  2071. Low CD36 and LOX-1 Levels and CD36 Gene Subexpression Are Associated with Metabolic Dysregulation in Older Individuals with Abdominal Obesity
  2072. Prostaglandin E receptor subtype 4 protects against diabetic cardiomyopathy by modulating cardiac fatty acid metabolism via FOXO1/CD36 signalling
  2073. A case of platelet transfusion refractoriness due to anti-CD36 with a successful treatment outcome
  2074. Critical residues and motifs for homodimerization of the first transmembrane domain of the plasma membrane glycoprotein CD36
  2075. 1-O-alkyl glycerophosphate-induced CD36 expression drives oxidative stress in microglial cells
  2076. Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36
  2077. CD36 ectodomain detects apoptosis in mammalian cells
  2078. New molecular basis associated with CD36‐negative phenotype in the sub‐Saharan African population
  2079. Contribution of rare coding mutations in CD36 to type 2 diabetes and cardio-metabolic complications
  2080. Vibrio cholerae OmpU mediates CD36-dependent reactive oxygen species generation triggering an additional pathway of MAPK activation in macrophages
  2081. A single-center investigational study of CD36 antigen deficiency and platelet alloantibody distribution in different populations in Northern China as well as platelet …
  2082. CD36 is indispensable for nutrient homeostasis and endurance exercise capacity during prolonged fasting
  2083. … pomace and rosemary extract improves fructose consumption-induced insulin resistance in rats: modulation of sarcolemmal CD36 and glucose transporter-4
  2084. Intestinal GLUT5 and FAT/CD36 transporters and blood glucose are reduced by a carotenoid/MUFA-rich oil in high-fat fed mice
  2085. Plasma soluble CD36, carotid intima-media thickness and cognitive function in patients with type 2 diabetes
  2086. The computational analyses, molecular dynamics of fatty-acid transport mechanism to the CD36 receptor
  2087. Alterations in the cardiac proteome of the spontaneously hypertensive rat induced by transgenic expression of CD36
  2088. Aza‐propargylglycine installation by aza‐amino acylation: Synthesis and Ala‐scan of an azacyclopeptide CD36 modulator
  2089. Anxiety leads to up-regulation of CD36 on the monocytes of chronic hepatitis B-infected patients
  2090. Synergistic effect of Betulinic acid, Apigenin and Skimmianine (BASk) in high cholesterol diet rabbit: Involvement of CD36-TLR2 signaling pathway
  2091. Scavenger receptor CD36 mediates uptake of high density lipoproteins by tissues in mice and by cultured cells
  2092. Utility of CD36 as a novel addition to the immunophenotypic signature of RAM‐phenotype acute myeloid leukemia and study of its clinicopathological characteristics
  2093. Loss of lysophosphatidic acid receptor 1 in hepatocytes reduces steatosis via down-regulation of CD36
  2094. A single aldehyde group can serve as a structural element for recognition by transmembrane protein CD36
  2095. Assessment of direct interaction between CD36 and an oxidized glycerophospholipid species
  2096. Effects of electroacupuncture on expression of CD36 in peritoneal macrophages of rabbits with atherosclerosis
  2097. The microvesicle/CD36 complex triggers a prothrombotic phenotype in patients with non‐valvular atrial fibrillation
  2098. Phenolic Compounds from Mori Cortex Ameliorate Sodium Oleate-Induced Epithelial–Mesenchymal Transition and Fibrosis in NRK-52e Cells through CD36
  2099. Commentary on SSO and other putative inhibitors of FA transport across membranes by CD36 disrupt intracellular metabolism, but do not affect fatty acid …
  2100. CD36 polymorphisms and the age of disease onset in patients with pathogenic variants within the mutation cluster region of APC
  2101. CD36 upregulation in HT-29 tumor cells cultured on 3D multicellular spheroids culturing platform based on anisotropic magnetic hydrogel
  2102. Effect of polymorphisms in the CD36 and STAT3 genes on different dietary interventions among patients with coronary artery disease: study protocol for a …
  2103. The neurorepellent, Slit2, prevents macrophage lipid loading by inhibiting CD36-dependent binding and internalization of oxidized low-density lipoprotein
  2104. CD36 deficiency ameliorates drug-induced acute liver injury in mice
  2105. Association between plasma CD36 levels and incident risk of coronary heart disease among Danish men and women
  2106. Gender-specific associations of CD36 polymorphisms with the lipid profile and susceptibility to premature multi-vessel coronary artery heart disease in the Northern …
  2107. A search for CD36 ligands from flavor volatiles in foods with an aldehyde moiety: identification of saturated aliphatic aldehydes with 9–16 carbon atoms as potential …
  2108. WITHDRAWN: SNX10 deficiency restricts foam cell formation and protects against atherosclerosis by suppressing CD36-Lyn axis
  2109. Fluorescent labelling of membrane fatty acid transporter CD36 (SR-B2) in the extracellular loop
  2110. Peptide-directed delivery of drug-loaded nanocarriers targeting CD36 overexpressing cells
  2111. The expression patterns of SNMP1 and SNMP2 underline distinct functions of two CD36-related proteins in the olfactory system of the tobacco budworm Heliothis …
  2112. CD36 — the Achilles’ heel of Treg cells
  2113. Effects of cigarette smoke and opium on the expression of CD9, CD36, and CD68 at mRNA and protein levels in human macrophage cell line THP-1
  2114. Treatment of growth hormone attenuates hepatic steatosis in hyperlipidemic mice via downregulation of hepatic CD36 expression
  2115. Rspo2 suppresses CD36-mediated apoptosis in oxidized low density lipoprotein-induced macrophages
  2116. Inhibition of ERK1/2 improves lipid balance in rat macrophages via ABCA1/G1 and CD36
  2117. KLF9 regulates hepatic lipid metabolism via inducing CD36 expression
  2118. Associations between CD36 gene polymorphisms and metabolic response to a short-term endurance-training program in a young-adult population
  2119. Linking metabolic dysfunction to atherosclerosis via activation of macrophage CD36 gene transcription by retinol binding protein-4
  2120. The role of rs1984112_G at CD36 gene in increasing reticulocyte level among sickle cell disease patients
  2121. Assessment of direct binding interaction between CD36 and its potential lipid ligands using a peptide mimic of the receptor labeled with a fluorophore
  2122. 369 Clinical update of VT1021, a first-in-class CD36 and CD47 targeting immunomodulating agent, in subjects with pancreatic cancer and other solid tumors stratified …
  2123. Deletion of CD36 gene ameliorates glucose metabolism abnormality induced by high-fat diet and promotes liver lipid accumulation
  2124. Association of FTO rs9939609 and CD36 rs1761667 with Visceral Obesity
  2125. Genome-wide transcriptome analysis of CD36 overexpression in HepG2. 2.15 cells to explore its regulatory role in metabolism and the hepatitis B virus life cycle
  2126. Is plasma-soluble CD36 associated with density of atheromatous plaque and ankle–brachial index in early-onset coronary artery disease patients?
  2127. Atheroprotective and atheroregressive potential of azapeptide derivatives of GHRP-6 as selective CD36 ligands in apolipoprotein E-deficient mice
  2128. Oxidized Lipids and CD36-Mediated Lipid Peroxidation in CD8 T Cells Suppress Anti-Tumor Immune Responses
  2129. Azasulfurylpeptide modulation of CD36-mediated inflammation without effect on neovascularization
  2130. Potentiation of Ecstasy-induced hyperthermia and FAT/CD36 expression in chronically exercised animals
  2131. Low-dose Exogenous Ouabain alleviates cardiac lipotoxicity through suppressing expression of CD36
  2132. Expression of genes encoding IGFBPs, SNARK, CD36, and PECAM1 in the liver of mice treated with chromium disilicide and titanium nitride nanoparticles
  2133. GW27-e0657 resveratrol protects against oxidized LDL-induced foam cells formation and apoptosis through inhibition of ER stress and downregulation of CD36
  2134. LCFA Uptake and FAT/CD36: molecular cloning, tissue expression and mRNA expression responses to dietary oil sources in grass carp (Ctenopharyngodon idellus)
  2135. Identification of the odor-active volatile compound (Z, Z)-4, 7-tridecadienal as a potential ligand for the transmembrane receptor CD36
  2136. The contrary effects of Sirt1 on MCF7 cells depend on CD36 expression level
  2137. Effects of homocysteine on adipocyte differentiation and CD36 gene expression in 3T3-L1 adipocytes
  2138. The role of CD36 in macrophage lipid metabolism and function in tumor microenvironment
  2139. Association between rs1761667 CD36 polymorphism and risk of stroke in Korean patients with type 2 diabetes
  2140. The circulating fatty acid transporter soluble CD36 is not associated with carotid atherosclerosis in subjects with type 1 and type 2 diabetes mellitus
  2141. Short‐Term Hypoxia Reverses Ox‐LDL‐Induced CD36 and GLUT4 Switching Metabolic Pathways in H9c2 Cardiomyoblast Cells
  2142. Anti-CD36 mediated platelet transfusion refractoriness and related cases after stem cell transplantation
  2143. Thrombospondin-1 induces apoptosis in megakaryocytic leukemia via CD36 and caspase-3 signaling
  2144. … induces compensatory left ventricular hypertrophy by a mechanism involving gap junction lateralization and overexpression of CD36, PKC and MMP-2
  2145. Effects of β2/aβ2 on oxLDL-induced CD36 activation in THP-1 macrophages
  2146. CYP7A1, NPC1L1, ABCB1, and CD36 Polymorphisms Are Associated with Increased Serum Coenzyme Q10 after Long-Term Supplementation in Women
  2147. Fe(III)-based immobilized metal–affinity chromatography (IMAC) method for the separation of the catechol siderophore from Bacillus tequilensis CD36
  2148. Plasma CD36 and incident diabetes: a case-cohort study in Danish men and women
  2149. In Vitro Analysis of the Expression of CD11, CD29, CD36, and DC-STAMP Molecules during the Formation of Multinuclear Macrophages in BCG-Infected Mice
  2150. Transcriptome and metabolome analysis of crGART, a novel cell model of de novo purine synthesis deficiency: Alterations in CD36 expression and activity
  2151. Oxidized Lipid Uptake by Scavenger Receptor CD36 (Cluster of Differentiation 36) modulates endothelial surface properties and may contribute to atherogenesis
  2152. Adipocytes up-regulates CD36 expression, fatty acid uptake and oxidation enhancing breast cancer cell progression
  2153. Interleukin‐4 increases phagocytosis of necrotic cells by macrophages through scavenger receptor CD36
  2154. The Impact of FoxO1 Overexpression on the Regulation of CD36 in Skeletal Muscle
  2155. Reduced fatty acid use from CD36 deficiency deteriorates streptozotocin-induced diabetic cardiomyopathy in mice
  2156. Association of CD36 expression and polymorphism with serum biochemical indices in Cherry Valley duck
  2157. Evolution of specific RNA aptamers via SELEX targeting recombinant human CD36 protein: A candidate therapeutic target in severe malaria
  2158. Effects of inflammatory response on renal function and TGF-β1 pathway of rats with aging-related kidney damage by upregulating the expression of CD36.
  2159. Obesity-and age-related alterations in FAT/CD36 translocation and lipin-1 subcellular localization in skeletal muscle of the Zucker rats
  2160. Microarray integrated analysis of a gene network for the CD36 myocardial phenotype
  2161. Effects of moxibustion and moxa smoke on blood lipids, and hepatic pathologic morphology and CD36 and ABCA1 expressions in ApoE-/-mice
  2162. Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARγ/CD36 Pathway in Obese Mice
  2163. Role of the Scavenger Receptor CD36 in Accelerated Diabetic Atherosclerosis
  2164. Two novel mutations at the CD36 gene splicing sites and their molecular basis for the CD36 deficiency
  2165. A novel CD36 mutation T538C (Trp180Arg) results in CD36 deficiency and establishment of a genotyping method for the novel mutation based on sequence-specific …
  2166. CD36: a New Therapeutic Target for Chronic Kidney Disease
  2167. Genetic variation in CD36 is associated with dietary intake in Korean males
  2168. CD36–a plausible modifier of disease phenotype in familial adenomatous polyposis
  2169. … marrow-derived endothelial progenitor cells promote the transformation of periostin-positive hepatocellular carcinoma cells into CD36-positive metastasis-initialing …
  2170. Overexpression of CD36, driven by STAT3, mediates free fatty acid uptake in CLL cells
  2171. Clinical efficacy and biomarker assessment of VT1021, a CD36/CD47 dual-targeting agent, in recurrent glioblastoma
  2172. Neonatal intracranial hemorrhage with a dramatic outcome due to maternal anti CD36 antibodies
  2173. Enhanced Free Fatty Acid Uptake Via CD36 Promotes a Metabolic Switch to B-Oxidation within Hematopoietic Stem Cells in Response to Acute Infection
  2174. Circulating Soluble CD36 is Similar in Type 1 and Type 2 Diabetes Mellitus versus Non-Diabetic Subjects
  2175. Oxaliplatin and methylprednisolone-induced thrombocytopenia and monocytopenia, owing to anti-GPIIbIIIa and-CD36 antibodies in a patient with colorectal cancer
  2176. The miR-145-5p/CD36 pathway mediates PCB2-induced apoptosis in MCF-7 cells
  2177. CD36 deficiency aggravates macrophage infiltration and hepatic inflammation by up-regulating MCP-1 expression of hepatocytes through HDAC2-dependant …
  2178. Identifying CD36 as a Receptor for Albumin Transcytosis by Dermal Microvascular Endothelial Cells
  2179. Involvement of CD36 in modulating the decrease of NPY and AgRP induced by acute palmitic acid stimulation in N1E-115 cells
  2180. New role for CD36 in metastasis through fat intake
  2181. Role of CD36 in nonalcoholic fatty liver disease
  2182. ASO author reflections: regulation of chemoresistance in pancreatic ductal adenocarcinoma by scavenger receptor CD36
  2183. Changes in the activity of some metabolic enzymes in the heart of SHR rat incurred by transgenic expression of CD36
  2184. Association of CD36 gene single nucleotide polymorphism with gestational diabetes mellitus in Chinese Han population
  2185. P880 The association of serum soluble CD36 levels with the presence and extent of coronary artery disease
  2186. CD36 gene polymorphisms and Alzheimer’s disease
  2187. Association of soluble CD36 with type 2 diabetes and its complications
  2188. FOXO1 overactivation via enhancing CD36 exacerbates myocardial ischemia reperfusion injury in diabetic rats
  2189. Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in twin sisters with two CD36 frameshift mutations
  2190. 2-Year follow-up of a patient with CD36 deficiency and takotsubo cardiomyopathy
  2191. Oily fish consumption modifies the association between CD36 rs6969989 polymorphism and lipid profiles in Korean women
  2192. CD36 in Perivascular Macrophages Contributes to Neurovascular and Cognitive Dysfunction and Amyloid Angiopathy in Mice Overexpressing the Alzheimer Aβ …
  2193. Role of CD36 expression on circulating monocytes subsets in children on regular hemodialysis
  2194. Association of serum soluble CD36 with clinical variables in diabetic patients with chronic kidney diseas
  2195. LPA/PKD-1-FoxO1-CD36 signaling axis regulates capillary arterialization in ischemic conditions
  2196. Artemisinin reduces lipid accumulation in hepatocytes by inhibition of CD36 expression
  2197. Localization of thrombospondin‐1 and its receptor CD36 in the ovary of the ostrich (Struthio camelus)
  2198. Treatment with medium chain fatty acids milk of CD36-deficient preschool children
  2199. TRPM2 deficiency protects against atherosclerosis by inhibiting TRPM2-CD36 inflammatory axis in macrophages
  2200. Study on the effect of shikonin on CD36 expression and phagocytic ability of microglia in the isolated cerebral haemorrhage model
  2201. Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) Knockout Mice Exhibits Hepatosteatosis Mediated by Enhanced CD36 Hepatic Expression as a Result of …
  2202. Associations between CD36 gene polymorphisms, fat tolerance and oral fat preference in a young-adult population
  2203. The effect of genetic variation of CD36 gene on sample of Iraqi patients with essential hypertension
  2204. Inhibition of Macrophage CD36 Expression by Tamoxifen—A PPARgamma Dependent Mechanism
  2205. Overexpression of CD36 promotes colorectal cancer cell proliferation via upregulation of survivin
  2206. A subpopulation of circulating epithelial tumor cells positive for fatty acid receptor CD36 is linked to aggressiveness of breast cancer disease
  2207. Association of serum carotenoid concentration with single nucleotide polymorphisms in APOE, BCMO1, NPC1L1, CD36, GSTP1, ABCG5, FABP1, FABP2 and LIPC …
  2208. CD36 Ligand Beta-Amyloid Promotes Coagulation and Inflammation Through Toll-Like Receptor 4
  2209. Correlation of fatty acid receptor (CD36) positive circulating epithelial tumor cells (CETCs) with aggressiveness of breast cancer disease.
  2210. Regulation of CD36 gene expression by Hibiscus sabdariffa tea extracts to affect the atherosclerosis biomarkers in Saudi women
  2211. Single Nucleotide Polymorphisms in BCO1 and CD36 Are Related to Macular Pigment Among Children (OR05-04-19)
  2212. Studies of CD36 interacting with fatty acids, oxidized low-density lipoprotein, and the cellular plasma membrane
  2213. the Importance of CD36 Expression in Evaluation of Thrombotic Risk in Patients with Myeloproliferative Neoplasms
  2214. CD36: Hemin interaction axis to control immune responses and cytokine secretion from macrophages involving Lyn kinase
  2215. Fatty acid translocase CD36/SR-B2 and its mediation in transmembrane transportation of long-chain fatty acids.
  2216. Identification of functional variants for platelet CD36 expression by Massively Parallel Reporter Assay
  2217. Intravenous Lipid Emulsion Induces Endocytosis in Human Coronary Artery Endothelial Cells by a CD36/Caveolin‐1 Pathway
  2218. Scavenger receptor CD36 mediates cell-surface antigen transfer to promote thymic regulatory T cell receptor repertoire development and allo-tolerance
  2219. ASO author reflections: CD36 expression is associated with cancer aggressiveness and energy source in esophageal squamous cell carcinoma
  2220. Imaging intimal macrophages in atherosclerotic lesions using CD36-targeted nanoparticles
  2221. Abrogation of GH action in Kupffer cells results in increased hepatic CD36 expression and exaggerated nonalcoholic fatty liver disease
  2222. Oral fatty acid taste sensitivity in healthy young individuals of both sexes is related to body mass index and soluble CD36 serum levels
  2223. Response by Raghavan et al to Letter Regarding Article,“Protein Kinase Cθ via Activating Transcription Factor 2–Mediated CD36 Expression and Foam Cell …
  2224. CD36: Russian roulette of host and parasites during malaria infection
  2225. CD36 neuronal identity in the olfactory epithelium
  2226. CD36 regulates β cell differentiation and influences type 2 diabetic sepsis
  2227. Hepatic stellate cells (HSCs) activating HSF1-mediated COMP secretion promote liver metastasis of pancreatic cancer through CD36/AKT/FOXM1 signaling
  2228. CD36 expression is associated with cancer aggressivenes and energy source in esophageal squamous cell carcinoma
  2229. Role of PPARγ/CD36 signaling pathway in macrophage lipid metabolism after Mycobacterium tuberculosis infection
  2230. CD36, a fatty acid translocase, promotes metastasis in CRC
  2231. Vimentin deficiency in macrophages induces CD36-mediated inflammation
  2232. CD36 Identifies a Subpopulation of Adipose-Derived Mesenchymal Stromal Cells with Enhanced Osteogenic Ability.
  2233. β-Amyloid Protein Induces Mitophagy-Dependent Ferroptosis Through the CD36/PINK/PARKIN Pathway Leading to Blood-Brain Barrier Destruction in Alzheimer’s …
  2234. The role of adaptor protein 3BP2 in CD36-mediated modified lipid uptake and macropinocytosis
  2235. Abstract P263: Interaction between CD36 and FABP4 regulates the import and metabolism of fatty acid in breast cancer cells
  2236. Knockdown CD44 Promotes Amyloid-Beta Degradation in Ovarian Cancer Cells By Regulating CD36 Expression
  2237. Establishment of a cell line expressing the CD36 on human platelets and its application to the detec-tion of anti-CD36 antibodies
  2238. Effects of Specific PfEMP1 Ligation Interactions with ICAM-1, Integrin αVβ3, and CD36 on Monocytes in an in vitro Malaria-Naïve Host Model
  2239. Cellular Long Chain Fatty Acid Uptake by CD36: Identifying an Amino Acid That Plays a Critical Role and Assessing Physiological Impact in Bone Marrow Derived …
  2240. BID‐deficiency leads to resistance to diet‐induced obesity and hepatic steatosis and reduced expression of fatty acid receptor, CD36
  2241. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
  2242. CD36 Scavenger Receptor Promotes Pulmonary Fibrosis in Response to Oropharyngeal Administration of Oxidized Phospholipid
  2243. SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2
  2244. Oxidatively Modified LDL Suppresses Lymphangiogenesis via CD36 Signaling. Antioxidants 2021, 10, 331
  2245. CD36 Antagonism Minimizes Skin Scarring By Inhibiting JUN-dependent Fibrotic Pathways Within Fibrogenic Fibroblast Subpopulations
  2246. The Macrophage Response to Klebsiella Pneumoniae Involves CD36-Mediated Syk Activation and Type I IFN-Dependent Cytokine Production
  2247. C64 ALI AND BARRIER FUNCTION: Lung Ischemia-Reperfusion Injury And Endothelial Ros-Induced Ca2+ Influx Are Attenuated By Loss Of CD36, A Fatty Acid …
  2248. Plasma Membrane Organization and Endocytosis of CD36 in Human Microvascular Endothelial Cells
  2249. Overexpression of CD36 promotes tumorigenesis in colorectal cancer
  2250. Influence of glucagon-like peptide 1 on the expression of ACAT1, CD36 gene and cholesterol metabolism in macrophages.
  2251. Effect of Scavenger Receptor CD36 Gene Defect on Ambulatory Blood Pressure Rhythm and Metabolic Parameters in Patients with High-normal Blood Pressure
  2252. Scavenger receptor CD36 on B cells senses modified self-antigens to prevent autoimmunity
  2253. Correspondance of plasma and liver fatty acid transporter CD36 levels in response to different macronutrient consisting diets in mice: Preliminary data
  2254. Association between peripheral monocyte CD36 expression and rheumatoid arthritis
  2255. Prenatal exposure to lipopolysaccharide results in lipid metabolism and FAT/CD36 expression in mice offspring
  2256. Foxo1-Activated CD36 Transcription Switches Arteriolar Differentiation of Endothelial Cells
  2257. Understanding the role of pancreatic β‐cell CD36 in the development of Type 2 Diabetes
  2258. Hepatic CD36 expression and traslocation to the plasma membrane are increased under hypoxic conditions
  2259. Role of CD36 in palmitic acid-induced apoptosis of astrocytes
  2260. Investigation of CD36 Antigen Deficiency in Unpaid Blood Donors in Hefei
  2261. Oxidized LDL/CD36/PPARγ circuitry is a trigger of adipogenesis in Arrhythmogenic Cardiomyopathy.
  2262. Expression and regulation of CD36 mRNA in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome
  2263. Effects of Obesity and Diabetes on Oxidized Low Density Lipoproteins and CD36 Membrane Receptor (FS18-06-19)
  2264. CD36 Polymorphism (rs1761667) Was Associated with Fatty Liver in a Japanese Population
  2265. The co-receptor CD36 as a target in regulation of subretinal inflammation
  2266. The Roles of SR-BI and CD36 in Maintenance of Macrophage Cholesterol Homeostasis
  2267. Macrophage-cancer cell fusion is mediated by phosphatidylserine-CD36 receptor interaction and induced by ionizing radiation
  2268. The (Pro) renin Receptor Regulates Scavenger Receptor CD36 Protein Degradation and Functions
  2269. Establishment and Identification of Liver-Specific CD36 Knockout Mice
  2270. Identification of Clostridia that Modulate Epithelial CD36 Expression and Their Role in Metabolic Disease
  2271. MP19-04 ELEVATED CD36 EXPRESSION CORRELATES WITH INCREASED VISCERAL ADIPOSE TISSUE AND PREDICTS POOR PROGNOSIS IN CCRCC …
  2272. Role of CD36 in ROS‐induced Calcium Influx in Human Lung Microvascular Endothelial Cells
  2273. Inhibition of Lpl and CD36 Does Not Prevent Lipid Accumulation in the Hearts of Adipose Triglyceride Lipase (ATGL) Deficient Mice
  2274. Genetic asymmetry in Type II CD36 deficiency
  2275. Mechanism of CD36 Signal Transduction by F-actin and Lipid Nanodomains
  2276. Lipid Remodelling in CD36 Nanoclusters Promotes Fyn Activation in Response to Thrombospondin-1
  2277. CD36 expression on oral squamous cell carcinoma cells correlates with enhanced proliferation and migratory activity
  2278. Endothelial cell CD36 optimizes tissue fatty acid uptake
  2279. Construction of eukaryotic expression vector for human platelet CD36 gene 220c> t and 429+ 4insg variants and analysis of their expressions in hek293t cells
  2280. … -Talk and Regulation of Endocrine and Metabolic Functions: GPR40 deficiency is associated with hepatic FAT/CD36 upregulation, steatosis, inflammation …
  2281. CD36 identified by weighted gene co-expression
  2282. Fatty Acid-like Pt (IV) Prodrugs Harnessing CD36 to Target Chemoresistant Ovarian Cancer Cells
  2283. Abstract WP292: Insulin Resistance is Associated with a Reduction of Leukocyte Surface CD36 Expression and an Increase of Soluble CD36
  2284. a‐Tocopheryl phosphate induces VEGF expression via CD36/PI3Kg/Akt in THP‐1 monocytes
  2285. Corrigendum to “CD36-mediated lipid accumulation and activation of NLRP3 inflammasome lead to podocyte injury in obesity-related glomerulopathy”
  2286. Detection of Intimal Macrophages in Atherosclerotic Lesions Using Biocompatible CD36‐Targeted Ligand Containing Nanoparticle
  2287. Periodontal Expression of CD36 and GPR40 in Patients with Metabolic Syndrome and/or Periodontitis
  2288. Lipogenesis and hepatic CD36 expression in the response to cafeteria and high-fructose diet
  2289. GW28-e0198 CML/CD36 accelerating atherosclerotic progression via inhibiting foam cell migration
  2290. CD36 receptor modulator as potential drug candidates for the treatment of age-related macular degeneration
  2291. Letter by Wu and Ballantyne Regarding Article,“Protein Kinase Cθ via Activating Transcription Factor 2–Mediated CD36 Expression and Foam Cell Formation of …
  2292. Siglec‐E Retards Atherosclerosis by Inhibiting CD36‐Mediated Foam Cell Formation
  2293. Role of Lipid Nanodomains and F-actin in CD36 Signal Transduction
  2294. CD36-mediated uptake of oxidized LDL induces retinal pigment epithelial cell death through NLRP3 inflammasome activation
  2295. SP444 HIGH GLUCOSE PROMOTES NLRP3 INFLAMMASOME ACTIVATION VIA CD36/ROS PATHWAY IN RENAL TUBULAR EPITHELIAL CELLS
  2296. Identification of the Genetic Variant Responsible for Variable Platelet CD36 Expression By Massively Parallel Reporter Assay
  2297. Role receptoru CD36 v patogenezi Alzheimerovy choroby
  2298. Variation of CD36 genotype in Adolescent Females
  2299. Platelet CD36 Promotes ERK5 and Caspase-Dependent Procoagulant Phosphatidylserine Externalization and In Vivo Fibrin Formation in Dyslipidemia
  2300. Regulation of the CD36 scavenger receptor by the antioxidant 7, 8-dihydroneopterin.
  2301. Studies on the expression and role of a transmembrane receptor CD36 in the mammalian olfactory system
  2302. Chapitre 4. Plasma apoB-to-PCSK9 ratio: an index of LDLR and CD36 pathway and NLRP3 inflammasome priming in human adipose tissue
  2303. The Role of CD36 in the Pathogenesis of Alcohol-Related Disease
  2304. Polymorphisms of peroxisome proliferator-activated receptor γ (PPARγ) and cluster of differentiation 36 (CD36) associated with valproate-induced obesity in epileptic …
  2305. Fat as a Basic Taste: CD36 and its Role in Fat Taste
  2306. Oxidized LDL Repurposes Mitochondria to Drive Immune Activation Through CD36-Regulated Fatty Acid Trafficking and Metabolism
  2307. The Innate Immunity Receptor CD36 Contributes to Ischemic Brain Injury by Regulating Post-ischemic Caspase-1 Activity and Interleukin-1b Production in Microglia
  2308. Myeloid Specific Deletion of CD36 Increases Microglia-Like CD45Low Subset and Exacerbates Stroke-Induced Brain Injury
  2309. Insulin-like Growth Factor-I Regulates the FAT/CD36 Expression in C2C12 Skeletal Muscle Cells
  2310. The upregulated scavenger receptor CD36 is associated with the progression of nontarget lesions after stent implantation in atherosclerotic rabbits
  2311. CD36 dependent Vav2, a guanine nucleotide exchange factor activation promotes ceramide induced inflammatory activation in pancreatic beta cells
  2312. Protein Cysteine Sulfenylation By CD36-Dependent Reactive Oxygen Species Signaling Promotes Platelet Activation
  2313. Platelet CD36 Potentiates Thrombus Formation in Hyperlipidemic Conditions By Activating Redox Sensitive MAP Kinase ERK5
  2314. 1647-P: Rare Disruptive Loss of Function Mutations in the Cluster of Differentiation 36 (CD36) Gene Overwhelmingly Cause a Metabolic Syndrome in Multiple …
  2315. Effects of Glycyrrhiza Flavone on the pathological changes of quadriceps and expression of fatty acid translocase/CD36 in training rats
  2316. Fluorescent labeling of fatty acid transporter CD36 in the extracellular loop
  2317. CD36 Promotes Platelet Phosphatidylserine Exposure through MAP Kinase ERK5
  2318. Role of enterocyte CD36 in intestinal adaptation to a high-fat diet
  2319. … umbilical tissue-derived cells rescue phagocytosis in cultured retinal pigment epithelial cells from Royal College of Surgeons rat through CD36 and integrin αvβ5
  2320. Azapeptide MPE-001, a CD36 ligand, reduces atherosclerosis lesions progression and inflammatory biomarkers expression in apolipoprotein E-deficient mice
  2321. Evaluation of CD36 polymorphisms as predisposition factors for Myocardial infarction among population from Turabah province, Saudi Arabia
  2322. ASK1 Activation in Platelets By Oxidized LDL Is Independent of CD36
  2323. Eukaryotic Elongation Factor 2 Kinase Regulates Cholesterol Uptake by Macrophages via CD36 Scavenger Receptor Expression
  2324. FAT/CD36 is involved in the suppression of the expression of NPY and AgRP genes by palmitic acid in N1E-115 cells.
  2325. 2288 Oxidized LDL/CD36/PPARg circuitry is a trigger of adipogenesis in arrhythmogenic cardiomyopathy
  2326. Atheroregressive Potential Of Azapeptides Analogues Of Ghrp-6 As Selective CD36 Ligands In Apolipoprotein E-Deficient Mice
  2327. Eukaryotic Elongation Factor 2 Kinase (eEF2k) Regulates Cholesterol Uptake by Macrophages via CD36 Scavenger Receptor Expression
  2328. Pro‐atherogenic disturbed flow increases endothelial stiffness via enhanced CD36/Cav1‐mediated oxLDL uptake
  2329. Flattening of diurnal glucocorticoid oscillations causes CD36 and insulin-mediated obesity
  2330. A scavenger receptor B (CD36)-like protein is a potential mediator of intestinal heme absorption in the hematophagous ectoparasite Lepeophtheirus salmonis
  2331. Ligand-Induced Growth of CD36-Fyn Clusters Induces Signaling
  2332. Tiliacora triandra (Colebr.) Diels Ameliorates Hepatic Steatosis by Inhibition of HMGR and Down‐regulation of FAT/CD36
  2333. Correlation between Lingual CD36 Gene Polymorphism (AA), Eating Disorder and Obesity in Algerian Adolescents
  2334. Editorial for 309907, Oxidized lipid uptake by scavenger receptor CD36 modulates endothelial surface properties and may contribute to atherogenesis
  2335. CD36 Activation Enhances Hydrogen Peroxide Generation in Human Platelets
  2336. Abstract P114: Genetic Polymorphisms of CD36 Associated With Metabolic Syndrome in Chinese Han Population: A Nested Case-Control Study
  2337. 3133 Hyperlipidaemia associated oxidised phospholipids induce sustained platelet hyperactivity by CD36 and PLC gamma 2 dependent ROS production
  2338. Association between CD36 gene variants, PROP taster status and oral fatty taste intensity perception among Malaysian obese and non-obese subjects.
  2339. Lung Ischemia-Reperfusion Injury And Endothelial Ros-Induced Ca2+ Influx Are Attenuated By Loss Of CD36, A Fatty Acid Transporter
  2340. Cardiac dysfunction due to CD36 deficiency was improved by administration of Β-blocker and angiotensin-converting enzyme inhibitor
  2341. Abstract TMP51: Activation of PGE2 EP1 Receptor Promotes Microglial Phagocytosis Though CD36 Receptor Recycling
  2342. … OF HDL IN RABBITS WITH CKD: CARBONYLATED-HDL EXHIBIT BLUNTED ANTI-AGGREGATIVE ACTIVITY ON HUMAN PLATELETS THROUGH A CD36 …
  2343. Na/K-ATPase Forms a Signaling Complex with CD36 and Toll-like Receptor 4 to Mediate NF-kappaB Activation in Macrophages
  2344. 5060 Dyslipidemia associated oxidised ldl induces platelet hyperactivity through a CD36-dependent activation of pde3a
  2345. Effect of duck CD36 gene expression on the proliferation of PC3 prostate cancer cells.
  2346. Limited Utilization of Fatty Acid With a Marked Increase in Glucose Uptake Exacerbates Cardiac Dysfunction During Pressure Overload in CD36 Deficient Mice
  2347. β-cell CD36 linked to insulin secretion
  2348. Role of CD36 and free fatty acid uptake in epithelial-mesenchymal transition of hepatocellular carcinoma cells
  2349. Mechanism of 7, 8-dihydroneopterin to downregulate CD36 scavenger receptor and foam cell formation.
  2350. CD36 Plays a Crucial Role in Exercise Endurance During Prolonged Fasting in Mice
  2351. The multiprotein complex which interacts with CD36 to generate the pre-chylomicron transport vesicle required for COP2 transport may be of significance in a …
  2352. CD36-mediated Lipid Metabolism Promotes Endothelial Cell Angiogenic Function and Vascular Repair Ina Hindlimb Ischemia Mouse Model
  2353. … Telomere Shortening, Which is Associated With Impaired Myocardial Fatty Acid Utilization and Downregulation of MiR-133a and Fatty Acid Translocase (CD36)
  2354. CD36 expression intensity on different subpopulations of circulating monocytes depending on the extent of subclinical atherosclerosis
  2355. Expression of thrombospondin-1 and CD36 and CD47 receptors in the rat brain after exposure to damaging factors in the early postnatal period
  2356. The rsl527483, but not rs3212018, CD36 polymorphism associates with oral lipid detection and adiposity in Czech young adults
  2357. Promotion of Arteriolar Differentiation of Vascular Endothelial Cells by PKD-1/CD36 Signaling-Mediated Chromatin Remodeling
  2358. Construction of CD36 gene silencing cell lines by lentivirus-mediated RNA interference and the effect on protein expression of caveolin-1
  2359. The role of scavenger receptor CD36 in CML inhibition of foam cell migration
  2360. … Modelling: Mechanisms of E‐Complex [Ca2+/Mg2+Ecto‐ATPase (EC 3.6.1.15) /E‐NTPDase (NTPDase1) EC 3.6.1.6) regulated E‐kinase/PKA‐induced E‐NTPase∞CD36/E‐NTPDase∞CD39 …
  2361. Trpm2 Deletion Alleviates Atherosclerosis by Inhibiting the Activation of CD36 in Macrophages
  2362. Experimental study on incidence of anti-CD36 antibodies in puerperae and platelet apoptosis induced by anti-CD36 antibodies
  2363. Effects of monocyte CD141 and platelet CD36 on peripheral vascular endothelial function in patients with hypothyroidism
  2364. 1139-P: CD36/FABP4/PPAR-d Axis-Induced Inflammation Is Dependent on ACSL1 under the Influence of Acute High-Fat Feeding
  2365. 281-OR: Endothelial Cell CD36 Regulates Systemic Glucose and Lipid Metabolism
  2366. The effect of alisol A 24-acetate on lipid metabolic factors ABCA1, CD36 and inflammatory factors CD147, MMP-9 in oxidized low density lipoprotein-induced …
  2367. Increased gene expression of resistin and CD36 in peripheral blood mononuclear cells is associated with hypercholesterolemia in patients with obstructive sleep …
  2368. Author Correction: CD36 regulates lipopolysaccharide-induced signaling pathways and mediates the internalization of Escherichia coli in cooperation with TLR4 in …
  2369. Nouvelle base moléculaire associée au phénotype CD36
  2370. The relationship between the expression of monocyte CD36 and carotid plaques in patients with rheumatoid arthritis
  2371. Role of the Scavenger Receptor CD36 in Accelerated Diabetic Atherosclerosis
  2372. The effect of homocysteine on the expression of CD36, PPAR gamma, and C/EBP alpha in adipose tissue of normal and obese mice
  2373. Nitro-fatty acid modulates expression of CD36 and LRP1 scavenger receptors on RAW264. 7 macrophages
  2374. The correlation between oxidized low density lipoprotein receptor CD36 and renal tubular injury in diabetic rats
  2375. CD36 a new cellular target of electrophilic nitro-fatty acids
  2376. Expression profiling and functional characterization of CD36 in turbot (Scophthalmus maximus L.).
  2377. CD36‐Myeloperoxidase Connection and the Activation of Intestinal Fibroblasts
  2378. CD36 regulates lipopolysaccharide-induced signaling pathways and mediates the internalization of Escherichia coli in cooperation with TLR4 in goat mammary …
  2379. NEGR1 may associate with a cluster of differentiation 36 (CD36) protein
  2380. The Circulating Fatty Acid Transporter Soluble CD36 Is Not Associated with Carotid Atherosclerosis in Subjects with Type 1 and Type 2 Diabetes Mellitus
  2381. The effects of maternal high fat diet on the lingual CD36 lipid sensors of the offspring sprague dawley rats
  2382. CD36 regulates malaria-induced innate immune responses
  2383. Effect Interaction of Endurance Training and Anabolic-Androgenic Steroids on Adipose Tissue’s Desnutrin, CD36, and Beta-HAD of Skeletal Muscle in Healthy Male …
  2384. Glucotoxicity and CD36 related beta cell dysfunction
  2385. Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice.
  2386. AB006. The co-receptor CD36 as a target in regulation of subretinal inflammation
  2387. Technical considerations on the NOD/SCID model for the study of anti-CD36 antibodies
  2388. Ineffective platelet transfusion caused by anti-CD36 antibody and the effective treatment strategy.
  2389. Polymorphism of the CD36 Gene and cerebrovascular disease in Korean patients with type 2 diabetes
  2390. CD36 Surface Expression on Monocytes in Type 2 Diabetes
  2391. Dietary α-linolenic acid supplementation alters skeletal muscle plasma membrane lipid 2 composition, sarcolemmal FAT/CD36 abundance and palmitate transport …
  2392. Inhibition of Rac1-Nox signaling attenuates high-glucose-induced CD36 expression in pancreatic beta cells
  2393. CD36-and obesity-associated granulosa cells dysfunction.
  2394. Palmitate aggravates proteinuria-induced cell death and inflammation via CD36-inflammasome axis in the proximal tubular cells of obese mice.
  2395. Abstract A223: CD36-mediated metabolic adaptation guides regulatory T-cells in tumors
  2396. Nobiletin inhibits CD36-dependent tumor angiogenesis, migration, invasion, and sphere formation through the CD36/Stat3/Nf-κB signaling axis.
  2397. Autophagy protein Atg5 regulates CD36 expression and anti-tumor MHC class Ⅱ antigen presentation in dendritic cells
  2398. OR34 Platelet refractoriness in a patient with 0% PRA due to a rare anti-CD36 (NAKa) antibody
  2399. Reactive Oxygen Species via Activation of Bruton Tyrosine Kinase Mediate Cholesterol Crystals-Induced CD36 Expression and Foam Cell Formation
  2400. Role of CD36 in Carotenoid Transport in the Vertebrate Eye
  2401. Pigment epithelium-derived factor negatively regulates CD36 expression and lipid accumulation in non-alcoholic fatty liver disease
  2402. CD36-Mediated Tethering Of Fyn Facilitates Trpv4 Phosphorylation And Responsiveness To Reactive Oxygen Species In Lung Microvascular Endothelial Cells
  2403. CD36 gene variants is associated with type 2 diabetes mellitus through the interaction of obesity in rural Chinese adults.
  2404. Palmitic acid interferes with energy metabolism balance by adversely switching the SIRT1-CD36-fatty acid pathway to the PKC zeta-GLUT4-glucose pathway in …
  2405. CD36 Antigen Deficiency and Platelet Transfusion
  2406. Corrigendum to” Characterization of human dermal sheath cells reveals CD36-expressing perivascular cells associated with capillary blood vessel formation in hair …
  2407. GW28-e0436 CML inhibits foam cells migration via CD36/Vav1 pathway
  2408. T3 enhances GLUT2, PEPT1 and CD36/SR-B2 content in the intestinal epithelium of mice
  2409. Endothelial cell CD36 optimizes tissue fatty acid uptake.
  2410. Abstract P337: CD36 Is Required To Prime Cardiomyocytes For Proliferation
  2411. Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice.
  2412. Inhibition of RAC1-NOX signaling attenuates high-glucose-induced CD36 expression in pancreatic β-cells
  2413. Limited Fatty Acid Use by CD36 Deficiency Accelerates the Development of Diabetic Cardiomyopathy
  2414. Association between plasma CD36 levels and incident risk of coronary heart disease among Danish men and women.
  2415. … prevents the development of high fat diet-induced non-alcoholic fatty liver disease (NAFLD) in mice via the inhibition of cluster of differentiation 36 (CD36).
  2416. Essential Oil from Alpinia zerumbet Rhizome Inhibits Macrophage-derived Foam Cell Formation Via Modulating Expression of CD36 and ABCA1
  2417. High density lipoprotein (HDL) reverses palmitic acid induced energy metabolism imbalance by switching CD36 and GLUT4 signaling pathways in cardiomyocyte.
  2418. CD36 Mediates Endothelial Stiffening in Young and Aged Mice
  2419. MicroRNA-26a-CD36 signaling pathway: pivotal role in lipid accumulation in hepatocytes induced by PM2.5 liposoluble extracts.
  2420. Fatty acid translocase CD36/SR-B2 and its mediation in transmembrane transportation of long-chain fatty acids.
  2421. The structural basis for CD36 binding by the malaria parasite.
  2422. 1840-P: GPR40 Deficiency Is Associated with Steatosis, Hepatic Inflammation, and CD36 Upregulation in C57BL/6 Mice
  2423. Potential effects of sCD40L, CD36, IL-23 and arginase-1 molecules on the pathogenesis of brucellosis
  2424. Molecular docking in Nεcarboxymethyl lysine targeting scavenger receptor CD36
  2425. CD36 Mediates Endothelial Stiffening in Young and Aged Mice
  2426. A Role for DPP4 Expression via Oxidized LDL/TLR4/TRIF/CD36 Pathways in Human Obesity and Atherosclerosis
  2427. Abstract P132: Increased Cardiovascular Parasympathetic Tone in African Americans With CD36 Partial Deficiency
  2428. LCFA uptake and FAT/CD36: molecular cloning, tissue expression and mRNA expression responses to dietary oil sources in grass carp (Ctenopharyngodon idellus).
  2429. Diet-Induced Obesity Links to Breast Cancer Progression via LPA/PKD-1-CD36 Signaling Axis-Mediated Microvascular Remodeling
  2430. GW29-e1663 Oxidized High-Density Lipoprotein Impairs Endothelial Progenitor Cells’ Function by Activation of CD36-MAPK-TSP-1 Pathways
  2431. Potentials of CD36 in sensing apoptotic cells and modulating hemin mediated immune response from macrophages
  2432. Il4 Increases Phagocytosis of Necrotic Cells in a CD36-dependent Manner
  2433. Oleate protects macrophages from palmitate-induced apoptosis through the downregulation of CD36 expression.
  2434. Effect of duck CD36 gene expression on the proliferation of PC3 prostate cancer cells.
  2435. Evaluation of the relationship between MARCO and CD36 single-nucleotide polymorphisms and susceptibility to pulmonary tuberculosis in a Chinese Han population.
  2436. Retinal amyloid pathology requires CD36 receptors.
  2437. CD36 gene polymorphisms are associated with intracerebral hemorrhage susceptibility in a Han Chinese population.
  2438. Aldehyde-Modified Hdl Has CD36-dependent Pro-Atherogenic Effects in Macrophages
  2439. Oxidized LDL Induce a Metabolic Switch Through CD36 in Macrophages
  2440. P2 Fatty acid transporter1 (FAT/CD36) and guanine nucleotide-binding protein G (I) subunit ALPHA-2 (GALPHAI2) are novel substrates of the cell surface localised …
  2441. … vitamin E antagonized the Aβ₂₅–₃₅-mediated neuron oxidative damage through activation of Nrf2 signaling pathways and regulation of CD36, SRB1 and FABP5 …
  2442. Regulatory effect of inhibiting PPARγ on CD36 expression and lipid accumulation in alveolar macrophages induced by SiO2.
  2443. P1941 The nuclear receptor corepressor 1 blocks CD36-mediated foam cell formation in atherogenesis
  2444. Abstract WP135: CD36 Contributes to Stroke Induced Cognitive Deficits
  2445. Treatment of peroxidase derived from foxtail millet bran attenuates atherosclerosis by inhibition of CD36 and STAT3 in vitro and in vivo.
  2446. Abstract P3011: Role of CD36 in Insulin Mediated Microvascular Vasodilation in African Americans
  2447. Corrigendum to” Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice”[Toxicol. Appl. Pharmacol …
  2448. … and vitamin E antagonized the Aβ25-35-mediated neuron oxidative damage through activation of Nrf2 signaling pathways and regulation of CD36, SRB1 and FABP5 …
  2449. Fatty acid translocase gene CD36 rs1527483 variant influences oral fat perception in Malaysian subjects.
  2450. The natural compound dansameum reduces foam cell formation by downregulating CD36 and peroxisome proliferator-activated receptor-gamma; expression.
  2451. … root extract ameliorates insulin resistance in fructose-fed rats by modulating sarcolemmal and intracellular fatty acid translocase/CD36 redistribution in skeletal …
  2452. Corrigendum to “Replication of a gene-diet interaction at CD36, NOS3 and PPARG in response to omega-3 fatty acid supplements on blood lipids: A double-blind …
  2453. Recognition and inflammation signal transduction of TLR4-TLR10-CD36 may be involved in natural low density lipoprotein oxidation
  2454. … profile to P. falciparum DBLα in patients with severe and uncomplicated malaria and their relation to rosette formation and binding ability to CD36 of causing isolates
  2455. Exploring the Role of miRNA in Regulating CD36 Fat Activity
  2456. FAT/CD36 participation in human skeletal muscle lipid metabolism: a systematic review
  2457. The role of CD36 in cancer progression and its value as a therapeutic target
  2458. The role of CD36 in cardiovascular disease
  2459. CD36: an emerging therapeutic target for cancer and its molecular mechanisms
  2460. CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease
  2461. CD36-fatty acid-mediated metastasis via the bidirectional interactions of cancer cells and macrophages
  2462. CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate
  2463. Role of CD36 in cancer progression, stemness, and targeting
  2464. Association between “cluster of differentiation 36 (CD36)” and adipose tissue lipolysis during exercise training: a systematic review
  2465. CD36 favours fat sensing and transport to govern lipid metabolism
  2466. Free Fatty Acids as Signaling Molecules: Role of Free Fatty Acid Receptors and CD36
  2467. A systematic review and meta-analysis on the association between CD36 rs1761667 polymorphism and cardiometabolic risk factors in adults
  2468. CD36: The Bridge between Lipids and Tumors
  2469. Metastatic potential: focus on lipid transport with emphasis on CD36
  2470. The past and present lives of the intraocular transmembrane protein CD36
  2471. CD36 and Its Role in Regulating the Tumor Microenvironment
  2472. Biological mechanisms and related natural inhibitors of CD36 in nonalcoholic fatty liver
  2473. CD36-mediated fatty acid oxidation in hematopoietic stem cells Is a novel mechanism of emergency hematopoiesis in response to infection
  2474. Ligand-dependent CD36 functions in cancer progression, metastasis, immune response, and drug resistance
  2475. Successful allogeneic hematopoietic stem cell transplantation in a patient with type I CD36 deficiency: a case study and literature review
  2476. Correlation between Serum CD36 Level and Lipid Profile in Patients with Type 2 Diabetes Mellitus, Khartoum State, Sudan
  2477. FABP4 controls fat mass expandability (adipocyte size and number) through inhibition of CD36/SR-B2 signalling
  2478. The regulatory role of CD36 in hematopoiesis beyond fatty acid uptake
  2479. The protective and pathogenic roles of CD36 in multiple sclerosis
  2480. Fatty acids, CD36, thrombospondin-1, and CD47 in glioblastoma: together and/or separately?
  2481. CD36 drives metastasis and relapse in acute myeloid leukemia
  2482. Postprandial consequences of lipid absorption in the onset of obesity: Role of intestinal CD36
  2483. Reduced Population of CD36-/ABCA1+ Macrophages is Correlated with An Increase of Coronary Artery Disease Risk Markers in Type 2 Diabetes Mellitus
  2484. CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis
  2485. CD36 regulates substrates utilisation in brown adipose tissue of spontaneously hypertensive rats: In vitro study
  2486. CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing
  2487. CD36—A host receptor necessary for malaria parasites to establish and maintain infection
  2488. Endothelial cell CD36 regulates membrane ceramide formation, exosome fatty acid transfer and circulating fatty acid levels
  2489. A CD36 transmembrane domain peptide interrupts CD36 interactions with membrane partners on macrophages and inhibits atherogenic functions
  2490. β-amyloid protein induces mitophagy-dependent ferroptosis through the CD36/PINK/PARKIN pathway leading to blood–brain barrier destruction in Alzheimer’s …
  2491. Inhibition of fatty acid translocase (FAT/CD36) palmitoylation enhances hepatic fatty acid β-oxidation by increasing its localization to mitochondria and interaction with …
  2492. Evidence that CD36 is expressed on red blood cells and constitutes a novel blood group system of clinical importance
  2493. CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis
  2494. Upregulation of CD36, a fatty acid translocase, promotes colorectal cancer metastasis by increasing MMP28 and decreasing E-cadherin expression
  2495. The role of CD36/GPIV in platelet biology
  2496. CD36 aggravates podocyte injury by activating NLRP3 inflammasome and inhibiting autophagy in lupus nephritis
  2497. The activated CD36-Src axis promotes lung adenocarcinoma cell proliferation and actin remodeling-involved metastasis in high-fat environment
  2498. Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab
  2499. Genetic inhibition of CARD9 accelerates the development of atherosclerosis in mice through CD36 dependent-defective autophagy
  2500. Oxidized high-density lipoprotein promotes CD36 palmitoylation and increases lipid uptake in macrophages
  2501. CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis
  2502. Astragaloside IV attenuates myocardial dysfunction in diabetic cardiomyopathy rats through downregulation of CD36‐mediated ferroptosis
  2503. Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin αvβ3/CD36-mediated activation of the MAPK …
  2504. IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia
  2505. Palmitic acid‐induced ferroptosis via CD36 activates ER stress to break calcium‐iron balance in colon cancer cells
  2506. CD36 maintains lipid homeostasis via selective uptake of monounsaturated fatty acids during matrix detachment and tumor progression
  2507. Alisol B alleviates hepatocyte lipid accumulation and lipotoxicity via regulating rarα-pparγ-CD36 cascade and attenuates non-alcoholic steatohepatitis in mice
  2508. … the polymorphisms and hypermethylation of the CD36 gene on a new biomarker of type 2 diabetes mellitus: circulating soluble CD36 (sCD36) in Senegalese …
  2509. CD36 regulates LPS-induced acute lung injury by promoting macrophages M1 polarization
  2510. The activation of PPARγ enhances Treg responses through up-regulating CD36/CPT1-mediated fatty acid oxidation and subsequent N-glycan branching of TβRII/IL …
  2511. Soluble CD36 Concentration in Diabetic Hypertensive Patients with Coronary Atherosclerosis
  2512. Deletion of CD36 exhibits limited impact on normal hematopoiesis and the leukemia microenvironment
  2513. HIF-2α-induced upregulation of CD36 promotes the development of ccRCC
  2514. Role of CD36 in central nervous system diseases
  2515. Hypoxia-induced CD36 expression in gastric cancer cells promotes peritoneal metastasis via fatty acid uptake
  2516. New understanding of Angelica sinensis polysaccharide improving fatty liver: The dual inhibition of lipid synthesis and CD36-mediated lipid uptake and the regulation …
  2517. CD36 accelerates the progression of hepatocellular carcinoma by promoting FAs absorption
  2518. Carbon Nanotube-Incorporated Nanofibers for Immunosensor Preparation against CD36
  2519. Immune regulation of the liver through the PCSK9/CD36 pathway during heart transplant rejection
  2520. Dnmt1/Tet2-mediated changes in Cmip methylation regulate the development of nonalcoholic fatty liver disease by controlling the Gbp2-Pparγ-CD36 axis
  2521. Preclinical Evaluation of CD36-Targeting Antiangiogenic Peptide ABT-510 for Near-Infrared Fluorescence Molecular Imaging of Colorectal Cancer
  2522. Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C/PPARα/CD36 pathway
  2523. Graphene oxide incorporated polystyrene electrospun nanofibers for immunosensing of CD36 as a marker of diabetic plasma
  2524. Chlorogenic acid alleviates LPS-induced inflammation and oxidative stress by modulating CD36/AMPK/PGC-1α in RAW264. 7 macrophages
  2525. TRPM2 deficiency in mice protects against atherosclerosis by inhibiting TRPM2–CD36 inflammatory axis in macrophages
  2526. CD36 deficiency inhibits proliferation by cell cycle control in skeletal muscle cells
  2527. Expression of the Adipocyte Progenitor Markers MSCA1 and CD36 is Associated With Adipose Tissue Function in Children
  2528. Selenoprotein K contributes to CD36 subcellular trafficking in hepatocytes by accelerating nascent COPII vesicle formation and aggravates hepatic steatosis
  2529. LncRNA MALAT1 promotes PPARα/CD36-mediated hepatic lipogenesis in nonalcoholic fatty liver disease by modulating miR-206/ARNT axis
  2530. Positive feedback loop of miR-320 and CD36 regulates the hyperglycemic memory-induced diabetic diastolic cardiac dysfunction
  2531. B-cell lymphoma 6 alleviates nonalcoholic fatty liver disease in mice through suppression of fatty acid transporter CD36
  2532. Correlation between Plasma Soluble CD36 Levels with Body Mass Index of Breast Cancer Patients in the Indonesian Population
  2533. CircRNA-02191 regulating unsaturated fatty acid synthesis by adsorbing miR-145 to enhance CD36 expression in bovine mammary gland
  2534. Contribution of adipocyte Na/K-ATPase α1/CD36 signaling induced exosome secretion in response to oxidized LDL
  2535. Ginsenoside Rg1 attenuates glomerular fibrosis by inhibiting CD36/TRPC6/NFAT2 signaling in type 2 diabetes mellitus mice
  2536. MiR-1254 suppresses the proliferation and invasion of cervical cancer cells by modulating CD36
  2537. Inside anticancer therapy resistance and metastasis. Focus on CD36
  2538. … reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC: CPT1A inhibits ccRCC cell proliferation via PPARα/CD36 axis
  2539. … targeting C-1-tetrahydrofolate synthase, carbonyl reductase, and glutathione S-transferase P and modification of the AMPK/SREBP-1c/FAS/CD36 signaling pathway in …
  2540. Glycolysis-Mediated Activation of v-ATPase by Nicotinamide Mononucleotide Ameliorates Lipid-Induced Cardiomyopathy by Repressing the CD36–TLR4 Axis
  2541. … CD36 expression by modulating glutathione-p38 signaling, exerting protective effects against macrophage foam cell formation: Transaldolase inhibits CD36 …
  2542. FOXO1 regulates the formation of bovine fat by targeting CD36 and STEAP4
  2543. Platelet CD36 links overweight and a prothrombotic phenotype in patients with non-valvular atrial fibrillation
  2544. Mitigation of non-alcoholic steatohepatitis via recombinant Orosomucoid 2, an acute phase protein modulating the Erk1/2-PPARγ-CD36 pathway
  2545. Circulating mir-21 and mir-146a are associated with increased cytokines and CD36 in Algerian obese male participants
  2546. CD36-BATF2\MYB Axis Predicts Anti-PD-1 Immunotherapy Response in Gastric Cancer
  2547. Inhibitory antibodies against PCSK9 reduce surface CD36 and mitigate diet-induced renal lipotoxicity
  2548. Amphipathic helical peptide L37pA protects against lung vascular endothelial dysfunction caused by truncated oxidized phospholipids via antagonism with CD36 …
  2549. Hemin acts as CD36 ligand to activate down-stream signalling to disturb immune responses and cytokine secretion from macrophages
  2550. Cellular interactions and fatty acid transporter CD36-mediated uptake of per-and polyfluorinated alkyl substances (PFAS)
  2551. Early-life stress perturbs the epigenetics of CD36 concurrent with adult onset of NAFLD in mice
  2552. Scavenger receptor CD36 governs recruitment of myeloid cells to the blood–CSF barrier after stroke in neonatal mice
  2553. Cluster-determinant 36 (CD36) mediates intestinal absorption of dietary astaxanthin and affects its secretion
  2554. Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF-β1 pathway: therapeutic role of roflumilast
  2555. Annexin A1 upregulates hematoma resolution via the FPR2/p-ERK (1/2)/DUSP1/CD36 signaling pathway after germinal matrix hemorrhage
  2556. Multiple Myeloma Induced IL-6 Reprograms Lipid Metabolism through a CD36 Dependent Mechanism
  2557. Six genetically linked mutations in the CD36 gene significantly delay the onset of Alzheimer’s disease
  2558. Farnesyl diphosphate synthase exacerbates nonalcoholic steatohepatitis via the activation of AHR‐CD36 axis
  2559. Bisphenol A coupled with a high-fat diet promotes hepatosteatosis through reactive-oxygen-species-Induced CD36 overexpression
  2560. Investigating dual inhibition of ACC and CD36 for the treatment of nonalcoholic fatty liver disease in mice
  2561. Targeting CD36 determines nicotine derivative NNK-induced lung adenocarcinoma carcinogenesis
  2562. Mechanism and intervention of murine transfusion-related acute lung injury caused by anti-CD36 antibodies
  2563. (−)-Epicatechin gallate blocked cellular foam formation in atherosclerosis by modulating CD36 expression in vitro and in vivo
  2564. Up‐regulation of hepatic CD36 by increased corticosterone/cortisol levels via GR leads to lipid accumulation in liver and hypertriglyceridaemia during pregnancy
  2565. Vitamin D counteracts lipid accumulation, augments free fatty acid-induced ABCA1 and CPT-1A expression while reducing CD36 and C/EBPβ protein levels in …
  2566. Visible light-activatable platinum (iv) prodrugs harnessing CD36 for ovarian cancer therapy
  2567. CD36 regulates diurnal glucose metabolism and hepatic clock to maintain glucose homeostasis in mice
  2568. Development and validation of a purification system for functional full-length human SR-B1 and CD36
  2569. Upregulation of hepatic CD36 via glucocorticoid receptor activation contributes to dexamethasone-induced liver lipid metabolism disorder in mice
  2570. … ameliorates traumatic brain injury‐induced gastrointestinal dysfunction by regulating CD36/15‐LO/NR4A1 signaling, which fails when CD36 and CX3CR1 are …
  2571. Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC
  2572. Increased platelet activation demonstrated by elevated CD36 and P-selectin expression in 1-year post-recovered COVID-19 patients
  2573. Catechins prevent obesity-induced kidney damage by modulating PPARγ/CD36 pathway and gut-kidney axis in rats
  2574. Fingolimod treatment modulates PPARγ and CD36 gene expression in women with multiple sclerosis
  2575. NRF2 deficiency attenuates diabetic kidney disease in Db/Db mice via Down-regulation of angiotensinogen, SGLT2, CD36, and FABP4 expression and lipid …
  2576. Fisetin treatment alleviates kidney injury in mice with diabetes-exacerbated atherosclerosis through inhibiting CD36/fibrosis pathway
  2577. A case of Philadelphia chromosome‐positive acute lymphocytic leukaemia with type I CD36 deficiency
  2578. Detection of CD36 gene polymorphism associated with chicken carcass traits and skin yellowness
  2579. Polysaccharide from Strongylocentrotus nudus eggs regulates intestinal epithelial autophagy through CD36/PI3K-Akt pathway to ameliorate inflammatory bowel …
  2580. Endothelial cell CD36 mediates stroke-induced brain injury via BBB dysfunction and monocyte infiltration in normal and obese conditions
  2581. Hepatocyte CD36 modulates UBQLN1-mediated proteasomal degradation of autophagic SNARE proteins contributing to septic liver injury
  2582. A novel in duck myoblasts: The transcription factor retinoid X receptor alpha (RXRA) inhibits lipid accumulation by promoting CD36 expression
  2583. Efficient megakaryopoiesis and platelet production require phospholipid remodeling and PUFA uptake through CD36
  2584. Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8+ T cells
  2585. Salvianolic acid B attenuates inflammation and prevent pathologic fibrosis by inhibiting CD36-mediated activation of the PI3K-Akt signaling pathway in frozen …
  2586. Plasmodium vivax merozoite-specific thrombospondin-related anonymous protein (PvMTRAP) interacts with human CD36, suggesting a novel ligand–receptor …
  2587. CD36 down regulation by the macrophage antioxidant 7, 8-dihydroneopterin through modulation of PPAR-γ activity
  2588. Adiponectin Enhances Fatty Acid Signaling in Human Taste Cells by Increasing Surface Expression of CD36
  2589. Glycolaldehyde-derived advanced glycation end products suppress STING/TBK1/IRF3 signaling via CD36
  2590. New evidence of genetic heterogeneity causing hereditary gingival fibromatosis and ALK and CD36 as new candidate genes
  2591. Molecular drug simulation and experimental validation of the CD36 receptor competitively binding to Long-Chain fatty acids by 7-Ketocholesteryl-9-carboxynonanoate
  2592. Peak fat oxidation is positively associated with vastus lateralis CD36 content, fed-state exercise fat oxidation, and endurance performance in trained males
  2593. Expression profiling and antibacterial analysis of CD36 in mandarin fish, Siniperca chuatsi
  2594. … -interfering RNA targeting proprotein convertase subtilisin/kexin type 9 might promote fatty liver disease and hepatocellular carcinoma through upregulation of CD36
  2595. A cyclic azapeptide ligand of the scavenger receptor CD36/SR-B2 reduces the atherosclerotic lesion progression and enhances plaque stability in …
  2596. Should unrelated haematopoietic progenitor cell donors be tested for CD36 in Japan?
  2597. Genetic variants, gene expression, and soluble CD36 analysis in acute coronary syndrome: Differential protein concentration between ST‐segment elevation …
  2598. Co-overexpression of CD36 and FABPpm increases fatty acid transport additively, not synergistically, within muscle
  2599. Hypoxia-inducible factor 2α attenuates renal ischemia-reperfusion injury by suppressing CD36-mediated lipid accumulation in dendritic cells in a mouse model
  2600. Dietary long-chain fatty acids promote colitis by regulating palmitoylation of STAT3 through CD36-mediated endocytosis
  2601. The effects of intermittent hypoxia on hepatic expression of fatty acid translocase CD36 in lean and diet-induced obese mice
  2602. The Exocyst Is Required for CD36 Fatty Acid Translocase Trafficking and Free Fatty Acid Uptake in Skeletal Muscle Cells
  2603. Is the suppression of CD36 a promising way for atherosclerosis therapy?
  2604. The scavenger receptor CD36 protects Nile tilapia (Oreochromis niloticus) against Streptococcus agalactiae infection and promotes the expression of inflammatory …
  2605. … of Chinese agarwood (Aquilaria sinensis) inhibits atherosclerosis progression through endoplasmic reticulum stress-mediated CD36 expression in macrophages
  2606. Amniotic fluid CD36 in pregnancies complicated by spontaneous preterm delivery: a retrospective cohort study
  2607. Targeting the KCa3. 1 channel suppresses diabetes-associated atherosclerosis via the STAT3/CD36 axis
  2608. TM6SF2 reduces lipid accumulation in vascular smooth muscle cells by inhibiting LOX-1 and CD36 expression
  2609. SELENOK-dependent CD36 palmitoylation regulates microglial functions and Aβ phagocytosis
  2610. NanoSPECT imaging reveals the uptake of 123I-labelled oxidized low-density lipoprotein in the brown adipose tissue of mice via CD36
  2611. ATF4-mediated CD36 upregulation contributes to palmitate-induced lipotoxicity in hepatocytes
  2612. Soluble Trem2 is a negative regulator of erythrophagocytosis after intracerebral hemorrhage in a CD36 receptor recycling manner
  2613. Modulation of CD36‐mediated lipid accumulation and senescence by vitamin E analogs in monocytes and macrophages
  2614. CD36/Lyn kinase interactions within macrophages promotes pulmonary fibrosis in response to oxidized phospholipid
  2615. CD36 neutralisation blunts TLR2-IRF7 but not IRF3 pathway in neonatal mouse brain and immature human microglia following innate immune challenge
  2616. Association between miR-138-5p, miR-132-3p, SIRT1, STAT3, and CD36 and atherogenic indices in blood mononuclear cells from patients with atherosclerosis
  2617. Antibody binding activity specific to monocyte scavenger receptor CD36 is frequently detectable in the plasma of patients with antiphospholipid syndrome
  2618. Hepatocyte CD36 protects mice from NASH diet-induced liver injury and fibrosis via blocking N1ICD production
  2619. Baicalein targets CD36 to prevent foam cell formation by suppressing the excessive uptake of oxLDL and accelerating ABCA1-mediated cholesterol efflux in …
  2620. Phylogenetic and Protein Structure Analyses Provide Insight into the Evolution and Diversification of the CD36 Domain “Apex” among Scavenger Receptor Class B …
  2621. Insulin-stimulated translocation of the fatty acid transporter CD36 to the plasma membrane is mediated by the small GTPase Rac1 in adipocytes
  2622. VR-10 polypeptide interacts with CD36 to induce cell apoptosis and autophagy in choroid-retinal endothelial cells: Identification of VR-10 as putative novel …
  2623. Plasma membrane localization of CD36 requires vimentin phosphorylation; a mechanism by which macrophage vimentin promotes atherosclerosis
  2624. CD36 promotes tubular ferroptosis by regulating the ubiquitination of FSP1 in acute kidney injury
  2625. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin induces liver lipid metabolism disorder via the ROS/AMPK/CD36 signaling pathway
  2626. Chi-circ_0006511 positively regulates the differentiation of goat intramuscular adipocytes via novel-miR-87/CD36 axis
  2627. Eicosapentaenoic acid-enriched phospholipids alleviate glucose and lipid metabolism in spontaneously hypertensive rats with CD36 mutation: a precise nutrition …
  2628. CD36 and GPR120 mediated orogustatory perception of dietary lipids and its physiological implication in the pygmy mouse Mus booduga
  2629. Prognostic impact of CD36 immunohistochemical expression in patients with muscle-invasive bladder cancer treated with cystectomy and adjuvant chemotherapy
  2630. Stearic acid promotes lipid synthesis through CD36/Fyn/FAK/mTORC1 axis in bovine mammary epithelial cells
  2631. Fatty acid translocase (FAT/CD36) in silver pomfret (Pampus argenteus): Molecular cloning and functional characterization
  2632. … Molecular Dynamics Simulations of Polyethylene Glycol (PEG) and LIMP-2 Reveal That PEG Penetrates Deep into the Proposed CD36 Cholesterol-Transport Tunnel
  2633. CD36 inhibition partially attenuates myocardial injury in diabetic rats with ischemic postconditioning
  2634. Neuroprotection via Carbon Monoxide Depends on the Circadian Regulation of CD36-Mediated Microglial Erythrophagocytosis in Hemorrhagic Stroke
  2635. Preventing the Fatty Acid-Transporter CD36 From Taking its Toll on the Heart
  2636. CD36 regulates macrophage and endothelial cell activation and multinucleate giant cell formation in anti neutrophil cytoplasm antibody vasculitis
  2637. CD36 as a double-edged sword in cancer
  2638. Naoxueshu oral liquid promotes hematoma absorption by targeting CD36 in M2 microglia via TLR4/MyD88/NF-κB signaling pathway in rats with intracerebral …
  2639. Hepatic DKK1-driven steatosis is CD36 dependent
  2640. Genetic Variants in CD36 Involved in Fat Taste Perception: Association with Anthropometric and Clinical Parameters in Overweight and Obese Subjects Affected by …
  2641. Microcystin-RR promote lipid accumulation through CD36 mediated signal pathway and fatty acid uptake in HepG2 cells
  2642. A replicative recombinant HPV16 E7 expression virus upregulates CD36 in C33A cells
  2643. Single-cell and bulk RNA-sequencing analysis to predict the role and clinical value of CD36 in lung squamous cell carcinoma
  2644. CD36 polymorphism, sugary drinks, and sedentarism are associated with hypertriglyceridemic waist phenotype
  2645. Macrophage CD36 and TLR4 cooperation promotes foam cell formation and vsmc migration and proliferation under circadian oscillations
  2646. Differential Roles of CD36 in Regulating Muscle Insulin Response Depend on Palmitic Acid Load
  2647. CD36 is associated with the development of coronary artery lesions in patients with Kawasaki disease
  2648. Elevated glycosylation of CD36 in platelets is a risk factor for oxLDL‐mediated platelet activation in type 2 diabetes
  2649. Improvement of anti-CD36 antibody detection Via monoclonal antibody immobilization of platelet antigens assay by using selected monoclonal antibodies
  2650. CD36 inhibition reduces non-small-cell lung cancer development through AKT-mTOR pathway
  2651. RFX1 regulates foam cell formation and atherosclerosis by mediating CD36 expression
  2652. GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiota
  2653. Arsenic trioxide alleviates atherosclerosis by inhibiting CD36-induced endocytosis and TLR4/NF-κB-induced inflammation in macrophage and ApoE-/-mice
  2654. Carotenoid transporter CD36 expression depends on hypoxia-inducible factor-1α in mouse soleus muscles
  2655. Coagulation factor FVII fine-tunes hepatic steatosis by blocking AKT-CD36-mediated fatty acid uptake
  2656. Cellular localization and potential ligands of a novel scavenger receptor class B/CD36 protein homolog (Pt-SRB2) identified in the marine crab, Portunus …
  2657. CD36‐Binding Amphiphilic Nanoparticles for Attenuation of α‐Synuclein‐Induced Microglial Activation
  2658. … intensity assay: identification of distinct fatty acetates as volatile compounds that bind specifically to amino acid region 149-168 of a transmembrane receptor CD36
  2659. The role of CD36-Fabp4-PPARγ in skeletal muscle involves insulin resistance in intrauterine growth retardation mice with catch-up growth
  2660. Interaction of n-3 polyunsaturated fatty acids with host CD36 genetic variant for gut microbiome and blood lipids in human cohorts
  2661. BDE-47 induces metabolic dysfunction-associated steatotic liver disease (MASLD) through CD36-mediated increased fatty acid uptake and PPARα-induced abnormal …
  2662. Stomatin‑knockdown effectively attenuates sepsis‑induced oxidative stress and inflammation of alveolar epithelial cells by regulating CD36
  2663. CD36 regulates factor VIII secretion from liver endothelial cells
  2664. Cancer-associated fibroblasts contributed to hepatocellular carcinoma recurrence and metastasis via CD36-mediated fatty-acid metabolic reprogramming
  2665. CD36 relative mean fluorescence intensity of CD105+ nucleated erythroid cells can be used to differentiate myelodysplastic syndrome from megaloblastic anemia
  2666. The CD36 and SR-A/CD204 scavenger receptors fine-tune Staphylococcus aureus-stimulated cytokine production in mouse macrophages
  2667. Toxoplasma gondii in CD36 -/- mice shows lethal infection and poor immunization with probable macrophage immune defects
  2668. … electromagnetic field protects against brain injury after intracerebral hemorrhage: involvement of anti-inflammatory processes and hematoma clearance via CD36
  2669. Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36
  2670. Opium may affect coronary artery disease by inducing inflammation but not through the expression of CD9, CD36, and CD68
  2671. Ubiquitin‐specific protease 11‐mediated CD36 deubiquitination acts on C1q/TNF‐related protein 9 against atherosclerosis
  2672. Circulating soluble CD36 as a novel biomarker for progression and prognosis of HBV-related liver diseases
  2673. Conjugated linoleic acid (CLA) reduces HFD‐induced obesity by enhancing BAT thermogenesis and iWAT browning via the CD36–AMPK pathway
  2674. … Deciphering of the Role of S100A8 and S100A9 Proteins and Their Changes in the Structure Assembly Influences Their Interaction with TLR4, RAGE, and CD36
  2675. Colquhounia Root Tablet Promotes Autophagy and Inhibits Apoptosis in Diabetic Nephropathy by Suppressing CD36 Expression In Vivo and In Vitro
  2676. Lipid handling protein gene expression in colorectal cancer: CD36 and targeting miRNAs
  2677. A Tale of Two Scavenger Receptors: Structure‐Function Relationships of Purified SR‐B1 and CD36
  2678. CYP7A1, NPC1L1, ABCB1, and CD36 polymorphisms associated with coenzyme Q10 availability affect the subjective quality of life score (SF-36) after long-term …
  2679. Positive feedback loop of miR-320 and CD36 regulates the hyperglycemic memory-induced diabetic diastolic cardiac dysfunction
  2680. PCSK9 single nucleotide variants might affect susceptibility to malaria through regulation of CD36
  2681. Prognostic Value of the Selected Polymorphisms in the CD36 Gene in the Domain-Encoding Lipid-Binding Region at a 10-Year Follow-Up for Early-Onset CAD …
  2682. LncRNA AK142643 promotes hepatic lipid accumulation by upregulating CD36 via interacting with IGF2BP2
  2683. … myocardial infarction with both familial hypercholesterolemia phenotype caused by possibly oligogenic variants of the PCSK9 and ABCG5 genes and type I CD36 …
  2684. Making Mountains out of Mole Hills: The Role of CD36 in Oxidized Phospholipid-driven Lung Injury
  2685. CD36 gene variant rs1761667(G/A) as a biomarker in obese type 2 diabetes mellitus cases
  2686. Microvascular insulin resistance associates with enhanced muscle glucose disposal in CD36 deficiency.
  2687. CD36 genetic polymorphism and salivary cues are associated with oleic acid sensitivity and dietary fat intake
  2688. Preferential deposition of dairy derived fatty acids in muscle tissue is partially due to the upregulation of CD36 in a low-birth-weight swine model
  2689. Chemosensing of fat digestion by the expression pattern of GPR40, GPR120, CD36 and enteroendocrine profile in sheep
  2690. Diet-induced insulin resistance altered cardiac GLUT4 and FATP/CD36 expression in rats
  2691. Metabolite Profiling of Antioxidant Rich Fractions of Punica granatum L. Mesocarp and CD36 Expression Regulation
  2692. Neuronal growth regulator 1 promotes adipocyte lipid trafficking via interaction with CD36
  2693. Estrogen Attenuates Diethylnitrosamine-Induced Hepatocellular Carcinoma in Female Rats via Modulation of Estrogen Receptor/FASN/CD36/IL-6 Axis
  2694. Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech …
  2695. Association between immune-related hub genes CD36, CXCL13, FGFR4, GABBR1, LAMP3, MMP12, and PPM1H and colorectal cancer prognosis
  2696. CD36− SREBP1 Axis Mediates TSLP Production in Obesity-Exacerbated Atopic Dermatitis
  2697. Perioperative management of a patient with CD36 deficiency undergoing urgent cardiac surgery
  2698. … of Spatial Memory in Rats with Alzheimer’s disease Through Changing the Expression of LncRNA TUSC7/miR-449a/PPARγ and CD36 Genes in the Brain …
  2699. Proteomics study of bone tissue around ameloblastoma and the potential mechanism of CD36 in bone remodelling
  2700. Worldwide diversity, association potential, and natural selection in the superimposed taste genes, CD36 and GNAT3
  2701. Effect of biliary tract infection on the expressions of peripheral blood CD36/mTORC1 pathways in patients with common bile duct stones.
  2702. Exosomal MEF2C’s Association With the Progression of CRC in Regulating CD36 Transcription
  2703. CD36-mediated podocyte lipotoxicity promotes foot process effacement
  2704. The Ferroptosis Induced by Palmitic Acid via CD36 Activating ER Stress to Break Calcium-Iron Balance in Colon Cancer Cells
  2705. Role of CD36 rs1761667 AA genotype in the expression of inflammatory cytokines and Parkinson’s disease progression: A case-control study in a northern Han …
  2706. Coexpression of PD-L1/PD-1 with CXCR3/CD36 and IL-19 Increase in Extranodal Lymphoma
  2707. Frequency and molecular basis of CD36 deficiency among platelet donors in Kunming, China
  2708. Opium may affect coronary artery disease by inducing inflammation but not through the expression of CD9, CD36, and CD68
  2709. P856: MULTIPLE MYELOMA DERIVED IL-6 REDUCES FATTY ACID METABOLISM IN THE LIVER BY DOWNREGULATING CD36 AND CPT1A IN HEPATOCYTES
  2710. Endothelial stiffening induced by CD36-mediated lipid uptake leads to endothelial barrier disruption and contributes to atherosclerotic lesions
  2711. A case of platelet transfusion refractoriness in a CD36‐negative patient with acute myeloid leukemia: Diagnostic and therapeutic management
  2712. CD47 and CD36 expressions in the placenta of mothers with chorioamnionitis
  2713. CD36-Pyruvate Kinase M2 Signaling Promotes Macrophage Phagocytosis Through Mitochondrial Reactive Oxygen Species
  2714. Plasma levels of CD36 and glutathione as biomarkers for ruptured intracranial aneurysm
  2715. CD36 gene deletion reduces muscle insulin sensitivity in mice by up-regulating PTP1B expression
  2716. Astragalus polysaccharide liposome nanoparticles mediate fatty acid translocase (FAT)/CD36 to improve fatty acid metabolism and regulate glucocorticoid receptor …
  2717. Loss of CD36 expression has limited impact on mouse normal hematopoiesis
  2718. The interaction between the dietary phytochemical index and CD36 rs1761667 polymorphism on the risk factors related to metabolic syndrome
  2719. P423: ACUTE MYELOID LEUKEMIA REPROGRAMS LIPID METABOLISM BY DOWNREGULATING CD36 EXPRESSION IN HEPATOCYTES.
  2720. Humanized CD36 (hCD36) mouse model supports the preclinical evaluation of therapeutic candidates targeting CD36
  2721. High-Throughput CD36 Phenotyping on Human Platelets Based on Sandwich ELISA and Mutant Gene Analysis
  2722. The CD36 scavenger receptor Bez regulates lipid redistribution from fat body to oocytes in Drosophila
  2723. Correction for: CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3β/β-catenin-mediated epithelial-to-mesenchymal transition in …
  2724. Apoptosis of Megakaryocytic Leukemia Cell Line Meg-01 Induced by TSP-1 Via CD36/Caspase-3
  2725. Generation of induced pluripotent stem cell line derived from FNAIT patient with CD36 deficiency mutations
  2726. The transcription factor RXRA regulates lipid metabolism in duck myoblasts by the CD36 network
  2727. Corrigendum to” Apigenin inhibits STAT3/CD36 signaling axis and reduces visceral obesity”[Pharmacol. Res.(2020) 152 104586]
  2728. Cloning and Tissue Distribution of Homologous Genes of CD36 Family in Orthosia songi Chen et Zhang (Lepidoptera: Noctuidae)
  2729. Palmitoylation of CD36 enhances lipid droplet accumulation and M2-like polarization in decidual macrophages at the maternal-fetal interface
  2730. Junctional Adhesion Molecule a (JAM-A) Associates with CD36 upon Platelet Activation and Cytoskeleton in a Phosphorylation-Dependent Manner to Promote …
  2731. CD36 deletion ameliorates diabetic kidney disease by restoring fatty acid oxidation and improving mitochondrial function
  2732. The Exocyst Is Required for CD36 Fatty Acid Translocase Trafficking and Free Fatty Acid Uptake in Skeletal and Cardiac Muscle Cells
  2733. Treatment of non-alcoholic steatohepatitis with recombinant Orosomucoid 2, an acute phase protein that attenuates the Erk1/2-PPARγ-CD36 signaling pathway
  2734. CD36 initiates Src signal transduction to promote actin remodeling-involved metastasis of lung adenocarcinoma in high-fat environment
  2735. Inducible co-stimulator inhibits lipid phagocytosis of human aortic smooth muscle cells by down-regulating CD36 expression
  2736. Evaluation of plasma CD36 and glutathione as potential biomarkers for intracranial aneurysm.
  2737. Effects of Lizhong Tongmai acupuncture on TMAO, CD36 expression, and cholesterol deposition in atherosclerotic mice.
  2738. The Interaction between CD36 rs1761667 Polymorphism and Dietary Phytochemical Index on the Risk Factors Related to Metabolic Syndrome
  2739. Genetic inhibition of CARD9 accelerates the development of experimental atherosclerosis through CD36 dependent-defective autophagy
  2740. Endothelial CD36 mediates endothelium stiffening and promotes barrier disruption in high-fat diet fed mice
  2741. Nutmeg extract modulates triglyceride levels and gene expressions of CD36, FATP1, and CPT1B in rat skeletal muscle
  2742. Association between polymorphisms and hypermethylation of CD36 gene in obese and obese diabetic Senegalese females
  2743. CD36 homologs determine microbial resistance to the Lyme disease spirochete
  2744. … oxygen species (ROS) mediate p300-dependent STAT1 protein interaction with peroxisome proliferator-activated receptor (PPAR)-γ in CD36 protein expression and …
  2745. Rapid Decrease and Subsequent Increase in the Serum Triglycerides Accompanied by CD36 Transcript Increase in an Acute Stress Mice Model
  2746. NRF2 DELETION ATTENUATES LIPID DROPLET ACCUMULATION AND PROXIMAL TUBULAR INJURY VIA INHIBITION CD36 AND FABP4 EXPRESSION IN TYPE …
  2747. Functional characterization of the impact of CD36 deletion on normal hematopoiesis and the leukemia microenvironment
  2748. Homocysteine promotes scavenger receptor CD36 mediated oxLDL uptake eliciting PON2 antioxidant defense response in ARPE-19 and THP-1 macrophage cells
  2749. Macrophage expressed CD36 promotes plaque vulnerability in atherosclerosis
  2750. Discordance between allelic and genotype frequencies for CD36 rs3211938 between Mexican mestizo samples: sample bias, genotyping error, or microevolution?
  2751. Down-regulation CD36 increased proliferation of endothelial cell in hypertrophic cardiomyopathy
  2752. Lipid metabolism marker CD36 is associated with 18FDG-PET/CT false negative lymph nodes in head and neck squamous cell carcinoma
  2753. The Peroxisome Proliferator-Activated Receptor–Alpha (PPARA) and expression of CD36 receptor scavenger on circulating cells as biomarkers of atherosclerosis
  2754. The Role of the Efferocytic Receptor CD36 In the Engulfment of Apoptotic Cells During the Resolution Of Inflammation and Its Consequences
  2755. The Lipoprotein (a)-Induced Soluble CD36/Interleukin-6/RAS Homolog Family Member A-GTP Signaling Axis Promotes M1 Macrophage Polarization in Coronary …
  2756. 3136–LOSS OF CD36 EXPRESSION HAS LIMITED IMPACT ON NORMAL HEMATOPOIESIS
  2757. Molecular Docking Study Reveals α-Santalol from Santalum album Linn. as Promising Inhibitor of CD36 for Atherosclerosis
  2758. Genetic variants in CD36: emerging role in oral fat perception and food preferences
  2759. 1401 PLT012, a monoclonal antibody targeting CD36, unleashes anti-tumor immunity via metabolic reprogramming in tumor microenvironment
  2760. CD36 plays in hepatocytes through an
  2761. Activation of macrophage TRPM2 and CD36 promotes
  2762. Inhibition of endothelial barrier dysfunction and acute lung injury by peptides targeting CD36
  2763. Abstract P2-13-12: High CD36 expression predicts worse event free survival in HER2-positive breast cancer patients treated with neoadjuvant trastuzumab-based …
  2764. … and salvianolic acid A synergistically attenuated hypoxia/reoxygenation induced H92 cells injury under high-glucose and high-fat condition via modulating CD36
  2765. Arsenic trioxide ameliorates atherosclerosis by inhibiting CD36-induced endocytosis and TLR4/NF-κB-induced inflammation in macrophage and ApoE-/-mice
  2766. Inhibition of CD36 and Nogo-B expression inhibited the proliferation and migration of triple negative breast cancer cells
  2767. Analysis of CD36 Expression and Genetic Variation in Blood Donors in Zhongshan City, China
  2768. Subcellular Recycling of CD36 as Target to Rescue Lipid Overload‐induced Myocardial Contractile Dysfunction
  2769. Understanding the Impact of Endothelial CD36 in the Progression of Dyslipidemia‐induced Dysfunction
  2770. Abstract P1087: CD36-retinoic Acid-PPARδ Signaling Axis Modulates Cardiomyocytes’ Ability To Proliferate In Newly Born Neonatal Mice
  2771. Mitochondrial CD36 expression is increased in endothelial cells exposed to elevated glucose in vitro
  2772. Multiplexed two-color imaging and analysis reveals the influence of actin cortex dynamics on CD36 receptor organization
  2773. The Role of CD36 in Cardiovascular Disease: A Critical Review
  2774. CD36 Restricts Lipid-Associated Macrophages Accumulation in White Adipose Tissues During Atherogenesis
  2775. CD44 Might Promote the Migration and Invasion of Ovarian Cancer by Regulating CD36
  2776. Intake of High Fat Diet leads to Over‐expression of CD36, QRFP and QRFPr in the Gustatory Neural Circuit
  2777. Caveolin-1 facilitates lipid uptake into endothelium by stabilizing CD36 at the plasma membrane
  2778. Effects of Huangqin Qingre Chubi Capsule on PPAR-γ/CD36/MnSOD axis and oxidative stress immune inflammation in patients with rheumatoid arthritis.
  2779. CD36 Facilitate Macrophage Phagocytosis Through Mitochondrial ROS During Initiation of Atherosclerosis
  2780. Farnesyl Diphosphate Synthase (FDPS) Exacerbates Non-Alcoholic Steatohepatitis (NASH) Via the Activation of AHR-CD36 Axis
  2781. … Acute High Fat Feeding Promotes a Foamy and Inflammatory Macrophage Phenotype Which Involves ACSL1-Associated Signaling via the CD36/FABP4/P38/PPARδ …
  2782. Lipolysis-Derived Linoleic Acid Drives Beige Fat Progenitor Cell Proliferation via CD36
  2783. BDE-47 Promotes Non-Alcoholic Fatty Liver Disease Through CD36-Mediated Increased Fatty Acid Uptake and PPARα-Induced Abnormal Fatty Acid Oxidation
  2784. Stem Cell-Derived Exosome Nebulization Therapy (SCENT) Promotes Cardiac Repair After Myocardial Infarction by Inhibiting CD36
  2785. Molecular polymorphism Analysis on CD36 Deficiency among Platelet Blood Donors in Shenzhen
  2786. The Function of CD36 in Tumorigenesis
  2787. Linking CD36-dependent lipid processing to the alveolar macrophage transcriptional program via GATA2
  2788. CD36 Mediates Mitochondrial Reactive Oxygen Species Production Through PKM2 In Macrophages
  2789. … genes for hereditary gingival fibromatosisNew evidences of genetic heterogeneity of causing hereditary gingival fibromatosis and ALK and CD36 as new candidate …
  2790. Novel humanized CD36 mouse model for therapeutic studies
  2791. Study on the expression of CD36 gene in mammary gland tissue of Dehong dairy buffalo.
  2792. Enhanced Endothelial CD36 Signaling Promotes Vascular Stiffening
  2793. Scavenger Receptor CD36 Regulates Inflammatory and Type-I Interferon Responses in Tumor-Associated Macrophages
  2794. Regulatory roles and mechanisms of CD36 palmitoylation in animal fat deposition.
  2795. Intestinal microenvironment and expressions of CD36/mTORC1 pathways in patients with colostomy infection after radical resection of rectal cancer.
  2796. 203-LB: The Role of the Exocyst Trafficking Complex in CD36 Fatty Acid Translocase Trafficking in Skeletal Muscle Cells
  2797. Amelioration of acute lung injury by peptides targeting scavenger receptor CD36
  2798. Corrigendum to “ROS via BTK-p300-STAT1-PPARγ signaling activation mediates cholesterol crystals-induced CD36 expression and foam cell formation”[Redox Biol …
  2799. The CD36 expression screening and genotype detection in Bijie blood donors in Guizhou Province.
  2800. Abstract TP242: The Absence Of CD36 Reduced KrasG12V-induced Brain Arteriovenous Malformations In Mice.
  2801. The Role of Anti-CD36 Antibodies in Immune Mediated Thrombocytopenia
  2802. Dissecting The Role Of Macrophage CD36 In Resolution Of Inflammation
  2803. Understanding the role of scavenger receptor CD36 in modulation of dendritic cell responses
  2804. Correction: Association between miR-138-5p, miR-132-3p, SIRT1, STAT3, and CD36 and atherogenic indices in blood mononuclear cells from patients with …
  2805. ASO Visual Abstract: Hypoxia-Induced CD36 Expression in Gastric Cancer Cells Promotes Peritoneal Metastasis via Fatty Acid Uptake
  2806. Author Correction: TRPM2 deficiency in mice protects against atherosclerosis by inhibiting TRPM2–CD36 inflammatory axis in macrophages (Nature Cardiovascular …
  2807. Author Correction: TRPM2 deficiency in mice protects against atherosclerosis by inhibiting TRPM2–CD36 inflammatory axis in macrophages (Nature Cardiovascular …
  2808. Publisher Correction: RPM2 deficiency in mice protects against atherosclerosis by inhibiting TRPM2–CD36 inflammatory axis in macrophages (Nature Cardiovascular …
  2809. Discordancia entre frecuencias alélicas y genotípicas para CD36 rs3211938 entre muestras de mestizos mexicanos:¿ Sesgo de la muestra, error de genotipado o …
Related Posts

Infectobesity

Ellagitannins

HSP90

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping